data_1vb8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1vb8 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.611 ' HB3' HG21 ' A' ' 13' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.744 0.307 . . . . 0.0 110.526 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.44 57.78 2.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.066 0.46 . . . . 0.0 111.21 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -151.9 116.33 5.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.167 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.734 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -110.5 118.52 36.47 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.521 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.6 OUTLIER -87.84 53.37 2.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.359 0.6 . . . . 0.0 111.495 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.901 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 8.0 t -65.82 -44.16 92.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.29 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -120.56 -60.47 1.67 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.245 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.2 OUTLIER -93.49 134.42 26.72 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.943 179.039 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.521 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 16.7 Cg_exo -68.86 162.46 41.34 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.875 2.383 . . . . 0.0 112.397 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 58.7 m -63.67 133.5 53.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.739 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.16 -30.21 1.77 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.68 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.12 -53.86 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.519 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.611 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -89.17 -0.94 57.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.754 0.311 . . . . 0.0 111.36 -179.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.17 -43.05 99.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.076 0.465 . . . . 0.0 110.562 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 tp -80.19 -2.61 45.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.172 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.45 -5.04 43.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.94 0.4 . . . . 0.0 110.495 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.51 46.72 2.48 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.735 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.2 m -128.24 130.52 48.07 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.22 156.53 24.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.809 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 54.8 m -78.12 96.28 5.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.437 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.22 -45.66 54.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.887 0.375 . . . . 0.0 110.64 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -162.79 79.35 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.73 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.901 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER 67.39 6.7 5.05 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.747 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.734 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 3.0 p -151.95 145.42 15.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.1 m -80.72 122.05 26.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.894 0.378 . . . . 0.0 110.278 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.69 98.85 2.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.119 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -133.49 88.2 2.46 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.765 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.09 -58.32 4.94 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.583 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.9 154.38 41.9 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.461 -0.429 0 C-N-CA 122.828 2.352 . . . . 0.0 111.783 -179.857 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.233 0.226 0 CA-C-O 120.698 0.285 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.51 54.74 2.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.053 0.454 . . . . 0.0 111.419 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -150.52 135.74 17.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.086 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.646 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -133.89 127.8 33.28 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.825 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -88.06 34.61 0.73 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.996 0.427 . . . . 0.0 112.135 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.879 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 20.7 t -62.74 -40.84 90.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -115.92 -62.54 1.58 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.756 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -108.52 136.01 19.96 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.342 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.825 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 20.7 Cg_exo -66.7 167.12 20.06 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.946 2.431 . . . . 0.0 112.627 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m -60.87 124.23 19.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.401 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.47 -29.83 2.17 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.595 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.5 t -90.24 -54.63 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.608 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.44 8.7 29.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.96 0.41 . . . . 0.0 111.476 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.8 -32.21 73.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.063 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.9 mt -72.23 -11.75 60.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.054 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 tp -94.88 4.28 53.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.052 0.453 . . . . 0.0 110.455 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.64 -3.95 86.44 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.757 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.772 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 80.0 m -61.2 101.4 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.958 0.408 . . . . 0.0 110.584 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -97.81 161.71 13.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.806 -179.084 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 93.1 m -75.06 92.03 2.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.55 -37.98 68.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.026 0.441 . . . . 0.0 110.163 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -167.16 75.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.294 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.879 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER 66.62 9.56 6.72 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.506 -179.602 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.646 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.1 p -149.79 144.67 17.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.537 ' N ' HG23 ' A' ' 24' ' ' VAL . 2.5 m -85.55 115.27 23.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.031 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.491 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 1.6 m-85 -136.16 125.74 25.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.52 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.772 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 63.2 t30 -138.21 74.08 1.46 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.45 -58.97 4.41 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.462 ' H ' HG13 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -96.18 156.34 37.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 109.983 -0.376 . . . . 0.0 109.983 178.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.491 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 5.1 Cg_exo . . . . . 0 N--CA 1.461 -0.409 0 C-N-CA 122.69 2.26 . . . . 0.0 112.093 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.66 57.08 1.56 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.964 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -155.86 111.71 3.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.149 0.499 . . . . 0.0 110.121 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.691 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -110.01 122.65 48.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.41 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.534 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -87.96 50.13 1.93 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.132 0.491 . . . . 0.0 111.311 -179.128 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.972 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 2.1 t -64.96 -48.2 85.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.44 -53.16 2.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.517 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -100.46 131.42 23.9 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.269 179.473 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.534 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 16.6 Cg_exo -68.22 149.43 76.04 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.884 2.39 . . . . 0.0 112.29 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -67.48 143.95 55.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.818 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.29 -24.62 1.6 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.439 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -80.64 -56.61 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.9 0.381 . . . . 0.0 111.64 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.551 ' HA ' HD11 ' A' ' 16' ' ' LEU . 40.3 p -88.29 -5.52 58.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.24 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.9 -39.76 93.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.63 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 mt -78.44 -4.11 46.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.809 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.551 HD11 ' HA ' ' A' ' 13' ' ' THR . 67.5 mt -100.42 2.5 42.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.389 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.93 -23.54 25.4 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.951 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.604 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 82.7 m -62.24 105.68 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.913 0.387 . . . . 0.0 110.624 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -110.09 155.78 21.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.688 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 t -65.52 101.46 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.011 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.77 -39.83 15.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.14 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -165.41 76.06 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.088 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.972 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER 67.38 8.8 6.53 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.458 -179.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.691 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 4.0 p -151.88 145.95 15.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 19' ' ' SER . 50.9 m -91.59 126.82 36.8 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.971 0.415 . . . . 0.0 110.949 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -132.2 149.37 52.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.609 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.604 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 58.1 t30 -158.99 73.74 0.62 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.96 -55.69 4.79 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -110.29 160.08 29.7 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo . . . . . 0 C--O 1.233 0.263 0 C-N-CA 122.782 2.322 . . . . 0.0 112.165 -179.621 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.441 ' HB3' HG22 ' A' ' 13' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.7 57.18 2.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.953 0.406 . . . . 0.0 111.629 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.693 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.8 mt-10 -153.01 137.15 16.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.759 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.687 ' HG ' ' HB ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -131.93 126.17 33.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.833 0.349 . . . . 0.0 110.413 -179.484 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.659 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -89.03 35.12 0.79 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.023 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.418 HG22 ' HB3' ' A' ' 23' ' ' LYS . 5.1 t -64.1 -31.4 53.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.44 0.638 . . . . 0.0 109.437 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -131.55 -46.02 0.98 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.012 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.622 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -122.22 129.09 25.24 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.925 179.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.659 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 30.3 Cg_endo -64.31 150.34 88.47 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.751 2.3 . . . . 0.0 112.844 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.693 ' SG ' ' HB3' ' A' ' 3' ' ' GLU . 47.5 m -60.03 135.09 57.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.814 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.79 -33.26 2.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.062 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.2 t -75.26 -53.11 16.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 0.0 111.149 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.441 HG22 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -89.58 6.48 40.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.006 0.431 . . . . 0.0 111.13 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.33 -31.41 72.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.084 0.468 . . . . 0.0 110.489 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mt -69.2 -13.87 62.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.983 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.26 6.35 49.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.345 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.53 6.21 89.05 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.506 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.71 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 19.5 m -62.17 111.75 2.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.824 0.345 . . . . 0.0 110.679 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -111.44 148.52 32.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.219 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.88 95.55 2.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.617 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -37.19 66.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.472 0.653 . . . . 0.0 110.213 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.575 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 4.9 t-20 -147.92 63.0 1.12 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.6 ' HZ1' ' HB2' ' A' ' 23' ' ' LYS . 0.6 OUTLIER 81.75 -52.44 0.25 Allowed 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.668 -177.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.687 ' HB ' ' HG ' ' A' ' 4' ' ' SER . 2.2 p -89.64 144.27 9.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.684 0.278 . . . . 0.0 110.318 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.71 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 21.7 m -74.7 124.63 27.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.891 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.81 96.42 3.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.604 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.651 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 64.7 t30 -118.53 76.2 1.07 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.03 -54.46 4.72 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -105.93 154.99 39.08 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 N--CA 1.463 -0.316 0 C-N-CA 122.336 2.024 . . . . 0.0 112.224 -179.822 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.62 ' HB3' HG22 ' A' ' 13' ' ' THR . 1.9 m . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.935 0.398 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.19 57.94 3.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.651 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -149.34 117.31 6.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.099 0.476 . . . . 0.0 109.931 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -109.22 142.76 39.58 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -88.94 -87.23 0.17 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.082 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.609 HG22 ' HB3' ' A' ' 23' ' ' LYS . 44.5 t 71.16 -55.38 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 123.301 0.64 . . . . 0.0 111.115 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -127.65 -38.22 1.91 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.073 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.438 ' H ' HG13 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -109.04 145.3 31.45 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.122 -179.424 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 5.3 Cg_exo -77.64 157.54 32.0 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.944 2.429 . . . . 0.0 112.131 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 m -61.34 128.68 37.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.049 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.68 -32.6 3.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.895 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.8 t -86.93 -49.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.687 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.62 HG22 ' HB3' ' A' ' 1' ' ' CYS . 70.9 p -89.62 4.13 50.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.913 0.387 . . . . 0.0 111.361 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.26 -35.35 78.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.569 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.489 ' H ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -73.08 -12.29 60.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.822 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.59 -1.21 44.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.247 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.5 -1.43 88.35 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.804 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.74 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 71.4 m -61.9 108.94 1.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.995 0.426 . . . . 0.0 110.522 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -103.3 154.95 18.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.933 -179.126 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.0 t -67.87 97.96 0.7 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.587 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.29 -42.21 19.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.542 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 2.7 t-20 -156.04 63.41 0.57 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.398 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.674 ' HB2' ' HZ3' ' A' ' 23' ' ' LYS . 1.7 mtmp? 76.67 9.1 3.01 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.7 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.1 p -148.39 142.76 19.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 1' ' ' CYS . 3.4 m -85.87 123.01 30.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.942 0.401 . . . . 0.0 111.321 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.484 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -139.34 148.74 43.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.348 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.74 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 63.7 t30 -160.58 74.27 0.52 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.063 0.459 . . . . 0.0 109.816 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.34 -59.7 4.0 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.469 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -89.85 156.82 46.88 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.484 ' HA ' ' CE2' ' A' ' 26' ' ' TYR . 2.8 Cg_exo . . . . . 0 N--CA 1.46 -0.482 0 C-N-CA 122.747 2.298 . . . . 0.0 112.024 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.21 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.51 60.0 2.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.031 0.444 . . . . 0.0 111.424 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.534 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 2.3 tt0 -152.23 122.57 7.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.032 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.0 OUTLIER -116.98 132.12 56.78 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.594 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -89.18 -73.06 0.52 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.12 -179.106 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.515 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 47.8 t 70.94 -56.27 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.505 0.722 . . . . 0.0 110.657 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -125.06 -41.17 2.1 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.393 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.2 mt -116.0 120.64 35.12 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.292 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.594 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 14.9 Cg_endo -57.54 150.16 62.23 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.114 2.543 . . . . 0.0 113.341 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.534 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 17.8 m -62.48 160.21 14.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.509 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.83 -26.3 1.36 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.904 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.1 t -80.96 -60.34 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.19 2.51 54.1 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.962 0.41 . . . . 0.0 111.221 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.15 -33.43 75.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.508 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mt -71.13 -12.32 61.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.952 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.84 6.2 49.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.087 0.47 . . . . 0.0 110.136 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.27 -8.19 79.6 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.372 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.64 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 68.7 m -62.0 107.15 0.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.884 0.373 . . . . 0.0 110.647 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -112.65 161.48 16.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.943 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.6 m -73.47 78.95 1.42 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.657 0.265 . . . . 0.0 111.095 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -36.25 82.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.388 0.613 . . . . 0.0 110.442 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 8.4 t-20 -144.14 57.21 1.33 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.294 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.3 OUTLIER 79.54 -38.77 0.19 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.418 -178.458 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.0 p -101.02 148.35 7.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.64 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 18.8 m -74.98 117.02 16.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.902 0.382 . . . . 0.0 111.184 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -139.38 115.79 10.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.58 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.629 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 57.4 t30 -135.69 77.96 1.7 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.615 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.21 -60.97 4.21 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -94.92 154.9 39.64 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.461 -0.435 0 C-N-CA 122.772 2.314 . . . . 0.0 112.115 -179.666 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 16.6 m . . . . . 0 C--O 1.233 0.231 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.34 54.64 1.44 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.021 0.439 . . . . 0.0 111.567 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.491 ' HB2' HG21 ' A' ' 13' ' ' THR . 4.2 tt0 -160.69 144.84 13.84 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.502 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.615 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.1 t -147.51 144.93 28.9 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.701 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -86.7 14.83 6.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.418 -178.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.524 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 5.0 t -63.59 -39.83 86.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -105.31 -63.42 1.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.205 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.701 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -124.14 158.77 59.6 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.553 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.06 161.76 43.78 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.392 2.061 . . . . 0.0 112.758 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.1 m -64.41 113.66 3.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.051 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.55 -32.95 2.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.719 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.5 t -87.1 -46.8 16.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.477 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.577 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 81.3 p -89.69 3.69 51.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.832 0.349 . . . . 0.0 111.459 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.01 83.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.006 0.432 . . . . 0.0 110.727 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.73 -4.28 42.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.049 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tp -99.83 -1.78 36.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.08 0.467 . . . . 0.0 110.345 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.11 -0.43 81.74 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.39 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.587 ' HA ' ' HB3' ' A' ' 27' ' ' ASN . 61.3 m -64.66 104.5 0.82 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.964 0.411 . . . . 0.0 110.464 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.29 149.91 21.54 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.827 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.5 t -76.16 111.18 11.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.012 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.436 ' HB2' ' H ' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -96.64 -102.0 0.18 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.436 ' H ' ' HB2' ' A' ' 21' ' ' SER . 7.6 p-10 -88.6 61.57 6.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.124 0.488 . . . . 0.0 109.738 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.524 ' HE3' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER 65.37 32.48 9.68 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.871 -179.119 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.4 p -151.69 145.54 16.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.517 ' N ' HG23 ' A' ' 24' ' ' VAL . 3.2 m -86.22 119.74 26.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.931 0.396 . . . . 0.0 110.994 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -134.33 139.49 45.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.607 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 35.6 p-10 -134.14 22.52 3.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.628 0.728 . . . . 0.0 109.963 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.09 -29.93 8.06 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -119.72 150.86 51.21 Favored Pre-proline 0 N--CA 1.446 -0.642 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo . . . . . 0 N--CA 1.464 -0.251 0 C-N-CA 122.293 1.995 . . . . 0.0 112.356 -178.971 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.234 0.258 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.16 54.67 1.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.998 0.428 . . . . 0.0 111.42 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.454 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 2.4 tt0 -157.92 123.86 4.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.192 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -120.27 132.07 55.18 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.244 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -88.87 -70.33 0.66 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.15 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.9 t 70.66 -56.61 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.578 0.751 . . . . 0.0 110.652 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -126.31 -39.87 2.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.66 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.464 ' H ' HG13 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -114.08 122.99 33.46 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.561 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 15.3 Cg_endo -57.38 149.5 65.0 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.204 2.603 . . . . 0.0 113.542 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.454 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 34.0 m -64.09 158.55 22.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.397 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.17 -25.55 1.35 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.828 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.09 -60.32 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.406 HG21 HD11 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -89.15 1.16 56.04 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.817 0.341 . . . . 0.0 111.468 -179.099 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.87 -32.76 74.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.068 0.461 . . . . 0.0 110.552 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.84 -7.48 53.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.034 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.406 HD11 HG21 ' A' ' 13' ' ' THR . 1.9 mp -97.54 7.31 46.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.12 0.486 . . . . 0.0 110.308 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.69 -10.02 70.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.485 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.815 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 70.9 m -62.55 109.21 1.31 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.793 0.33 . . . . 0.0 110.673 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.13 154.68 29.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.015 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.4 m -71.28 84.27 0.77 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.656 0.265 . . . . 0.0 111.196 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -34.51 58.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.221 0.534 . . . . 0.0 110.329 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.548 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 3.8 t-20 -151.03 61.84 0.91 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.416 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.597 ' HZ1' ' HB2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER 79.9 -45.18 0.3 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.708 -178.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.499 HG23 ' N ' ' A' ' 25' ' ' CYS . 1.7 p -96.57 148.9 5.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.815 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 4.2 m -76.57 126.27 30.69 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.158 0.504 . . . . 0.0 111.553 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -134.46 138.45 44.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.114 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.471 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 29.2 p-10 -133.98 15.86 3.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.734 0.778 . . . . 0.0 109.777 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.36 -36.93 2.28 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.411 HG13 ' OD1' ' A' ' 27' ' ' ASN . 0.9 OUTLIER -121.42 159.66 49.25 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo . . . . . 0 N--CA 1.461 -0.393 0 C-N-CA 122.175 1.917 . . . . 0.0 112.471 -179.11 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.453 -0.304 0 CA-C-O 120.741 0.305 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.93 58.09 2.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 111.533 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.443 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 2.5 tt0 -157.68 138.85 13.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.773 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.633 ' HG ' ' HB ' ' A' ' 24' ' ' VAL . 0.6 OUTLIER -137.88 135.44 36.15 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.702 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -88.45 22.34 2.58 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.563 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.4 t -70.4 -23.19 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.427 0.632 . . . . 0.0 109.497 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.04 -51.27 1.32 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.566 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.702 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.7 OUTLIER -126.91 148.06 63.93 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.554 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.05 157.42 57.84 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.474 2.116 . . . . 0.0 112.171 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.7 m -62.74 118.94 8.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.925 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.7 -32.56 2.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.653 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.7 t -87.27 -48.14 15.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.549 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.1 p -89.4 -3.97 58.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.821 0.343 . . . . 0.0 111.397 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.08 -37.67 83.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.723 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.52 -12.21 61.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.008 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.8 mt -97.24 4.46 50.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.319 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.39 -5.07 84.26 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.036 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.795 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 85.2 m -63.73 101.86 0.4 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.995 0.426 . . . . 0.0 110.739 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -95.27 156.59 16.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.837 -179.3 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.6 t -76.23 96.98 4.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.273 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.2 -43.49 33.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.933 0.397 . . . . 0.0 111.054 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -156.97 66.56 0.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.31 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.418 ' HB2' ' HZ3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER 72.73 14.01 5.09 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.644 -179.299 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.633 ' HB ' ' HG ' ' A' ' 4' ' ' SER . 1.5 p -151.42 141.22 15.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.447 ' N ' HG22 ' A' ' 24' ' ' VAL . 1.4 m -81.99 118.07 22.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.903 0.382 . . . . 0.0 110.491 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.46 125.33 24.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.9 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.795 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 59.1 t30 -136.33 67.37 1.46 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.68 -59.68 4.42 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.421 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.7 mm -97.37 135.31 21.85 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo . . . . . 0 C--N 1.345 0.387 0 C-N-CA 122.995 2.463 . . . . 0.0 112.578 -179.429 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.634 ' HB3' HG23 ' A' ' 13' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.709 0.29 . . . . 0.0 110.366 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.83 55.95 2.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.025 0.44 . . . . 0.0 111.238 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.495 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 0.7 OUTLIER -155.91 135.15 12.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.804 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.729 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -123.72 130.28 52.4 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.627 ' H ' ' HA ' ' A' ' 24' ' ' VAL . 0.1 OUTLIER -88.12 49.99 1.9 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.236 -179.411 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.802 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -72.25 -66.07 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.755 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.542 ' HZ3' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -127.36 8.8 6.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.727 178.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.1 pt -141.21 151.74 62.53 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.359 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.535 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 13.8 Cg_endo -90.43 151.69 4.42 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.98 2.453 . . . . 0.0 111.967 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.76 128.34 35.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.452 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.58 -34.69 2.2 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.028 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.43 -56.11 7.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.929 0.395 . . . . 0.0 111.259 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.634 HG23 ' HB3' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -89.8 11.23 20.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.038 0.447 . . . . 0.0 111.262 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.77 -35.37 80.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.462 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.12 -11.59 61.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.19 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.87 2.82 55.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.377 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.01 0.65 89.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.705 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.689 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 86.7 m -62.32 103.4 0.39 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.83 0.347 . . . . 0.0 110.74 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -98.46 159.57 14.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.664 -179.255 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 5' ' ' CYS . 1.6 m -77.04 81.87 3.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.9 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -61.44 1.89 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.128 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.433 ' O ' HG12 ' A' ' 24' ' ' VAL . 3.8 t30 -130.48 67.33 1.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 0.0 110.496 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.802 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.4 OUTLIER 64.99 16.25 10.46 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.041 -179.498 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.729 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.1 p -151.04 144.9 16.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 19' ' ' SER . 3.6 m -80.51 110.76 16.28 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -135.28 118.45 16.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.195 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.689 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 62.3 t30 -131.4 70.04 1.47 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.41 -60.45 4.53 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.42 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.519 HG13 ' HD2' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -95.01 138.27 22.07 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.519 ' HD2' HG13 ' A' ' 29' ' ' ILE . 21.9 Cg_endo . . . . . 0 C--N 1.346 0.417 0 C-N-CA 122.513 2.142 . . . . 0.0 112.266 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.592 ' HB3' HG22 ' A' ' 13' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.815 0.34 . . . . 0.0 110.708 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.82 59.54 4.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.648 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.467 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 1.3 tt0 -151.22 134.34 15.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.824 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.698 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -123.28 137.0 54.96 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -86.39 -7.84 58.13 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.123 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.638 HG23 ' HG3' ' A' ' 23' ' ' LYS . 1.4 m -74.36 -12.23 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.461 0.648 . . . . 0.0 109.48 178.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -112.31 -54.98 2.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.868 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.5 OUTLIER -149.29 148.5 26.71 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.05 179.602 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 21.8 Cg_exo -64.39 144.78 86.72 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.167 1.911 . . . . 0.0 111.407 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.74 115.56 2.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.983 0.42 . . . . 0.0 110.955 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.87 -33.74 2.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.686 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.2 t -77.86 -55.86 9.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.747 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.592 HG22 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -90.03 10.44 24.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.059 0.457 . . . . 0.0 111.036 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.88 -32.54 74.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.446 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 tp -66.71 -16.03 63.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.083 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.415 HD12 HG21 ' A' ' 13' ' ' THR . 14.0 mt -98.04 3.25 49.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.553 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.67 6.6 88.96 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.828 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.646 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 55.6 m -64.95 103.46 0.73 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.683 0.278 . . . . 0.0 110.888 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 m -104.34 143.13 33.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.152 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -66.32 99.15 0.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.9 0.381 . . . . 0.0 111.214 -179.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.85 -71.46 0.68 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.741 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -90.61 60.39 4.54 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.638 ' HG3' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER 74.84 -40.86 0.45 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.871 -178.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.698 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 0.5 OUTLIER -103.17 154.69 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 3.9 m -69.54 120.56 15.51 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.891 0.377 . . . . 0.0 110.594 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -130.37 145.23 51.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.496 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.646 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 65.4 t30 -164.57 73.74 0.25 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.11 -57.33 4.97 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.339 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -106.36 148.73 37.24 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.053 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 29' ' ' ILE . 13.4 Cg_exo . . . . . 0 C--N 1.345 0.349 0 C-N-CA 122.647 2.231 . . . . 0.0 111.857 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.743 0.306 . . . . 0.0 110.632 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.93 55.5 1.44 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.094 0.473 . . . . 0.0 111.712 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.412 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 2.0 tt0 -149.35 110.48 4.38 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.887 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.677 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -110.94 117.21 32.76 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -87.93 69.51 9.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.279 0.561 . . . . 0.0 110.737 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.9 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 4.7 t -64.13 -38.76 83.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.175 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -127.79 -58.07 1.24 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.969 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 0.6 OUTLIER -97.42 143.85 26.9 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.269 179.32 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 21.0 Cg_exo -66.5 158.4 55.73 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 123.075 2.517 . . . . 0.0 112.942 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.412 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 4.4 m -68.36 151.9 46.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.026 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.45 -25.47 1.31 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.716 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.49 -58.97 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.553 ' HA ' HD13 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -88.96 -1.66 58.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.79 0.329 . . . . 0.0 111.432 -179.182 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.33 -34.06 77.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.08 0.467 . . . . 0.0 110.271 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.45 -5.1 48.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.898 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.553 HD13 ' HA ' ' A' ' 13' ' ' THR . 0.9 OUTLIER -100.51 10.07 41.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.351 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.59 -18.22 57.82 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.727 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.652 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 65.8 m -63.27 108.73 1.36 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.821 0.344 . . . . 0.0 110.374 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -104.9 156.84 17.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.697 -179.279 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.5 m -64.42 100.99 0.39 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.879 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.77 71.79 1.18 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.765 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.4 t30 72.17 75.52 0.16 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.095 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.9 ' HG2' ' HA ' ' A' ' 6' ' ' VAL . 7.4 mttp 66.28 4.6 3.25 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.677 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.2 p -150.72 135.81 10.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.501 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 4.7 m -81.65 132.65 35.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.083 0.468 . . . . 0.0 111.964 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -137.84 163.58 31.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.85 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.652 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 47.9 t30 -167.1 -104.73 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -97.68 -17.2 31.48 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.703 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.481 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -146.0 164.72 23.75 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 47.2 Cg_endo . . . . . 0 CA--C 1.529 0.274 0 C-N-CA 122.287 1.991 . . . . 0.0 111.913 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.725 0.298 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.55 51.0 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.0 111.735 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -158.59 119.06 3.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.892 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.71 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -119.87 121.37 38.9 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.861 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -88.0 56.25 3.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.312 0.577 . . . . 0.0 111.133 -179.38 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 12.5 t -65.89 -33.09 61.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.384 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -135.48 -48.25 0.7 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.919 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -110.01 132.2 21.56 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.195 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.861 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 22.9 Cg_exo -65.22 153.19 79.44 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.95 2.433 . . . . 0.0 112.622 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.0 m -67.63 147.74 52.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.312 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.81 -23.37 1.57 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.294 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 t -84.36 -57.07 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.846 0.355 . . . . 0.0 111.899 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.67 ' HA ' HD11 ' A' ' 16' ' ' LEU . 35.7 p -88.1 -3.29 58.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.709 0.29 . . . . 0.0 111.373 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 18' ' ' CYS . . . -61.65 -37.03 82.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.108 0.48 . . . . 0.0 110.523 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mt -80.39 -0.78 38.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.007 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.67 HD11 ' HA ' ' A' ' 13' ' ' THR . 39.6 mt -105.11 8.91 34.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.041 0.448 . . . . 0.0 110.584 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.23 -21.57 39.22 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.879 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.742 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 84.8 m -64.07 108.29 1.49 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.979 0.419 . . . . 0.0 110.505 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.37 149.6 32.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.666 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.9 m -65.35 109.44 2.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.329 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.86 -63.28 1.14 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.2 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.78 68.38 1.47 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.109 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 6' ' ' VAL . 19.8 mttm 68.08 15.41 9.43 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.021 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.71 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 3.0 p -152.12 149.26 13.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.742 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 3.9 m -90.95 130.01 36.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.098 0.475 . . . . 0.0 111.491 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -132.33 138.9 47.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.415 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.42 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 31.5 p-10 -133.61 18.47 3.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.932 0.872 . . . . 0.0 109.165 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.53 -32.9 3.25 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.411 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -131.67 161.42 62.42 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 114.216 -0.992 . . . . 0.0 108.436 178.135 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.411 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 40.7 Cg_endo . . . . . 0 CA--C 1.529 0.241 0 C-N-CA 122.037 1.825 . . . . 0.0 112.424 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.233 0.233 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.21 54.62 1.4 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.969 0.414 . . . . 0.0 111.384 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.533 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 4.7 tt0 -152.75 105.45 2.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.354 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.413 ' OG ' ' HB ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -102.09 138.85 38.5 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.089 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.67 -61.32 1.74 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.846 0.355 . . . . 0.0 111.021 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.979 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 48.3 t 70.09 -59.31 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.704 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -135.15 -33.56 0.9 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.614 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 mt -109.28 123.51 36.55 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.563 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.89 140.38 93.61 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.859 2.373 . . . . 0.0 112.964 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.533 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 2.7 m -64.1 153.77 36.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.091 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.8 -23.83 1.35 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.7 t -77.39 -61.71 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.899 0.38 . . . . 0.0 111.77 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.39 1.15 56.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.908 0.385 . . . . 0.0 111.259 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.03 -34.0 76.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.083 0.468 . . . . 0.0 110.371 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -8.9 57.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.831 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.36 3.91 53.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.219 0.533 . . . . 0.0 110.154 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.92 -14.78 58.59 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.455 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 62.0 m -62.82 104.55 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.915 0.388 . . . . 0.0 110.649 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -107.37 148.52 28.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.511 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.6 t -61.7 107.89 0.9 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.289 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.45 ' HB2' ' H ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER -106.0 -94.58 0.36 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.722 179.557 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.45 ' H ' ' HB2' ' A' ' 21' ' ' SER . 6.7 p-10 -86.33 58.53 5.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.983 0.42 . . . . 0.0 110.333 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.979 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER 72.48 3.62 4.74 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.648 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.413 ' HB ' ' OG ' ' A' ' 4' ' ' SER . 2.1 p -139.19 149.44 23.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 19' ' ' SER . 54.5 m -84.36 124.6 31.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.894 0.378 . . . . 0.0 111.813 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.535 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 6.3 m-85 -129.01 150.75 50.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.076 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.461 ' OD1' HG13 ' A' ' 29' ' ' ILE . 27.4 p-10 -140.56 16.08 2.36 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.63 0.728 . . . . 0.0 109.997 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.22 -41.54 1.56 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.461 HG13 ' OD1' ' A' ' 27' ' ' ASN . 0.7 OUTLIER -113.08 160.03 32.53 Favored Pre-proline 0 N--CA 1.446 -0.672 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.218 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.535 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 57.2 Cg_endo . . . . . 0 N--CA 1.46 -0.457 0 C-N-CA 121.739 1.626 . . . . 0.0 112.912 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.68 -33.69 76.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.699 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.706 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 2.4 mt-10 -75.88 138.43 41.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.101 0.477 . . . . 0.0 110.902 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.507 ' HG ' ' HB ' ' A' ' 24' ' ' VAL . 1.0 OUTLIER -133.81 126.14 29.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.722 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.603 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 1.8 m -88.79 36.82 0.81 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.532 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 12.9 t -65.71 -31.31 53.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -131.0 -49.8 1.02 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.623 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.607 HG21 ' HD2' ' A' ' 9' ' ' PRO . 1.2 mt -117.58 128.45 26.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.906 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.607 ' HD2' HG21 ' A' ' 8' ' ' ILE . 30.7 Cg_endo -63.96 151.17 86.41 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.726 2.284 . . . . 0.0 113.066 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.706 ' SG ' ' HB3' ' A' ' 3' ' ' GLU . 77.3 m -59.89 134.78 57.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.908 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.93 -38.55 2.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.737 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 13' ' ' THR . 5.5 p -88.32 -37.84 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.566 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -91.96 -5.5 52.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.015 0.436 . . . . 0.0 110.881 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.35 -31.82 73.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.091 0.472 . . . . 0.0 110.549 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -71.84 -11.24 60.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.968 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.38 8.36 44.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.081 0.467 . . . . 0.0 110.218 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.42 -3.94 83.96 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.413 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.781 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 55.6 m -63.28 110.17 1.8 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 110.811 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.5 141.53 48.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.764 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.83 96.78 1.7 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.782 0.325 . . . . 0.0 110.898 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.76 -37.16 27.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.42 0.629 . . . . 0.0 110.187 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.558 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 5.0 t-20 -146.29 64.99 1.2 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.9 OUTLIER 80.1 -53.61 0.37 Allowed 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.096 -178.124 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.507 ' HB ' ' HG ' ' A' ' 4' ' ' SER . 1.3 m -89.43 150.64 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.705 0.288 . . . . 0.0 110.364 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.781 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 1.6 m -77.35 130.88 37.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.974 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.57 114.74 10.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.395 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.578 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 35.0 p-10 -116.01 19.15 15.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.812 0.815 . . . . 0.0 109.454 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.0 -33.1 3.13 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.64 157.18 75.94 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.127 -1.036 . . . . 0.0 108.269 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo . . . . . 0 N--CA 1.461 -0.386 0 C-N-CA 122.006 1.804 . . . . 0.0 112.524 -179.098 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.467 ' HB3' HG21 ' A' ' 13' ' ' THR . 2.0 m . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 120.729 0.299 . . . . 0.0 110.462 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.64 56.42 1.83 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.513 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -147.28 120.4 8.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.992 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.727 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -122.61 123.05 40.3 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.862 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -86.77 58.31 5.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.242 0.544 . . . . 0.0 111.836 -178.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.6 t -83.04 -29.01 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.27 -47.51 0.71 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.547 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -116.44 133.78 22.94 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.974 179.784 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.862 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 61.2 Cg_endo -73.62 175.25 10.96 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.739 2.293 . . . . 0.0 112.768 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.4 m -60.32 120.1 9.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.848 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.01 -39.61 2.49 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.345 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.1 m -95.93 -42.21 12.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.467 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -90.7 3.52 54.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.015 0.436 . . . . 0.0 111.26 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.62 -35.42 80.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.309 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.3 tp -71.36 -11.44 60.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.937 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.35 2.68 56.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.021 0.438 . . . . 0.0 110.237 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.71 -6.43 83.01 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.596 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.706 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 72.0 m -64.53 98.39 0.25 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.867 0.365 . . . . 0.0 110.784 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 1.2 m -92.37 155.61 17.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.34 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.4 m -63.8 97.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.078 0.466 . . . . 0.0 111.53 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.44 62.5 3.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.707 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.0 t30 69.83 90.92 0.09 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.024 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 69.54 -10.13 0.6 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.727 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 1.7 p -149.32 138.49 15.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 121.532 -0.73 . . . . 0.0 111.25 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 19' ' ' SER . 6.8 m -80.95 125.25 29.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.66 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.464 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -138.53 150.58 46.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.886 0.374 . . . . 0.0 110.966 -179.594 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.706 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 64.0 t30 -161.77 67.88 0.28 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.184 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.87 -60.22 4.42 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.94 156.3 46.95 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.464 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 61.1 Cg_endo . . . . . 0 N--CA 1.461 -0.415 0 C-N-CA 122.413 2.075 . . . . 0.0 112.254 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 10.8 m . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.633 0.254 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.77 49.21 1.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.913 0.387 . . . . 0.0 111.815 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.567 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 5.8 tt0 -154.63 135.36 13.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.586 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.4 t -130.08 134.96 47.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.823 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.724 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -89.85 -77.48 0.39 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.525 -179.147 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 23' ' ' LYS . 55.4 t 72.02 -56.77 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.691 0.797 . . . . 0.0 110.444 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -115.62 -46.92 2.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.303 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mt -118.51 121.21 31.16 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.152 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.724 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 52.2 Cg_exo -55.01 144.81 66.73 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.019 2.479 . . . . 0.0 112.821 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.567 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 3.3 m -57.39 150.35 18.62 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.936 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.1 -20.84 4.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.734 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.8 t -81.2 -54.77 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 0.0 111.321 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.652 ' HA ' HD12 ' A' ' 16' ' ' LEU . 40.9 p -88.85 4.08 48.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.812 0.339 . . . . 0.0 111.601 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.34 86.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.156 0.503 . . . . 0.0 110.421 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.82 -6.01 52.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.75 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.652 HD12 ' HA ' ' A' ' 13' ' ' THR . 3.4 mp -96.17 -11.1 26.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.319 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.3 -16.02 27.32 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.464 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.729 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 78.1 m -62.74 119.07 8.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.78 0.324 . . . . 0.0 110.765 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.63 154.58 40.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.75 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.6 m -70.47 92.7 0.84 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.146 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.532 ' OG ' ' HB2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -91.38 -34.02 15.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.015 0.436 . . . . 0.0 110.993 -179.688 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 12.2 t-20 -148.69 63.62 1.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.696 ' HZ1' ' HB2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER 78.51 -49.41 0.46 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.113 -178.396 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.6 m -93.93 169.18 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.729 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 1.8 m -90.77 130.58 36.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.096 0.474 . . . . 0.0 111.539 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.532 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 7.9 m-85 -125.88 148.61 49.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.08 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.67 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 48.9 t30 -166.39 74.6 0.17 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.73 -53.84 4.75 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.554 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -124.52 164.38 30.91 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.424 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.554 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 45.1 Cg_endo . . . . . 0 CA--C 1.53 0.304 0 C-N-CA 122.176 1.917 . . . . 0.0 112.109 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.435 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 120.702 0.287 . . . . 0.0 110.236 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.15 -26.71 56.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.507 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.591 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 2.3 mt-10 -80.55 150.81 29.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.474 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.2 t -147.44 130.79 16.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.492 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 1.7 m -89.38 39.62 0.95 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.07 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.579 HG11 ' HD1' ' A' ' 7' ' ' TRP . 7.4 p -66.32 -28.11 42.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.737 0.78 . . . . 0.0 109.456 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.579 ' HD1' HG11 ' A' ' 6' ' ' VAL . 48.3 m95 -135.79 -44.85 0.66 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.737 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -126.72 131.09 23.75 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.86 179.618 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.54 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 33.9 Cg_exo -60.7 148.61 91.09 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.891 2.394 . . . . 0.0 113.004 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.591 ' SG ' ' HB3' ' A' ' 3' ' ' GLU . 17.4 m -62.14 143.58 56.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.91 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.17 -33.57 2.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.29 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.8 t -83.9 -46.99 18.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.85 0.357 . . . . 0.0 111.959 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.435 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 68.7 p -88.84 -7.5 56.04 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.768 0.318 . . . . 0.0 111.382 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.95 -34.66 78.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.139 0.495 . . . . 0.0 110.088 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -73.36 -11.77 60.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.612 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.9 mt -94.01 -2.79 52.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.426 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.92 -13.95 52.75 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.952 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.755 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 1.7 m -63.08 115.65 4.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.995 0.426 . . . . 0.0 110.655 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -110.02 156.42 20.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.551 -179.569 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.9 m -65.84 100.99 0.6 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.138 0.494 . . . . 0.0 111.768 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.513 ' HB2' ' HD2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -121.49 108.44 13.64 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.6 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 19.6 t-20 65.04 46.3 2.83 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.231 0.538 . . . . 0.0 109.866 -178.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.6 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER 82.7 -50.96 0.18 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.25 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 3.1 m -87.2 163.55 2.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.363 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.755 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 1.2 m -85.41 130.13 34.66 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.111 0.481 . . . . 0.0 111.199 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.513 ' HD2' ' HB2' ' A' ' 21' ' ' SER . 3.2 m-85 -128.33 150.14 50.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.852 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.676 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 58.5 t30 -173.64 71.1 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.43 -52.98 4.75 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.01 157.99 49.14 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 N--CA 1.463 -0.274 0 C-N-CA 122.668 2.245 . . . . 0.0 111.975 -179.714 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 12.8 m . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.07 51.57 1.17 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.826 0.346 . . . . 0.0 111.493 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -158.28 149.01 20.51 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -142.38 121.72 13.13 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.926 0.394 . . . . 0.0 109.943 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.509 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 1.1 p -87.15 60.03 5.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.416 0.627 . . . . 0.0 111.238 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.88 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 12.9 t -65.68 -41.14 89.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.362 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -123.4 -56.46 1.71 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.6 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.539 HG23 ' HD2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -96.47 131.68 27.92 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.84 179.12 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.539 ' HD2' HG23 ' A' ' 8' ' ' ILE . 37.9 Cg_endo -66.83 143.04 65.35 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.619 2.213 . . . . 0.0 112.249 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.405 ' HB3' ' OG1' ' A' ' 13' ' ' THR . 1.6 m -57.84 107.99 0.53 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.788 0.328 . . . . 0.0 110.337 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.19 -40.9 6.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.778 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.8 t -72.64 -32.11 39.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.235 0.54 . . . . 0.0 110.521 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.422 ' HB ' ' HB2' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -89.21 -1.8 58.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.657 -179.44 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.86 -37.22 84.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.798 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tp -69.07 -16.42 63.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.894 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 tp -91.23 -5.3 55.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.216 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.18 1.96 81.03 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.4 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 50.0 m -72.55 88.66 1.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.903 0.382 . . . . 0.0 110.493 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.03 153.47 26.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.012 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.9 m -76.52 106.87 8.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.911 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.44 ' OG ' ' HB2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -81.67 -47.77 12.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.363 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -165.84 83.82 0.32 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.184 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.88 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER 68.08 5.95 4.92 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.93 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.5 p -151.43 148.04 15.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.494 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.89 135.68 33.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.758 0.313 . . . . 0.0 111.152 -178.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.44 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 4.8 m-85 -137.7 124.41 21.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.909 0.385 . . . . 0.0 111.254 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.589 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 27.1 t-20 -137.55 81.67 1.88 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.3 -53.99 4.25 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -124.05 163.68 34.14 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo . . . . . 0 C--N 1.343 0.284 0 C-N-CA 122.415 2.077 . . . . 0.0 111.695 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.232 0.179 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.15 57.28 2.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.018 0.437 . . . . 0.0 111.184 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -150.23 155.66 40.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.318 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.646 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 40.7 t -150.18 143.78 25.24 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.95 -68.81 0.75 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.701 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 56.9 t 70.81 -56.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 123.61 0.764 . . . . 0.0 111.184 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -118.95 -43.46 2.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.115 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.54 122.17 32.19 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.543 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -51.68 141.93 42.26 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.146 2.564 . . . . 0.0 112.84 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.603 ' HB3' ' OG1' ' A' ' 13' ' ' THR . 2.3 m -47.96 111.51 0.44 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.651 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.98 -41.47 5.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.238 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.412 ' H ' HG23 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -79.44 -20.85 12.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.968 0.413 . . . . 0.0 111.123 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.603 ' OG1' ' HB3' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -88.32 7.74 30.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.094 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.19 -28.69 69.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.516 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.37 -14.93 61.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.41 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.82 -13.28 15.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.257 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.08 18.86 79.39 Favored Glycine 0 C--O 1.227 -0.315 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.72 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.827 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 75.0 m -75.81 107.3 7.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.023 0.44 . . . . 0.0 111.197 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.63 161.25 23.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.207 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.8 m -72.9 101.89 3.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.013 0.435 . . . . 0.0 110.934 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.95 111.48 16.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.512 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 64.05 49.61 2.69 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.573 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.489 ' HZ2' ' HB2' ' A' ' 23' ' ' LYS . 0.1 OUTLIER 74.89 -34.96 0.28 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.529 179.718 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.646 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 1.7 m -95.06 174.69 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.699 0.285 . . . . 0.0 111.162 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.5 m -98.87 124.49 43.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.765 0.317 . . . . 0.0 110.494 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.502 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 1.4 m-30 -133.99 144.4 48.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.072 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.827 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 57.4 t30 -160.16 73.83 0.54 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.74 -59.06 4.48 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.424 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -100.09 157.82 33.15 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.549 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.502 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 2.8 Cg_exo . . . . . 0 N--CA 1.459 -0.541 0 C-N-CA 122.803 2.335 . . . . 0.0 112.18 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.611 ' HB3' HG21 ' A' ' 13' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.744 0.307 . . . . 0.0 110.526 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.44 57.78 2.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.066 0.46 . . . . 0.0 111.21 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -151.9 116.33 5.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.167 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.734 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -110.5 118.52 36.47 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.521 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.6 OUTLIER -87.84 53.37 2.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.359 0.6 . . . . 0.0 111.495 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.901 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 8.0 t -65.82 -44.16 92.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.29 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -120.56 -60.47 1.67 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.245 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.2 OUTLIER -93.49 134.42 26.72 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.943 179.039 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.521 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 16.7 Cg_exo -68.86 162.46 41.34 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.875 2.383 . . . . 0.0 112.397 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 58.7 m -63.67 133.5 53.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.739 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.16 -30.21 1.77 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.68 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.12 -53.86 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.519 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.611 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -89.17 -0.94 57.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.754 0.311 . . . . 0.0 111.36 -179.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.17 -43.05 99.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.076 0.465 . . . . 0.0 110.562 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 tp -80.19 -2.61 45.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.172 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.45 -5.04 43.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.94 0.4 . . . . 0.0 110.495 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.51 46.72 2.48 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.735 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.2 m -128.24 130.52 48.07 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.22 156.53 24.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.809 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 54.8 m -78.12 96.28 5.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.437 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.22 -45.66 54.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.887 0.375 . . . . 0.0 110.64 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -162.79 79.35 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.73 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.901 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER 67.39 6.7 5.05 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.747 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.734 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 3.0 p -151.95 145.42 15.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.1 m -80.72 122.05 26.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.894 0.378 . . . . 0.0 110.278 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.69 98.85 2.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.119 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -133.49 88.2 2.46 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.765 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.09 -58.32 4.94 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.583 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.9 154.38 41.9 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.461 -0.429 0 C-N-CA 122.828 2.352 . . . . 0.0 111.783 -179.857 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.233 0.226 0 CA-C-O 120.698 0.285 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.51 54.74 2.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.053 0.454 . . . . 0.0 111.419 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -150.52 135.74 17.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.086 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.646 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -133.89 127.8 33.28 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.825 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -88.06 34.61 0.73 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.996 0.427 . . . . 0.0 112.135 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.879 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 20.7 t -62.74 -40.84 90.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -115.92 -62.54 1.58 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.756 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -108.52 136.01 19.96 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.342 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.825 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 20.7 Cg_exo -66.7 167.12 20.06 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.946 2.431 . . . . 0.0 112.627 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m -60.87 124.23 19.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.401 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.47 -29.83 2.17 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.595 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.5 t -90.24 -54.63 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.608 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.44 8.7 29.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.96 0.41 . . . . 0.0 111.476 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.8 -32.21 73.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.063 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.9 mt -72.23 -11.75 60.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.054 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 tp -94.88 4.28 53.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.052 0.453 . . . . 0.0 110.455 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.64 -3.95 86.44 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.757 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.772 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 80.0 m -61.2 101.4 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.958 0.408 . . . . 0.0 110.584 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -97.81 161.71 13.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.806 -179.084 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 93.1 m -75.06 92.03 2.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.55 -37.98 68.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.026 0.441 . . . . 0.0 110.163 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -167.16 75.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.294 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.879 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER 66.62 9.56 6.72 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.506 -179.602 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.646 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.1 p -149.79 144.67 17.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.537 ' N ' HG23 ' A' ' 24' ' ' VAL . 2.5 m -85.55 115.27 23.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.031 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.491 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 1.6 m-85 -136.16 125.74 25.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.52 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.772 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 63.2 t30 -138.21 74.08 1.46 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.45 -58.97 4.41 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.462 ' H ' HG13 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -96.18 156.34 37.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 109.983 -0.376 . . . . 0.0 109.983 178.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.491 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 5.1 Cg_exo . . . . . 0 N--CA 1.461 -0.409 0 C-N-CA 122.69 2.26 . . . . 0.0 112.093 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.66 57.08 1.56 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.964 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -155.86 111.71 3.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.149 0.499 . . . . 0.0 110.121 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.691 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -110.01 122.65 48.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.41 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.534 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -87.96 50.13 1.93 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.132 0.491 . . . . 0.0 111.311 -179.128 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.972 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 2.1 t -64.96 -48.2 85.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.44 -53.16 2.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.517 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -100.46 131.42 23.9 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.269 179.473 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.534 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 16.6 Cg_exo -68.22 149.43 76.04 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.884 2.39 . . . . 0.0 112.29 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -67.48 143.95 55.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.818 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.29 -24.62 1.6 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.439 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -80.64 -56.61 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.9 0.381 . . . . 0.0 111.64 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.551 ' HA ' HD11 ' A' ' 16' ' ' LEU . 40.3 p -88.29 -5.52 58.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.24 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.9 -39.76 93.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.63 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 mt -78.44 -4.11 46.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.809 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.551 HD11 ' HA ' ' A' ' 13' ' ' THR . 67.5 mt -100.42 2.5 42.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.389 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.93 -23.54 25.4 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.951 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.604 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 82.7 m -62.24 105.68 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.913 0.387 . . . . 0.0 110.624 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -110.09 155.78 21.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.688 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 t -65.52 101.46 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.011 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.77 -39.83 15.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.14 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -165.41 76.06 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.088 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.972 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER 67.38 8.8 6.53 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.458 -179.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.691 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 4.0 p -151.88 145.95 15.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 19' ' ' SER . 50.9 m -91.59 126.82 36.8 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.971 0.415 . . . . 0.0 110.949 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -132.2 149.37 52.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.609 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.604 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 58.1 t30 -158.99 73.74 0.62 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.96 -55.69 4.79 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -110.29 160.08 29.7 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo . . . . . 0 C--O 1.233 0.263 0 C-N-CA 122.782 2.322 . . . . 0.0 112.165 -179.621 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.441 ' HB3' HG22 ' A' ' 13' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.7 57.18 2.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.953 0.406 . . . . 0.0 111.629 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.693 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.8 mt-10 -153.01 137.15 16.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.759 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.687 ' HG ' ' HB ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -131.93 126.17 33.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.833 0.349 . . . . 0.0 110.413 -179.484 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.659 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -89.03 35.12 0.79 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.023 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.418 HG22 ' HB3' ' A' ' 23' ' ' LYS . 5.1 t -64.1 -31.4 53.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.44 0.638 . . . . 0.0 109.437 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -131.55 -46.02 0.98 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.012 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.622 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -122.22 129.09 25.24 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.925 179.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.659 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 30.3 Cg_endo -64.31 150.34 88.47 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.751 2.3 . . . . 0.0 112.844 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.693 ' SG ' ' HB3' ' A' ' 3' ' ' GLU . 47.5 m -60.03 135.09 57.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.814 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.79 -33.26 2.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.062 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.2 t -75.26 -53.11 16.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 0.0 111.149 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.441 HG22 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -89.58 6.48 40.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.006 0.431 . . . . 0.0 111.13 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.33 -31.41 72.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.084 0.468 . . . . 0.0 110.489 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mt -69.2 -13.87 62.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.983 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.26 6.35 49.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.345 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.53 6.21 89.05 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.506 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.71 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 19.5 m -62.17 111.75 2.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.824 0.345 . . . . 0.0 110.679 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -111.44 148.52 32.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.219 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.88 95.55 2.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.617 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -37.19 66.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.472 0.653 . . . . 0.0 110.213 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.575 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 4.9 t-20 -147.92 63.0 1.12 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.6 ' HZ1' ' HB2' ' A' ' 23' ' ' LYS . 0.6 OUTLIER 81.75 -52.44 0.25 Allowed 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.668 -177.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.687 ' HB ' ' HG ' ' A' ' 4' ' ' SER . 2.2 p -89.64 144.27 9.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.684 0.278 . . . . 0.0 110.318 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.71 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 21.7 m -74.7 124.63 27.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.891 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.81 96.42 3.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.604 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.651 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 64.7 t30 -118.53 76.2 1.07 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.03 -54.46 4.72 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -105.93 154.99 39.08 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 N--CA 1.463 -0.316 0 C-N-CA 122.336 2.024 . . . . 0.0 112.224 -179.822 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.62 ' HB3' HG22 ' A' ' 13' ' ' THR . 1.9 m . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.935 0.398 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.19 57.94 3.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.651 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -149.34 117.31 6.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.099 0.476 . . . . 0.0 109.931 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -109.22 142.76 39.58 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -88.94 -87.23 0.17 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.082 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.609 HG22 ' HB3' ' A' ' 23' ' ' LYS . 44.5 t 71.16 -55.38 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 123.301 0.64 . . . . 0.0 111.115 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -127.65 -38.22 1.91 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.073 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.438 ' H ' HG13 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -109.04 145.3 31.45 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.122 -179.424 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 5.3 Cg_exo -77.64 157.54 32.0 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.944 2.429 . . . . 0.0 112.131 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 m -61.34 128.68 37.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.049 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.68 -32.6 3.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.895 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.8 t -86.93 -49.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.687 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.62 HG22 ' HB3' ' A' ' 1' ' ' CYS . 70.9 p -89.62 4.13 50.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.913 0.387 . . . . 0.0 111.361 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.26 -35.35 78.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.569 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.489 ' H ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -73.08 -12.29 60.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.822 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.59 -1.21 44.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.247 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.5 -1.43 88.35 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.804 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.74 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 71.4 m -61.9 108.94 1.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.995 0.426 . . . . 0.0 110.522 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -103.3 154.95 18.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.933 -179.126 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.0 t -67.87 97.96 0.7 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.587 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.29 -42.21 19.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.542 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 2.7 t-20 -156.04 63.41 0.57 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.398 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.674 ' HB2' ' HZ3' ' A' ' 23' ' ' LYS . 1.7 mtmp? 76.67 9.1 3.01 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.7 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.1 p -148.39 142.76 19.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 1' ' ' CYS . 3.4 m -85.87 123.01 30.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.942 0.401 . . . . 0.0 111.321 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.484 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -139.34 148.74 43.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.348 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.74 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 63.7 t30 -160.58 74.27 0.52 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.063 0.459 . . . . 0.0 109.816 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.34 -59.7 4.0 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.469 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -89.85 156.82 46.88 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.484 ' HA ' ' CE2' ' A' ' 26' ' ' TYR . 2.8 Cg_exo . . . . . 0 N--CA 1.46 -0.482 0 C-N-CA 122.747 2.298 . . . . 0.0 112.024 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.21 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.51 60.0 2.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.031 0.444 . . . . 0.0 111.424 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.534 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 2.3 tt0 -152.23 122.57 7.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.032 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.0 OUTLIER -116.98 132.12 56.78 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.594 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -89.18 -73.06 0.52 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.12 -179.106 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.515 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 47.8 t 70.94 -56.27 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.505 0.722 . . . . 0.0 110.657 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -125.06 -41.17 2.1 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.393 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.2 mt -116.0 120.64 35.12 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.292 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.594 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 14.9 Cg_endo -57.54 150.16 62.23 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.114 2.543 . . . . 0.0 113.341 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.534 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 17.8 m -62.48 160.21 14.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.509 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.83 -26.3 1.36 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.904 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.1 t -80.96 -60.34 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.19 2.51 54.1 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.962 0.41 . . . . 0.0 111.221 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.15 -33.43 75.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.508 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mt -71.13 -12.32 61.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.952 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.84 6.2 49.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.087 0.47 . . . . 0.0 110.136 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.27 -8.19 79.6 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.372 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.64 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 68.7 m -62.0 107.15 0.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.884 0.373 . . . . 0.0 110.647 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -112.65 161.48 16.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.943 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.6 m -73.47 78.95 1.42 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.657 0.265 . . . . 0.0 111.095 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -36.25 82.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.388 0.613 . . . . 0.0 110.442 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 8.4 t-20 -144.14 57.21 1.33 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.294 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.3 OUTLIER 79.54 -38.77 0.19 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.418 -178.458 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.0 p -101.02 148.35 7.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.64 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 18.8 m -74.98 117.02 16.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.902 0.382 . . . . 0.0 111.184 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -139.38 115.79 10.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.58 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.629 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 57.4 t30 -135.69 77.96 1.7 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.615 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.21 -60.97 4.21 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -94.92 154.9 39.64 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.461 -0.435 0 C-N-CA 122.772 2.314 . . . . 0.0 112.115 -179.666 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 16.6 m . . . . . 0 C--O 1.233 0.231 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.34 54.64 1.44 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.021 0.439 . . . . 0.0 111.567 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.491 ' HB2' HG21 ' A' ' 13' ' ' THR . 4.2 tt0 -160.69 144.84 13.84 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.502 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.615 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.1 t -147.51 144.93 28.9 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.701 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -86.7 14.83 6.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.418 -178.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.524 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 5.0 t -63.59 -39.83 86.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -105.31 -63.42 1.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.205 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.701 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -124.14 158.77 59.6 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.553 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.06 161.76 43.78 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.392 2.061 . . . . 0.0 112.758 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.1 m -64.41 113.66 3.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.051 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.55 -32.95 2.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.719 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.5 t -87.1 -46.8 16.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.477 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.577 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 81.3 p -89.69 3.69 51.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.832 0.349 . . . . 0.0 111.459 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.01 83.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.006 0.432 . . . . 0.0 110.727 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.73 -4.28 42.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.049 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tp -99.83 -1.78 36.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.08 0.467 . . . . 0.0 110.345 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.11 -0.43 81.74 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.39 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.587 ' HA ' ' HB3' ' A' ' 27' ' ' ASN . 61.3 m -64.66 104.5 0.82 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.964 0.411 . . . . 0.0 110.464 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.29 149.91 21.54 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.827 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.5 t -76.16 111.18 11.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.012 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.436 ' HB2' ' H ' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -96.64 -102.0 0.18 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.436 ' H ' ' HB2' ' A' ' 21' ' ' SER . 7.6 p-10 -88.6 61.57 6.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.124 0.488 . . . . 0.0 109.738 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' HE3' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER 65.37 32.48 9.68 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.871 -179.119 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.4 p -151.69 145.54 16.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.517 ' N ' HG23 ' A' ' 24' ' ' VAL . 3.2 m -86.22 119.74 26.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.931 0.396 . . . . 0.0 110.994 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -134.33 139.49 45.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.607 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 35.6 p-10 -134.14 22.52 3.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.628 0.728 . . . . 0.0 109.963 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.09 -29.93 8.06 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -119.72 150.86 51.21 Favored Pre-proline 0 N--CA 1.446 -0.642 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo . . . . . 0 N--CA 1.464 -0.251 0 C-N-CA 122.293 1.995 . . . . 0.0 112.356 -178.971 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.234 0.258 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.16 54.67 1.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.998 0.428 . . . . 0.0 111.42 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.454 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 2.4 tt0 -157.92 123.86 4.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.192 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -120.27 132.07 55.18 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.244 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -88.87 -70.33 0.66 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.15 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 45.9 t 70.66 -56.61 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.578 0.751 . . . . 0.0 110.652 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -126.31 -39.87 2.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.66 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.464 ' H ' HG13 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -114.08 122.99 33.46 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.561 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 15.3 Cg_endo -57.38 149.5 65.0 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.204 2.603 . . . . 0.0 113.542 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.454 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 34.0 m -64.09 158.55 22.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.397 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.17 -25.55 1.35 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.828 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.09 -60.32 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.406 HG21 HD11 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -89.15 1.16 56.04 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.817 0.341 . . . . 0.0 111.468 -179.099 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.87 -32.76 74.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.068 0.461 . . . . 0.0 110.552 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.84 -7.48 53.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.034 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.406 HD11 HG21 ' A' ' 13' ' ' THR . 1.9 mp -97.54 7.31 46.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.12 0.486 . . . . 0.0 110.308 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.69 -10.02 70.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.485 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.815 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 70.9 m -62.55 109.21 1.31 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.793 0.33 . . . . 0.0 110.673 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.13 154.68 29.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.015 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.4 m -71.28 84.27 0.77 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.656 0.265 . . . . 0.0 111.196 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -34.51 58.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.221 0.534 . . . . 0.0 110.329 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.548 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 3.8 t-20 -151.03 61.84 0.91 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.416 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.597 ' HZ1' ' HB2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER 79.9 -45.18 0.3 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.708 -178.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.499 HG23 ' N ' ' A' ' 25' ' ' CYS . 1.7 p -96.57 148.9 5.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.815 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 4.2 m -76.57 126.27 30.69 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.158 0.504 . . . . 0.0 111.553 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -134.46 138.45 44.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.114 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.471 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 29.2 p-10 -133.98 15.86 3.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.734 0.778 . . . . 0.0 109.777 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.36 -36.93 2.28 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.411 HG13 ' OD1' ' A' ' 27' ' ' ASN . 0.9 OUTLIER -121.42 159.66 49.25 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo . . . . . 0 N--CA 1.461 -0.393 0 C-N-CA 122.175 1.917 . . . . 0.0 112.471 -179.11 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.453 -0.304 0 CA-C-O 120.741 0.305 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.93 58.09 2.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 111.533 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.443 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 2.5 tt0 -157.68 138.85 13.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.773 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.633 ' HG ' ' HB ' ' A' ' 24' ' ' VAL . 0.6 OUTLIER -137.88 135.44 36.15 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.702 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -88.45 22.34 2.58 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.563 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.4 t -70.4 -23.19 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.427 0.632 . . . . 0.0 109.497 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.04 -51.27 1.32 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.566 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.702 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.7 OUTLIER -126.91 148.06 63.93 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.554 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.05 157.42 57.84 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.474 2.116 . . . . 0.0 112.171 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.7 m -62.74 118.94 8.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.925 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.7 -32.56 2.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.653 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.7 t -87.27 -48.14 15.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.549 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.1 p -89.4 -3.97 58.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.821 0.343 . . . . 0.0 111.397 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.08 -37.67 83.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.723 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.52 -12.21 61.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.008 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.8 mt -97.24 4.46 50.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.319 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.39 -5.07 84.26 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.036 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.795 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 85.2 m -63.73 101.86 0.4 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.995 0.426 . . . . 0.0 110.739 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -95.27 156.59 16.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.837 -179.3 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.6 t -76.23 96.98 4.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.273 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.2 -43.49 33.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.933 0.397 . . . . 0.0 111.054 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -156.97 66.56 0.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.31 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.418 ' HB2' ' HZ3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER 72.73 14.01 5.09 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.644 -179.299 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.633 ' HB ' ' HG ' ' A' ' 4' ' ' SER . 1.5 p -151.42 141.22 15.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.447 ' N ' HG22 ' A' ' 24' ' ' VAL . 1.4 m -81.99 118.07 22.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.903 0.382 . . . . 0.0 110.491 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.46 125.33 24.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.9 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.795 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 59.1 t30 -136.33 67.37 1.46 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.68 -59.68 4.42 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.421 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.7 mm -97.37 135.31 21.85 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo . . . . . 0 C--N 1.345 0.387 0 C-N-CA 122.995 2.463 . . . . 0.0 112.578 -179.429 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.634 ' HB3' HG23 ' A' ' 13' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.709 0.29 . . . . 0.0 110.366 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.83 55.95 2.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.025 0.44 . . . . 0.0 111.238 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.495 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 0.7 OUTLIER -155.91 135.15 12.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.804 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.729 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -123.72 130.28 52.4 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.627 ' H ' ' HA ' ' A' ' 24' ' ' VAL . 0.1 OUTLIER -88.12 49.99 1.9 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.236 -179.411 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.802 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -72.25 -66.07 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.755 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.542 ' HZ3' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -127.36 8.8 6.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.727 178.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.1 pt -141.21 151.74 62.53 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.359 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.535 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 13.8 Cg_endo -90.43 151.69 4.42 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.98 2.453 . . . . 0.0 111.967 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.76 128.34 35.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.452 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.58 -34.69 2.2 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.028 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.43 -56.11 7.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.929 0.395 . . . . 0.0 111.259 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.634 HG23 ' HB3' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -89.8 11.23 20.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.038 0.447 . . . . 0.0 111.262 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.77 -35.37 80.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.462 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.12 -11.59 61.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.19 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.87 2.82 55.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.377 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.01 0.65 89.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.705 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.689 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 86.7 m -62.32 103.4 0.39 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.83 0.347 . . . . 0.0 110.74 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -98.46 159.57 14.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.664 -179.255 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 5' ' ' CYS . 1.6 m -77.04 81.87 3.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.9 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -61.44 1.89 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.128 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.433 ' O ' HG12 ' A' ' 24' ' ' VAL . 3.8 t30 -130.48 67.33 1.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 0.0 110.496 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.802 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.4 OUTLIER 64.99 16.25 10.46 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.041 -179.498 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.729 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.1 p -151.04 144.9 16.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 19' ' ' SER . 3.6 m -80.51 110.76 16.28 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -135.28 118.45 16.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.195 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.689 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 62.3 t30 -131.4 70.04 1.47 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.41 -60.45 4.53 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.42 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.519 HG13 ' HD2' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -95.01 138.27 22.07 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.519 ' HD2' HG13 ' A' ' 29' ' ' ILE . 21.9 Cg_endo . . . . . 0 C--N 1.346 0.417 0 C-N-CA 122.513 2.142 . . . . 0.0 112.266 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.592 ' HB3' HG22 ' A' ' 13' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.815 0.34 . . . . 0.0 110.708 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.82 59.54 4.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.648 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.467 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 1.3 tt0 -151.22 134.34 15.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.824 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.698 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -123.28 137.0 54.96 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -86.39 -7.84 58.13 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.123 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.638 HG23 ' HG3' ' A' ' 23' ' ' LYS . 1.4 m -74.36 -12.23 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.461 0.648 . . . . 0.0 109.48 178.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -112.31 -54.98 2.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.868 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.5 OUTLIER -149.29 148.5 26.71 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.05 179.602 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 21.8 Cg_exo -64.39 144.78 86.72 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.167 1.911 . . . . 0.0 111.407 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.74 115.56 2.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.983 0.42 . . . . 0.0 110.955 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.87 -33.74 2.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.686 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.2 t -77.86 -55.86 9.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.747 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.592 HG22 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -90.03 10.44 24.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.059 0.457 . . . . 0.0 111.036 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.88 -32.54 74.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.446 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 tp -66.71 -16.03 63.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.083 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.415 HD12 HG21 ' A' ' 13' ' ' THR . 14.0 mt -98.04 3.25 49.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.553 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.67 6.6 88.96 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.828 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.646 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 55.6 m -64.95 103.46 0.73 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.683 0.278 . . . . 0.0 110.888 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 m -104.34 143.13 33.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.152 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -66.32 99.15 0.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.9 0.381 . . . . 0.0 111.214 -179.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.85 -71.46 0.68 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.741 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -90.61 60.39 4.54 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.638 ' HG3' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER 74.84 -40.86 0.45 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.871 -178.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.698 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 0.5 OUTLIER -103.17 154.69 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 3.9 m -69.54 120.56 15.51 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.891 0.377 . . . . 0.0 110.594 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -130.37 145.23 51.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.496 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.646 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 65.4 t30 -164.57 73.74 0.25 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.11 -57.33 4.97 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.339 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -106.36 148.73 37.24 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.053 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 29' ' ' ILE . 13.4 Cg_exo . . . . . 0 C--N 1.345 0.349 0 C-N-CA 122.647 2.231 . . . . 0.0 111.857 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.743 0.306 . . . . 0.0 110.632 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.93 55.5 1.44 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.094 0.473 . . . . 0.0 111.712 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.412 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 2.0 tt0 -149.35 110.48 4.38 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.887 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.677 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -110.94 117.21 32.76 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -87.93 69.51 9.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.279 0.561 . . . . 0.0 110.737 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.9 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 4.7 t -64.13 -38.76 83.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.175 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -127.79 -58.07 1.24 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.969 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 0.6 OUTLIER -97.42 143.85 26.9 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.269 179.32 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 21.0 Cg_exo -66.5 158.4 55.73 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 123.075 2.517 . . . . 0.0 112.942 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.412 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 4.4 m -68.36 151.9 46.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.026 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.45 -25.47 1.31 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.716 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.49 -58.97 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.553 ' HA ' HD13 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -88.96 -1.66 58.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.79 0.329 . . . . 0.0 111.432 -179.182 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.33 -34.06 77.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.08 0.467 . . . . 0.0 110.271 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.45 -5.1 48.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.898 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.553 HD13 ' HA ' ' A' ' 13' ' ' THR . 0.9 OUTLIER -100.51 10.07 41.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.351 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.59 -18.22 57.82 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.727 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.652 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 65.8 m -63.27 108.73 1.36 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.821 0.344 . . . . 0.0 110.374 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -104.9 156.84 17.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.697 -179.279 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.5 m -64.42 100.99 0.39 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.879 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.77 71.79 1.18 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.765 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.4 t30 72.17 75.52 0.16 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.095 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.9 ' HG2' ' HA ' ' A' ' 6' ' ' VAL . 7.4 mttp 66.28 4.6 3.25 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.677 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.2 p -150.72 135.81 10.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.501 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 4.7 m -81.65 132.65 35.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.083 0.468 . . . . 0.0 111.964 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -137.84 163.58 31.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.85 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.652 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 47.9 t30 -167.1 -104.73 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -97.68 -17.2 31.48 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.703 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.481 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -146.0 164.72 23.75 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 47.2 Cg_endo . . . . . 0 CA--C 1.529 0.274 0 C-N-CA 122.287 1.991 . . . . 0.0 111.913 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.725 0.298 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.55 51.0 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.0 111.735 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -158.59 119.06 3.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.892 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.71 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -119.87 121.37 38.9 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.861 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -88.0 56.25 3.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.312 0.577 . . . . 0.0 111.133 -179.38 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 12.5 t -65.89 -33.09 61.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.384 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -135.48 -48.25 0.7 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.919 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -110.01 132.2 21.56 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.195 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.861 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 22.9 Cg_exo -65.22 153.19 79.44 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.95 2.433 . . . . 0.0 112.622 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.0 m -67.63 147.74 52.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.312 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.81 -23.37 1.57 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.294 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 t -84.36 -57.07 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.846 0.355 . . . . 0.0 111.899 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.67 ' HA ' HD11 ' A' ' 16' ' ' LEU . 35.7 p -88.1 -3.29 58.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.709 0.29 . . . . 0.0 111.373 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 18' ' ' CYS . . . -61.65 -37.03 82.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.108 0.48 . . . . 0.0 110.523 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mt -80.39 -0.78 38.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.007 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.67 HD11 ' HA ' ' A' ' 13' ' ' THR . 39.6 mt -105.11 8.91 34.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.041 0.448 . . . . 0.0 110.584 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.23 -21.57 39.22 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.879 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.742 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 84.8 m -64.07 108.29 1.49 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.979 0.419 . . . . 0.0 110.505 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.37 149.6 32.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.666 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.9 m -65.35 109.44 2.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.329 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.86 -63.28 1.14 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.2 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.78 68.38 1.47 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.109 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 6' ' ' VAL . 19.8 mttm 68.08 15.41 9.43 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.021 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.71 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 3.0 p -152.12 149.26 13.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.742 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 3.9 m -90.95 130.01 36.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.098 0.475 . . . . 0.0 111.491 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -132.33 138.9 47.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.415 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.42 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 31.5 p-10 -133.61 18.47 3.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.932 0.872 . . . . 0.0 109.165 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.53 -32.9 3.25 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.411 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -131.67 161.42 62.42 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 114.216 -0.992 . . . . 0.0 108.436 178.135 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.411 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 40.7 Cg_endo . . . . . 0 CA--C 1.529 0.241 0 C-N-CA 122.037 1.825 . . . . 0.0 112.424 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.233 0.233 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.21 54.62 1.4 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.969 0.414 . . . . 0.0 111.384 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.533 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 4.7 tt0 -152.75 105.45 2.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.354 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.413 ' OG ' ' HB ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -102.09 138.85 38.5 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.089 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.67 -61.32 1.74 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.846 0.355 . . . . 0.0 111.021 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.979 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 48.3 t 70.09 -59.31 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.704 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -135.15 -33.56 0.9 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.614 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 mt -109.28 123.51 36.55 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.563 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.89 140.38 93.61 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.859 2.373 . . . . 0.0 112.964 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.533 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 2.7 m -64.1 153.77 36.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.091 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.8 -23.83 1.35 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.7 t -77.39 -61.71 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.899 0.38 . . . . 0.0 111.77 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.39 1.15 56.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.908 0.385 . . . . 0.0 111.259 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.03 -34.0 76.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.083 0.468 . . . . 0.0 110.371 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -8.9 57.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.831 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.36 3.91 53.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.219 0.533 . . . . 0.0 110.154 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.92 -14.78 58.59 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.455 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 62.0 m -62.82 104.55 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.915 0.388 . . . . 0.0 110.649 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -107.37 148.52 28.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.511 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.6 t -61.7 107.89 0.9 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.289 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.45 ' HB2' ' H ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER -106.0 -94.58 0.36 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.722 179.557 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.45 ' H ' ' HB2' ' A' ' 21' ' ' SER . 6.7 p-10 -86.33 58.53 5.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.983 0.42 . . . . 0.0 110.333 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.979 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER 72.48 3.62 4.74 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.648 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.413 ' HB ' ' OG ' ' A' ' 4' ' ' SER . 2.1 p -139.19 149.44 23.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 19' ' ' SER . 54.5 m -84.36 124.6 31.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.894 0.378 . . . . 0.0 111.813 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.535 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 6.3 m-85 -129.01 150.75 50.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.076 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.461 ' OD1' HG13 ' A' ' 29' ' ' ILE . 27.4 p-10 -140.56 16.08 2.36 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.63 0.728 . . . . 0.0 109.997 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.22 -41.54 1.56 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.461 HG13 ' OD1' ' A' ' 27' ' ' ASN . 0.7 OUTLIER -113.08 160.03 32.53 Favored Pre-proline 0 N--CA 1.446 -0.672 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.218 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.535 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 57.2 Cg_endo . . . . . 0 N--CA 1.46 -0.457 0 C-N-CA 121.739 1.626 . . . . 0.0 112.912 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.68 -33.69 76.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.699 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.706 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 2.4 mt-10 -75.88 138.43 41.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.101 0.477 . . . . 0.0 110.902 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.507 ' HG ' ' HB ' ' A' ' 24' ' ' VAL . 1.0 OUTLIER -133.81 126.14 29.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.722 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.603 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 1.8 m -88.79 36.82 0.81 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.532 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 12.9 t -65.71 -31.31 53.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -131.0 -49.8 1.02 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.623 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.607 HG21 ' HD2' ' A' ' 9' ' ' PRO . 1.2 mt -117.58 128.45 26.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.906 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.607 ' HD2' HG21 ' A' ' 8' ' ' ILE . 30.7 Cg_endo -63.96 151.17 86.41 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.726 2.284 . . . . 0.0 113.066 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.706 ' SG ' ' HB3' ' A' ' 3' ' ' GLU . 77.3 m -59.89 134.78 57.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.908 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.93 -38.55 2.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.737 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 13' ' ' THR . 5.5 p -88.32 -37.84 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.566 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -91.96 -5.5 52.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.015 0.436 . . . . 0.0 110.881 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.35 -31.82 73.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.091 0.472 . . . . 0.0 110.549 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -71.84 -11.24 60.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.968 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.38 8.36 44.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.081 0.467 . . . . 0.0 110.218 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.42 -3.94 83.96 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.413 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.781 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 55.6 m -63.28 110.17 1.8 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 110.811 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.5 141.53 48.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.764 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.83 96.78 1.7 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.782 0.325 . . . . 0.0 110.898 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.76 -37.16 27.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.42 0.629 . . . . 0.0 110.187 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.558 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 5.0 t-20 -146.29 64.99 1.2 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.9 OUTLIER 80.1 -53.61 0.37 Allowed 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.096 -178.124 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.507 ' HB ' ' HG ' ' A' ' 4' ' ' SER . 1.3 m -89.43 150.64 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.705 0.288 . . . . 0.0 110.364 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.781 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 1.6 m -77.35 130.88 37.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.974 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.57 114.74 10.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.395 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.578 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 35.0 p-10 -116.01 19.15 15.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.812 0.815 . . . . 0.0 109.454 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.0 -33.1 3.13 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -128.64 157.18 75.94 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.127 -1.036 . . . . 0.0 108.269 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo . . . . . 0 N--CA 1.461 -0.386 0 C-N-CA 122.006 1.804 . . . . 0.0 112.524 -179.098 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.467 ' HB3' HG21 ' A' ' 13' ' ' THR . 2.0 m . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 120.729 0.299 . . . . 0.0 110.462 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.64 56.42 1.83 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.513 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -147.28 120.4 8.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.992 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.727 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -122.61 123.05 40.3 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.862 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -86.77 58.31 5.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.242 0.544 . . . . 0.0 111.836 -178.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.6 t -83.04 -29.01 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.27 -47.51 0.71 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.547 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -116.44 133.78 22.94 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.974 179.784 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.862 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 61.2 Cg_endo -73.62 175.25 10.96 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.739 2.293 . . . . 0.0 112.768 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.4 m -60.32 120.1 9.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.848 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.01 -39.61 2.49 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.345 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.1 m -95.93 -42.21 12.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.467 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -90.7 3.52 54.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.015 0.436 . . . . 0.0 111.26 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.62 -35.42 80.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.309 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.3 tp -71.36 -11.44 60.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.937 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.35 2.68 56.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.021 0.438 . . . . 0.0 110.237 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.71 -6.43 83.01 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.596 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.706 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 72.0 m -64.53 98.39 0.25 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.867 0.365 . . . . 0.0 110.784 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 1.2 m -92.37 155.61 17.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.34 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.4 m -63.8 97.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.078 0.466 . . . . 0.0 111.53 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.44 62.5 3.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.707 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.0 t30 69.83 90.92 0.09 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.024 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 69.54 -10.13 0.6 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.727 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 1.7 p -149.32 138.49 15.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 121.532 -0.73 . . . . 0.0 111.25 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 19' ' ' SER . 6.8 m -80.95 125.25 29.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.66 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.464 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -138.53 150.58 46.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.886 0.374 . . . . 0.0 110.966 -179.594 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.706 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 64.0 t30 -161.77 67.88 0.28 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.184 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.87 -60.22 4.42 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.94 156.3 46.95 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.464 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 61.1 Cg_endo . . . . . 0 N--CA 1.461 -0.415 0 C-N-CA 122.413 2.075 . . . . 0.0 112.254 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 10.8 m . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.633 0.254 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.77 49.21 1.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.913 0.387 . . . . 0.0 111.815 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.567 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 5.8 tt0 -154.63 135.36 13.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.586 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.4 t -130.08 134.96 47.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.823 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.724 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -89.85 -77.48 0.39 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.525 -179.147 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 23' ' ' LYS . 55.4 t 72.02 -56.77 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.691 0.797 . . . . 0.0 110.444 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -115.62 -46.92 2.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.303 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mt -118.51 121.21 31.16 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.152 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.724 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 52.2 Cg_exo -55.01 144.81 66.73 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.019 2.479 . . . . 0.0 112.821 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.567 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 3.3 m -57.39 150.35 18.62 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.936 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.1 -20.84 4.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.734 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.8 t -81.2 -54.77 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 0.0 111.321 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.652 ' HA ' HD12 ' A' ' 16' ' ' LEU . 40.9 p -88.85 4.08 48.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.812 0.339 . . . . 0.0 111.601 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.34 86.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.156 0.503 . . . . 0.0 110.421 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.82 -6.01 52.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.75 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.652 HD12 ' HA ' ' A' ' 13' ' ' THR . 3.4 mp -96.17 -11.1 26.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.319 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.3 -16.02 27.32 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.464 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.729 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 78.1 m -62.74 119.07 8.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.78 0.324 . . . . 0.0 110.765 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.63 154.58 40.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.75 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.6 m -70.47 92.7 0.84 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.146 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.532 ' OG ' ' HB2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -91.38 -34.02 15.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.015 0.436 . . . . 0.0 110.993 -179.688 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 12.2 t-20 -148.69 63.62 1.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.696 ' HZ1' ' HB2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER 78.51 -49.41 0.46 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.113 -178.396 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.6 m -93.93 169.18 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.729 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 1.8 m -90.77 130.58 36.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.096 0.474 . . . . 0.0 111.539 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.532 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 7.9 m-85 -125.88 148.61 49.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.08 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.67 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 48.9 t30 -166.39 74.6 0.17 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.73 -53.84 4.75 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.554 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -124.52 164.38 30.91 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.424 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.554 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 45.1 Cg_endo . . . . . 0 CA--C 1.53 0.304 0 C-N-CA 122.176 1.917 . . . . 0.0 112.109 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.435 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 120.702 0.287 . . . . 0.0 110.236 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.15 -26.71 56.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.507 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.591 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 2.3 mt-10 -80.55 150.81 29.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.474 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.2 t -147.44 130.79 16.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.492 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 1.7 m -89.38 39.62 0.95 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.07 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.579 HG11 ' HD1' ' A' ' 7' ' ' TRP . 7.4 p -66.32 -28.11 42.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.737 0.78 . . . . 0.0 109.456 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.579 ' HD1' HG11 ' A' ' 6' ' ' VAL . 48.3 m95 -135.79 -44.85 0.66 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.737 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -126.72 131.09 23.75 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.86 179.618 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.54 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 33.9 Cg_exo -60.7 148.61 91.09 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.891 2.394 . . . . 0.0 113.004 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.591 ' SG ' ' HB3' ' A' ' 3' ' ' GLU . 17.4 m -62.14 143.58 56.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.91 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.17 -33.57 2.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.29 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.8 t -83.9 -46.99 18.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.85 0.357 . . . . 0.0 111.959 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.435 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 68.7 p -88.84 -7.5 56.04 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.768 0.318 . . . . 0.0 111.382 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.95 -34.66 78.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.139 0.495 . . . . 0.0 110.088 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -73.36 -11.77 60.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.612 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.9 mt -94.01 -2.79 52.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.426 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.92 -13.95 52.75 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.952 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.755 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 1.7 m -63.08 115.65 4.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.995 0.426 . . . . 0.0 110.655 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -110.02 156.42 20.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.551 -179.569 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.9 m -65.84 100.99 0.6 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.138 0.494 . . . . 0.0 111.768 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.513 ' HB2' ' HD2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -121.49 108.44 13.64 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.6 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 19.6 t-20 65.04 46.3 2.83 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.231 0.538 . . . . 0.0 109.866 -178.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.6 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER 82.7 -50.96 0.18 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.25 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 3.1 m -87.2 163.55 2.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.363 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.755 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 1.2 m -85.41 130.13 34.66 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.111 0.481 . . . . 0.0 111.199 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.513 ' HD2' ' HB2' ' A' ' 21' ' ' SER . 3.2 m-85 -128.33 150.14 50.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.852 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.676 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 58.5 t30 -173.64 71.1 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.43 -52.98 4.75 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.01 157.99 49.14 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 N--CA 1.463 -0.274 0 C-N-CA 122.668 2.245 . . . . 0.0 111.975 -179.714 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 12.8 m . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.07 51.57 1.17 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.826 0.346 . . . . 0.0 111.493 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -158.28 149.01 20.51 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -142.38 121.72 13.13 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.926 0.394 . . . . 0.0 109.943 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.509 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 1.1 p -87.15 60.03 5.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.416 0.627 . . . . 0.0 111.238 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.88 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 12.9 t -65.68 -41.14 89.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.362 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -123.4 -56.46 1.71 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.6 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.539 HG23 ' HD2' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -96.47 131.68 27.92 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.84 179.12 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.539 ' HD2' HG23 ' A' ' 8' ' ' ILE . 37.9 Cg_endo -66.83 143.04 65.35 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.619 2.213 . . . . 0.0 112.249 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.405 ' HB3' ' OG1' ' A' ' 13' ' ' THR . 1.6 m -57.84 107.99 0.53 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.788 0.328 . . . . 0.0 110.337 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.19 -40.9 6.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.778 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.8 t -72.64 -32.11 39.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.235 0.54 . . . . 0.0 110.521 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.422 ' HB ' ' HB2' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -89.21 -1.8 58.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.657 -179.44 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.86 -37.22 84.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.798 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tp -69.07 -16.42 63.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.894 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 tp -91.23 -5.3 55.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.216 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.18 1.96 81.03 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.4 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 50.0 m -72.55 88.66 1.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.903 0.382 . . . . 0.0 110.493 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.03 153.47 26.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.012 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.9 m -76.52 106.87 8.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.911 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.44 ' OG ' ' HB2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -81.67 -47.77 12.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.363 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -165.84 83.82 0.32 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.184 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.88 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER 68.08 5.95 4.92 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.93 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.5 p -151.43 148.04 15.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.494 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.89 135.68 33.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.758 0.313 . . . . 0.0 111.152 -178.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.44 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 4.8 m-85 -137.7 124.41 21.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.909 0.385 . . . . 0.0 111.254 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.589 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 27.1 t-20 -137.55 81.67 1.88 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.3 -53.99 4.25 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -124.05 163.68 34.14 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo . . . . . 0 C--N 1.343 0.284 0 C-N-CA 122.415 2.077 . . . . 0.0 111.695 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.232 0.179 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.15 57.28 2.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.018 0.437 . . . . 0.0 111.184 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -150.23 155.66 40.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.318 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.646 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 40.7 t -150.18 143.78 25.24 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.95 -68.81 0.75 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.701 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 56.9 t 70.81 -56.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 123.61 0.764 . . . . 0.0 111.184 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -118.95 -43.46 2.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.115 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.54 122.17 32.19 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.543 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -51.68 141.93 42.26 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.146 2.564 . . . . 0.0 112.84 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.603 ' HB3' ' OG1' ' A' ' 13' ' ' THR . 2.3 m -47.96 111.51 0.44 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.651 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.98 -41.47 5.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.238 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.412 ' H ' HG23 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -79.44 -20.85 12.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.968 0.413 . . . . 0.0 111.123 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.603 ' OG1' ' HB3' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -88.32 7.74 30.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.094 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.19 -28.69 69.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.516 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.37 -14.93 61.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.41 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.82 -13.28 15.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.257 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.08 18.86 79.39 Favored Glycine 0 C--O 1.227 -0.315 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.72 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.827 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 75.0 m -75.81 107.3 7.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.023 0.44 . . . . 0.0 111.197 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.63 161.25 23.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.207 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.8 m -72.9 101.89 3.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.013 0.435 . . . . 0.0 110.934 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.95 111.48 16.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.512 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 64.05 49.61 2.69 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.573 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.489 ' HZ2' ' HB2' ' A' ' 23' ' ' LYS . 0.1 OUTLIER 74.89 -34.96 0.28 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.529 179.718 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.646 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 1.7 m -95.06 174.69 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.699 0.285 . . . . 0.0 111.162 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.5 m -98.87 124.49 43.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.765 0.317 . . . . 0.0 110.494 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.502 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 1.4 m-30 -133.99 144.4 48.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.072 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.827 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 57.4 t30 -160.16 73.83 0.54 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.74 -59.06 4.48 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.424 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -100.09 157.82 33.15 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.549 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.502 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 2.8 Cg_exo . . . . . 0 N--CA 1.459 -0.541 0 C-N-CA 122.803 2.335 . . . . 0.0 112.18 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.654 ' HB3' HG21 ' A' ' 13' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.744 0.307 . . . . 0.0 110.526 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.44 57.78 2.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.066 0.46 . . . . 0.0 111.21 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -151.9 116.33 5.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.167 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.776 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -110.5 118.52 36.47 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.605 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.6 OUTLIER -87.84 53.37 2.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.359 0.6 . . . . 0.0 111.495 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.909 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 8.0 t -65.82 -44.16 92.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.29 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -120.56 -60.47 1.67 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.245 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.2 OUTLIER -93.49 134.42 26.72 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.943 179.039 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.605 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 16.7 Cg_exo -68.86 162.46 41.34 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.875 2.383 . . . . 0.0 112.397 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 58.7 m -63.67 133.5 53.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.739 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.16 -30.21 1.77 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.68 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.12 -53.86 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.519 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.654 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -89.17 -0.94 57.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.754 0.311 . . . . 0.0 111.36 -179.404 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.17 -43.05 99.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.076 0.465 . . . . 0.0 110.562 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 tp -80.19 -2.61 45.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.172 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.45 -5.04 43.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.94 0.4 . . . . 0.0 110.495 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.51 46.72 2.48 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.735 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.2 m -128.24 130.52 48.07 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.22 156.53 24.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.809 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 54.8 m -78.12 96.28 5.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.437 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.22 -45.66 54.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.887 0.375 . . . . 0.0 110.64 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -162.79 79.35 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.73 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.909 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER 67.39 6.7 5.05 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.747 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.776 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 3.0 p -151.95 145.42 15.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.1 m -80.72 122.05 26.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.894 0.378 . . . . 0.0 110.278 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.69 98.85 2.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.119 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -133.49 88.2 2.46 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.765 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.09 -58.32 4.94 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.583 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.453 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -108.9 154.38 41.9 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.306 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.461 -0.429 0 C-N-CA 122.828 2.352 . . . . 0.0 111.783 -179.857 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.462 ' HB3' HG21 ' A' ' 13' ' ' THR . 1.9 m . . . . . 0 C--O 1.233 0.226 0 CA-C-O 120.698 0.285 . . . . 0.0 110.334 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.51 54.74 2.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.053 0.454 . . . . 0.0 111.419 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -150.52 135.74 17.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.086 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.694 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -133.89 127.8 33.28 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.83 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -88.06 34.61 0.73 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.996 0.427 . . . . 0.0 112.135 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.921 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 20.7 t -62.74 -40.84 90.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -115.92 -62.54 1.58 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.756 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -108.52 136.01 19.96 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.342 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.83 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 20.7 Cg_exo -66.7 167.12 20.06 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.946 2.431 . . . . 0.0 112.627 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m -60.87 124.23 19.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.401 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.47 -29.83 2.17 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.595 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.5 t -90.24 -54.63 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.608 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -89.44 8.7 29.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.96 0.41 . . . . 0.0 111.476 -179.502 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.8 -32.21 73.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.063 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.9 mt -72.23 -11.75 60.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.054 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 tp -94.88 4.28 53.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.052 0.453 . . . . 0.0 110.455 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.64 -3.95 86.44 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.757 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.795 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 80.0 m -61.2 101.4 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.958 0.408 . . . . 0.0 110.584 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -97.81 161.71 13.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.806 -179.084 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 93.1 m -75.06 92.03 2.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.55 -37.98 68.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.026 0.441 . . . . 0.0 110.163 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.421 ' O ' HG12 ' A' ' 24' ' ' VAL . 56.4 t30 -167.16 75.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.294 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.921 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER 66.62 9.56 6.72 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.506 -179.602 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.694 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.1 p -149.79 144.67 17.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 19' ' ' SER . 2.5 m -85.55 115.27 23.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.031 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.501 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 1.6 m-85 -136.16 125.74 25.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.52 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.795 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 63.2 t30 -138.21 74.08 1.46 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.45 -58.97 4.41 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.437 HG13 ' H ' ' A' ' 29' ' ' ILE . 1.0 OUTLIER -96.18 156.34 37.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 109.983 -0.376 . . . . 0.0 109.983 178.824 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.501 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 5.1 Cg_exo . . . . . 0 N--CA 1.461 -0.409 0 C-N-CA 122.69 2.26 . . . . 0.0 112.093 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.66 57.08 1.56 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.964 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -155.86 111.71 3.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.149 0.499 . . . . 0.0 110.121 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.737 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -110.01 122.65 48.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.41 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.591 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -87.96 50.13 1.93 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.132 0.491 . . . . 0.0 111.311 -179.128 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.992 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 2.1 t -64.96 -48.2 85.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.44 -53.16 2.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.517 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -100.46 131.42 23.9 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.269 179.473 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.591 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 16.6 Cg_exo -68.22 149.43 76.04 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.884 2.39 . . . . 0.0 112.29 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -67.48 143.95 55.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.818 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.29 -24.62 1.6 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.439 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -80.64 -56.61 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.9 0.381 . . . . 0.0 111.64 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.538 ' HA ' HD12 ' A' ' 16' ' ' LEU . 40.3 p -88.29 -5.52 58.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.24 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.9 -39.76 93.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.63 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 mt -78.44 -4.11 46.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.809 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.538 HD12 ' HA ' ' A' ' 13' ' ' THR . 67.5 mt -100.42 2.5 42.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.389 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.93 -23.54 25.4 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.951 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.628 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 82.7 m -62.24 105.68 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.913 0.387 . . . . 0.0 110.624 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -110.09 155.78 21.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.688 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 t -65.52 101.46 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.011 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.77 -39.83 15.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.14 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -165.41 76.06 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.088 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.992 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER 67.38 8.8 6.53 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.458 -179.385 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.737 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 4.0 p -151.88 145.95 15.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 19' ' ' SER . 50.9 m -91.59 126.82 36.8 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.971 0.415 . . . . 0.0 110.949 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -132.2 149.37 52.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.609 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.628 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 58.1 t30 -158.99 73.74 0.62 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.96 -55.69 4.79 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -110.29 160.08 29.7 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo . . . . . 0 C--O 1.233 0.263 0 C-N-CA 122.782 2.322 . . . . 0.0 112.165 -179.621 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.4 ' HB3' HG21 ' A' ' 13' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.7 57.18 2.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.953 0.406 . . . . 0.0 111.629 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.707 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.8 mt-10 -153.01 137.15 16.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.759 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.659 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -131.93 126.17 33.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.833 0.349 . . . . 0.0 110.413 -179.484 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.633 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER -89.03 35.12 0.79 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.023 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.503 HG22 ' HB3' ' A' ' 23' ' ' LYS . 5.1 t -64.1 -31.4 53.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.44 0.638 . . . . 0.0 109.437 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -131.55 -46.02 0.98 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.012 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.633 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -122.22 129.09 25.24 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.925 179.652 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.617 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 30.3 Cg_endo -64.31 150.34 88.47 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.751 2.3 . . . . 0.0 112.844 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.707 ' SG ' ' HB3' ' A' ' 3' ' ' GLU . 47.5 m -60.03 135.09 57.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.814 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.79 -33.26 2.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.062 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.2 t -75.26 -53.11 16.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 0.0 111.149 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.4 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -89.58 6.48 40.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.006 0.431 . . . . 0.0 111.13 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.33 -31.41 72.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.084 0.468 . . . . 0.0 110.489 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mt -69.2 -13.87 62.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.983 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.26 6.35 49.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.345 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.53 6.21 89.05 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.506 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.722 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 19.5 m -62.17 111.75 2.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.824 0.345 . . . . 0.0 110.679 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -111.44 148.52 32.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.219 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -73.88 95.55 2.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.617 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -37.19 66.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.472 0.653 . . . . 0.0 110.213 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.584 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 4.9 t-20 -147.92 63.0 1.12 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.6 OUTLIER 81.75 -52.44 0.25 Allowed 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.668 -177.779 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.659 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.2 p -89.64 144.27 9.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.684 0.278 . . . . 0.0 110.318 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.722 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 21.7 m -74.7 124.63 27.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.891 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.81 96.42 3.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.604 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.681 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 64.7 t30 -118.53 76.2 1.07 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.03 -54.46 4.72 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.446 ' H ' HG13 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -105.93 154.99 39.08 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 N--CA 1.463 -0.316 0 C-N-CA 122.336 2.024 . . . . 0.0 112.224 -179.822 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.555 ' HB3' HG21 ' A' ' 13' ' ' THR . 1.9 m . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.935 0.398 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.19 57.94 3.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.651 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -149.34 117.31 6.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.099 0.476 . . . . 0.0 109.931 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -109.22 142.76 39.58 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -88.94 -87.23 0.17 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.082 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.592 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 44.5 t 71.16 -55.38 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 123.301 0.64 . . . . 0.0 111.115 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -127.65 -38.22 1.91 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.073 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.523 ' H ' HG13 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -109.04 145.3 31.45 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.122 -179.424 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 5.3 Cg_exo -77.64 157.54 32.0 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.944 2.429 . . . . 0.0 112.131 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 m -61.34 128.68 37.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.049 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.68 -32.6 3.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.895 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.8 t -86.93 -49.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.687 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.555 HG21 ' HB3' ' A' ' 1' ' ' CYS . 70.9 p -89.62 4.13 50.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.913 0.387 . . . . 0.0 111.361 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.26 -35.35 78.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.569 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.541 ' H ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -73.08 -12.29 60.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.822 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.59 -1.21 44.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.247 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.5 -1.43 88.35 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.804 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.763 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 71.4 m -61.9 108.94 1.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.995 0.426 . . . . 0.0 110.522 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -103.3 154.95 18.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.933 -179.126 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.0 t -67.87 97.96 0.7 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.587 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.29 -42.21 19.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 2.7 t-20 -156.04 63.41 0.57 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.398 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.592 ' HG2' ' HA ' ' A' ' 6' ' ' VAL . 1.7 mtmp? 76.67 9.1 3.01 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.7 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.662 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.1 p -148.39 142.76 19.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 19' ' ' SER . 3.4 m -85.87 123.01 30.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.942 0.401 . . . . 0.0 111.321 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.461 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -139.34 148.74 43.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.348 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.763 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 63.7 t30 -160.58 74.27 0.52 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.063 0.459 . . . . 0.0 109.816 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.34 -59.7 4.0 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.469 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -89.85 156.82 46.88 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.461 ' HA ' ' CE2' ' A' ' 26' ' ' TYR . 2.8 Cg_exo . . . . . 0 N--CA 1.46 -0.482 0 C-N-CA 122.747 2.298 . . . . 0.0 112.024 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.21 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.51 60.0 2.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.031 0.444 . . . . 0.0 111.424 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.534 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 2.3 tt0 -152.23 122.57 7.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.032 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.0 OUTLIER -116.98 132.12 56.78 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.649 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -89.18 -73.06 0.52 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.12 -179.106 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.54 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 47.8 t 70.94 -56.27 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.505 0.722 . . . . 0.0 110.657 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -125.06 -41.17 2.1 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.393 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.2 mt -116.0 120.64 35.12 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.292 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.649 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 14.9 Cg_endo -57.54 150.16 62.23 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.114 2.543 . . . . 0.0 113.341 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.534 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 17.8 m -62.48 160.21 14.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.509 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.83 -26.3 1.36 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.904 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.1 t -80.96 -60.34 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.19 2.51 54.1 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.962 0.41 . . . . 0.0 111.221 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.15 -33.43 75.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.508 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mt -71.13 -12.32 61.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.952 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.84 6.2 49.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.087 0.47 . . . . 0.0 110.136 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.27 -8.19 79.6 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.372 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.661 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 68.7 m -62.0 107.15 0.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.884 0.373 . . . . 0.0 110.647 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -112.65 161.48 16.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.943 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.6 m -73.47 78.95 1.42 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.657 0.265 . . . . 0.0 111.095 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -36.25 82.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.388 0.613 . . . . 0.0 110.442 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 8.4 t-20 -144.14 57.21 1.33 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.294 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.54 ' HG2' ' HA ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER 79.54 -38.77 0.19 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.418 -178.458 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.0 p -101.02 148.35 7.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.66 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 18.8 m -74.98 117.02 16.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.902 0.382 . . . . 0.0 111.184 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -139.38 115.79 10.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.58 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.661 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 57.4 t30 -135.69 77.96 1.7 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.615 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.21 -60.97 4.21 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -94.92 154.9 39.64 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.461 -0.435 0 C-N-CA 122.772 2.314 . . . . 0.0 112.115 -179.666 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.472 ' HB3' HG21 ' A' ' 13' ' ' THR . 16.6 m . . . . . 0 C--O 1.233 0.231 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.34 54.64 1.44 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.021 0.439 . . . . 0.0 111.567 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -160.69 144.84 13.84 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.502 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.661 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.1 t -147.51 144.93 28.9 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.713 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -86.7 14.83 6.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.418 -178.768 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.519 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 5.0 t -63.59 -39.83 86.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -105.31 -63.42 1.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.205 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.713 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -124.14 158.77 59.6 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.553 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.06 161.76 43.78 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.392 2.061 . . . . 0.0 112.758 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.1 m -64.41 113.66 3.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.051 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.55 -32.95 2.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.719 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.5 t -87.1 -46.8 16.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.477 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.584 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 81.3 p -89.69 3.69 51.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.832 0.349 . . . . 0.0 111.459 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.01 83.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.006 0.432 . . . . 0.0 110.727 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.73 -4.28 42.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.049 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tp -99.83 -1.78 36.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.08 0.467 . . . . 0.0 110.345 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.11 -0.43 81.74 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.39 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.595 ' HA ' ' HB3' ' A' ' 27' ' ' ASN . 61.3 m -64.66 104.5 0.82 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.964 0.411 . . . . 0.0 110.464 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.29 149.91 21.54 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.827 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.5 t -76.16 111.18 11.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.012 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.504 ' HB2' ' H ' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -96.64 -102.0 0.18 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.504 ' H ' ' HB2' ' A' ' 21' ' ' SER . 7.6 p-10 -88.6 61.57 6.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.124 0.488 . . . . 0.0 109.738 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.519 ' HE3' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER 65.37 32.48 9.68 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.871 -179.119 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.661 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.4 p -151.69 145.54 16.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.2 m -86.22 119.74 26.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.931 0.396 . . . . 0.0 110.994 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -134.33 139.49 45.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.607 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.595 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 35.6 p-10 -134.14 22.52 3.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.628 0.728 . . . . 0.0 109.963 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.09 -29.93 8.06 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -119.72 150.86 51.21 Favored Pre-proline 0 N--CA 1.446 -0.642 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo . . . . . 0 N--CA 1.464 -0.251 0 C-N-CA 122.293 1.995 . . . . 0.0 112.356 -178.971 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.234 0.258 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.16 54.67 1.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.998 0.428 . . . . 0.0 111.42 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.452 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 2.4 tt0 -157.92 123.86 4.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.192 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -120.27 132.07 55.18 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.244 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.515 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -88.87 -70.33 0.66 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.15 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.42 HG22 ' HB3' ' A' ' 23' ' ' LYS . 45.9 t 70.66 -56.61 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.578 0.751 . . . . 0.0 110.652 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -126.31 -39.87 2.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.66 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.442 ' H ' HG13 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -114.08 122.99 33.46 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.561 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.515 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 15.3 Cg_endo -57.38 149.5 65.0 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.204 2.603 . . . . 0.0 113.542 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.452 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 34.0 m -64.09 158.55 22.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.397 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.17 -25.55 1.35 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.828 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.09 -60.32 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.15 1.16 56.04 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.817 0.341 . . . . 0.0 111.468 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.87 -32.76 74.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.068 0.461 . . . . 0.0 110.552 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.84 -7.48 53.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.034 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 mp -97.54 7.31 46.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.12 0.486 . . . . 0.0 110.308 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.69 -10.02 70.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.485 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.846 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 70.9 m -62.55 109.21 1.31 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.793 0.33 . . . . 0.0 110.673 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -116.13 154.68 29.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.015 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.4 m -71.28 84.27 0.77 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.656 0.265 . . . . 0.0 111.196 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -34.51 58.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.221 0.534 . . . . 0.0 110.329 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 3.8 t-20 -151.03 61.84 0.91 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.416 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER 79.9 -45.18 0.3 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.708 -178.742 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 1.7 p -96.57 148.9 5.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.846 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 4.2 m -76.57 126.27 30.69 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.158 0.504 . . . . 0.0 111.553 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -134.46 138.45 44.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.114 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.488 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 29.2 p-10 -133.98 15.86 3.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.734 0.778 . . . . 0.0 109.777 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.36 -36.93 2.28 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.418 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -121.42 159.66 49.25 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.587 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo . . . . . 0 N--CA 1.461 -0.393 0 C-N-CA 122.175 1.917 . . . . 0.0 112.471 -179.11 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.453 -0.304 0 CA-C-O 120.741 0.305 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.93 58.09 2.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 111.533 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.449 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 2.5 tt0 -157.68 138.85 13.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.773 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.652 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.6 OUTLIER -137.88 135.44 36.15 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.777 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.708 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -88.45 22.34 2.58 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.563 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.42 HG22 ' HB3' ' A' ' 23' ' ' LYS . 12.4 t -70.4 -23.19 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.427 0.632 . . . . 0.0 109.497 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.04 -51.27 1.32 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.566 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.708 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.7 OUTLIER -126.91 148.06 63.93 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.554 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.05 157.42 57.84 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.474 2.116 . . . . 0.0 112.171 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.7 m -62.74 118.94 8.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.925 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.7 -32.56 2.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.653 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.7 t -87.27 -48.14 15.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.549 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.594 ' HA ' HD12 ' A' ' 16' ' ' LEU . 69.1 p -89.4 -3.97 58.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.821 0.343 . . . . 0.0 111.397 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.08 -37.67 83.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.723 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.52 -12.21 61.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.008 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.594 HD12 ' HA ' ' A' ' 13' ' ' THR . 14.8 mt -97.24 4.46 50.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.319 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.39 -5.07 84.26 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.036 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.822 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 85.2 m -63.73 101.86 0.4 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.995 0.426 . . . . 0.0 110.739 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -95.27 156.59 16.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.837 -179.3 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.6 t -76.23 96.98 4.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.273 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.2 -43.49 33.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.933 0.397 . . . . 0.0 111.054 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -156.97 66.56 0.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.31 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER 72.73 14.01 5.09 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.644 -179.299 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.652 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 1.5 p -151.42 141.22 15.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 3' ' ' GLU . 1.4 m -81.99 118.07 22.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.903 0.382 . . . . 0.0 110.491 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.46 125.33 24.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.9 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.822 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 59.1 t30 -136.33 67.37 1.46 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.68 -59.68 4.42 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.421 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.7 mm -97.37 135.31 21.85 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo . . . . . 0 C--N 1.345 0.387 0 C-N-CA 122.995 2.463 . . . . 0.0 112.578 -179.429 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.668 ' HB3' HG21 ' A' ' 13' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.709 0.29 . . . . 0.0 110.366 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.83 55.95 2.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.025 0.44 . . . . 0.0 111.238 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.504 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 0.7 OUTLIER -155.91 135.15 12.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.804 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.773 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -123.72 130.28 52.4 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -88.12 49.99 1.9 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.236 -179.411 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.818 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -72.25 -66.07 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.755 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.565 ' HZ3' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -127.36 8.8 6.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.727 178.854 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.1 pt -141.21 151.74 62.53 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.359 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.571 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 13.8 Cg_endo -90.43 151.69 4.42 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.98 2.453 . . . . 0.0 111.967 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.76 128.34 35.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.452 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.58 -34.69 2.2 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.028 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.43 -56.11 7.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.929 0.395 . . . . 0.0 111.259 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.668 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -89.8 11.23 20.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.038 0.447 . . . . 0.0 111.262 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.77 -35.37 80.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.462 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.12 -11.59 61.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.19 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.87 2.82 55.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.377 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.01 0.65 89.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.705 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.717 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 86.7 m -62.32 103.4 0.39 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.83 0.347 . . . . 0.0 110.74 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -98.46 159.57 14.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.664 -179.255 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 5' ' ' CYS . 1.6 m -77.04 81.87 3.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.9 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -61.44 1.89 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.128 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.452 ' O ' HG12 ' A' ' 24' ' ' VAL . 3.8 t30 -130.48 67.33 1.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 0.0 110.496 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.818 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.4 OUTLIER 64.99 16.25 10.46 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.041 -179.498 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.773 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.1 p -151.04 144.9 16.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 19' ' ' SER . 3.6 m -80.51 110.76 16.28 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -135.28 118.45 16.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.195 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.717 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 62.3 t30 -131.4 70.04 1.47 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.41 -60.45 4.53 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.42 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.498 HG13 ' HD2' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -95.01 138.27 22.07 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.814 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.498 ' HD2' HG13 ' A' ' 29' ' ' ILE . 21.9 Cg_endo . . . . . 0 C--N 1.346 0.417 0 C-N-CA 122.513 2.142 . . . . 0.0 112.266 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.615 ' HB3' HG21 ' A' ' 13' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.815 0.34 . . . . 0.0 110.708 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.82 59.54 4.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.648 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.473 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 1.3 tt0 -151.22 134.34 15.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.824 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.743 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -123.28 137.0 54.96 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -86.39 -7.84 58.13 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.123 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.4 m -74.36 -12.23 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.461 0.648 . . . . 0.0 109.48 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -112.31 -54.98 2.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.868 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.5 OUTLIER -149.29 148.5 26.71 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.05 179.602 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.456 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 21.8 Cg_exo -64.39 144.78 86.72 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.167 1.911 . . . . 0.0 111.407 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.74 115.56 2.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.983 0.42 . . . . 0.0 110.955 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.87 -33.74 2.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.686 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.2 t -77.86 -55.86 9.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.747 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.615 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -90.03 10.44 24.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.059 0.457 . . . . 0.0 111.036 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.88 -32.54 74.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.446 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 tp -66.71 -16.03 63.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.083 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.04 3.25 49.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.553 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.67 6.6 88.96 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.828 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.673 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 55.6 m -64.95 103.46 0.73 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.683 0.278 . . . . 0.0 110.888 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 m -104.34 143.13 33.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.152 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -66.32 99.15 0.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.9 0.381 . . . . 0.0 111.214 -179.393 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.85 -71.46 0.68 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.741 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -90.61 60.39 4.54 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.712 ' HD2' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER 74.84 -40.86 0.45 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.871 -178.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.743 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 0.5 OUTLIER -103.17 154.69 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.723 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 3.9 m -69.54 120.56 15.51 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.891 0.377 . . . . 0.0 110.594 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -130.37 145.23 51.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.496 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.673 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 65.4 t30 -164.57 73.74 0.25 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.11 -57.33 4.97 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.339 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -106.36 148.73 37.24 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.053 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 29' ' ' ILE . 13.4 Cg_exo . . . . . 0 C--N 1.345 0.349 0 C-N-CA 122.647 2.231 . . . . 0.0 111.857 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.464 ' HB3' HG21 ' A' ' 13' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.743 0.306 . . . . 0.0 110.632 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.93 55.5 1.44 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.094 0.473 . . . . 0.0 111.712 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.421 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 2.0 tt0 -149.35 110.48 4.38 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.887 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.715 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -110.94 117.21 32.76 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.646 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.473 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.6 OUTLIER -87.93 69.51 9.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.279 0.561 . . . . 0.0 110.737 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.921 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 4.7 t -64.13 -38.76 83.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.175 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -127.79 -58.07 1.24 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.969 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.476 ' H ' HG13 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -97.42 143.85 26.9 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.269 179.32 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.473 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 21.0 Cg_exo -66.5 158.4 55.73 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 123.075 2.517 . . . . 0.0 112.942 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.421 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 4.4 m -68.36 151.9 46.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.026 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.45 -25.47 1.31 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.716 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.49 -58.97 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.464 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -88.96 -1.66 58.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.79 0.329 . . . . 0.0 111.432 -179.182 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.33 -34.06 77.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.08 0.467 . . . . 0.0 110.271 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.45 -5.1 48.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.898 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.51 10.07 41.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.351 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.59 -18.22 57.82 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.727 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.675 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 65.8 m -63.27 108.73 1.36 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.821 0.344 . . . . 0.0 110.374 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -104.9 156.84 17.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.697 -179.279 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.5 m -64.42 100.99 0.39 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.879 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.77 71.79 1.18 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.765 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.4 t30 72.17 75.52 0.16 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.095 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.921 ' HG2' ' HA ' ' A' ' 6' ' ' VAL . 7.4 mttp 66.28 4.6 3.25 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.2 p -150.72 135.81 10.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 4.7 m -81.65 132.65 35.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.083 0.468 . . . . 0.0 111.964 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -137.84 163.58 31.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.85 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.675 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 47.9 t30 -167.1 -104.73 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -97.68 -17.2 31.48 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.703 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.475 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -146.0 164.72 23.75 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 47.2 Cg_endo . . . . . 0 CA--C 1.529 0.274 0 C-N-CA 122.287 1.991 . . . . 0.0 111.913 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.725 0.298 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.55 51.0 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.0 111.735 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -158.59 119.06 3.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.892 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.761 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -119.87 121.37 38.9 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.901 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -88.0 56.25 3.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.312 0.577 . . . . 0.0 111.133 -179.38 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.428 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 12.5 t -65.89 -33.09 61.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.384 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -135.48 -48.25 0.7 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.919 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -110.01 132.2 21.56 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.195 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.901 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 22.9 Cg_exo -65.22 153.19 79.44 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.95 2.433 . . . . 0.0 112.622 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.0 m -67.63 147.74 52.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.312 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.81 -23.37 1.57 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.294 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 t -84.36 -57.07 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.846 0.355 . . . . 0.0 111.899 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.678 ' HA ' HD12 ' A' ' 16' ' ' LEU . 35.7 p -88.1 -3.29 58.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.709 0.29 . . . . 0.0 111.373 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 18' ' ' CYS . . . -61.65 -37.03 82.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.108 0.48 . . . . 0.0 110.523 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mt -80.39 -0.78 38.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.007 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.678 HD12 ' HA ' ' A' ' 13' ' ' THR . 39.6 mt -105.11 8.91 34.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.041 0.448 . . . . 0.0 110.584 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.23 -21.57 39.22 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.879 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.774 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 84.8 m -64.07 108.29 1.49 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.979 0.419 . . . . 0.0 110.505 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.37 149.6 32.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.666 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.9 m -65.35 109.44 2.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.329 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.86 -63.28 1.14 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.2 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.78 68.38 1.47 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.109 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' ' 6' ' ' VAL . 19.8 mttm 68.08 15.41 9.43 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.021 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.761 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 3.0 p -152.12 149.26 13.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.774 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 3.9 m -90.95 130.01 36.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.098 0.475 . . . . 0.0 111.491 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -132.33 138.9 47.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.415 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.431 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 31.5 p-10 -133.61 18.47 3.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.932 0.872 . . . . 0.0 109.165 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.53 -32.9 3.25 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -131.67 161.42 62.42 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 114.216 -0.992 . . . . 0.0 108.436 178.135 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 40.7 Cg_endo . . . . . 0 CA--C 1.529 0.241 0 C-N-CA 122.037 1.825 . . . . 0.0 112.424 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.233 0.233 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.21 54.62 1.4 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.969 0.414 . . . . 0.0 111.384 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.547 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 4.7 tt0 -152.75 105.45 2.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.354 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -102.09 138.85 38.5 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.089 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.67 -61.32 1.74 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.846 0.355 . . . . 0.0 111.021 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.992 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 48.3 t 70.09 -59.31 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.704 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -135.15 -33.56 0.9 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.614 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 mt -109.28 123.51 36.55 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.563 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.89 140.38 93.61 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.859 2.373 . . . . 0.0 112.964 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.547 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 2.7 m -64.1 153.77 36.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.091 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.8 -23.83 1.35 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.7 t -77.39 -61.71 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.899 0.38 . . . . 0.0 111.77 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.39 1.15 56.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.908 0.385 . . . . 0.0 111.259 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.03 -34.0 76.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.083 0.468 . . . . 0.0 110.371 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -8.9 57.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.831 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.36 3.91 53.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.219 0.533 . . . . 0.0 110.154 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.92 -14.78 58.59 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.455 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 62.0 m -62.82 104.55 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.915 0.388 . . . . 0.0 110.649 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -107.37 148.52 28.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.511 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.6 t -61.7 107.89 0.9 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.289 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.42 ' HB2' ' H ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER -106.0 -94.58 0.36 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.722 179.557 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.42 ' H ' ' HB2' ' A' ' 21' ' ' SER . 6.7 p-10 -86.33 58.53 5.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.983 0.42 . . . . 0.0 110.333 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.992 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER 72.48 3.62 4.74 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.648 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.1 p -139.19 149.44 23.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 19' ' ' SER . 54.5 m -84.36 124.6 31.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.894 0.378 . . . . 0.0 111.813 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.54 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 6.3 m-85 -129.01 150.75 50.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.076 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.467 ' OD1' HG13 ' A' ' 29' ' ' ILE . 27.4 p-10 -140.56 16.08 2.36 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.63 0.728 . . . . 0.0 109.997 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.22 -41.54 1.56 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.484 HG13 ' H ' ' A' ' 29' ' ' ILE . 0.7 OUTLIER -113.08 160.03 32.53 Favored Pre-proline 0 N--CA 1.446 -0.672 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.218 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.54 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 57.2 Cg_endo . . . . . 0 N--CA 1.46 -0.457 0 C-N-CA 121.739 1.626 . . . . 0.0 112.912 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.68 -33.69 76.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.699 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.72 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 2.4 mt-10 -75.88 138.43 41.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.101 0.477 . . . . 0.0 110.902 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.81 126.14 29.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.722 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 1.8 m -88.79 36.82 0.81 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.556 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 12.9 t -65.71 -31.31 53.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -131.0 -49.8 1.02 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.623 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.61 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.2 mt -117.58 128.45 26.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.906 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 30.7 Cg_endo -63.96 151.17 86.41 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.726 2.284 . . . . 0.0 113.066 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.72 ' SG ' ' HB3' ' A' ' 3' ' ' GLU . 77.3 m -59.89 134.78 57.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.908 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.93 -38.55 2.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.737 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.5 p -88.32 -37.84 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 0.2 OUTLIER -91.96 -5.5 52.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.015 0.436 . . . . 0.0 110.881 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.35 -31.82 73.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.091 0.472 . . . . 0.0 110.549 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 15' ' ' LEU . 1.2 mm? -71.84 -11.24 60.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.968 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.38 8.36 44.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.081 0.467 . . . . 0.0 110.218 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.42 -3.94 83.96 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.413 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.784 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 55.6 m -63.28 110.17 1.8 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 110.811 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.5 141.53 48.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.764 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.83 96.78 1.7 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.782 0.325 . . . . 0.0 110.898 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.76 -37.16 27.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.42 0.629 . . . . 0.0 110.187 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.563 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 5.0 t-20 -146.29 64.99 1.2 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.9 OUTLIER 80.1 -53.61 0.37 Allowed 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.096 -178.124 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.3 m -89.43 150.64 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.705 0.288 . . . . 0.0 110.364 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.784 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 1.6 m -77.35 130.88 37.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.974 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.57 114.74 10.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.395 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.584 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 35.0 p-10 -116.01 19.15 15.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.812 0.815 . . . . 0.0 109.454 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.0 -33.1 3.13 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -128.64 157.18 75.94 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.127 -1.036 . . . . 0.0 108.269 177.856 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo . . . . . 0 N--CA 1.461 -0.386 0 C-N-CA 122.006 1.804 . . . . 0.0 112.524 -179.098 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.515 ' HB3' HG21 ' A' ' 13' ' ' THR . 2.0 m . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 120.729 0.299 . . . . 0.0 110.462 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.64 56.42 1.83 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.513 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -147.28 120.4 8.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.992 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.754 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -122.61 123.05 40.3 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.836 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -86.77 58.31 5.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.242 0.544 . . . . 0.0 111.836 -178.916 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.483 HG22 ' HG2' ' A' ' 23' ' ' LYS . 1.6 t -83.04 -29.01 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.27 -47.51 0.71 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.547 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -116.44 133.78 22.94 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.974 179.784 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.836 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 61.2 Cg_endo -73.62 175.25 10.96 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.739 2.293 . . . . 0.0 112.768 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.4 m -60.32 120.1 9.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.848 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.01 -39.61 2.49 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.345 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.1 m -95.93 -42.21 12.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.515 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -90.7 3.52 54.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.015 0.436 . . . . 0.0 111.26 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.62 -35.42 80.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.309 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.3 tp -71.36 -11.44 60.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.937 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.35 2.68 56.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.021 0.438 . . . . 0.0 110.237 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.71 -6.43 83.01 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.596 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.724 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 72.0 m -64.53 98.39 0.25 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.867 0.365 . . . . 0.0 110.784 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 1.2 m -92.37 155.61 17.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.34 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.4 m -63.8 97.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.078 0.466 . . . . 0.0 111.53 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.44 62.5 3.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.707 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.0 t30 69.83 90.92 0.09 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.024 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.483 ' HG2' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER 69.54 -10.13 0.6 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 178.308 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.754 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 1.7 p -149.32 138.49 15.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 121.532 -0.73 . . . . 0.0 111.25 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 19' ' ' SER . 6.8 m -80.95 125.25 29.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.66 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.452 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -138.53 150.58 46.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.886 0.374 . . . . 0.0 110.966 -179.594 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.724 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 64.0 t30 -161.77 67.88 0.28 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.184 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.87 -60.22 4.42 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.94 156.3 46.95 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 61.1 Cg_endo . . . . . 0 N--CA 1.461 -0.415 0 C-N-CA 122.413 2.075 . . . . 0.0 112.254 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 10.8 m . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.633 0.254 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.77 49.21 1.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.913 0.387 . . . . 0.0 111.815 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.576 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 5.8 tt0 -154.63 135.36 13.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.586 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.4 t -130.08 134.96 47.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.823 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.778 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -89.85 -77.48 0.39 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.525 -179.147 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.4 t 72.02 -56.77 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.691 0.797 . . . . 0.0 110.444 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -115.62 -46.92 2.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.303 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mt -118.51 121.21 31.16 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.152 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.778 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 52.2 Cg_exo -55.01 144.81 66.73 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.019 2.479 . . . . 0.0 112.821 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.576 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 3.3 m -57.39 150.35 18.62 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.936 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.1 -20.84 4.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.734 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.8 t -81.2 -54.77 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 0.0 111.321 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.594 ' HA ' HD13 ' A' ' 16' ' ' LEU . 40.9 p -88.85 4.08 48.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.812 0.339 . . . . 0.0 111.601 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.34 86.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.156 0.503 . . . . 0.0 110.421 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.82 -6.01 52.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.75 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.594 HD13 ' HA ' ' A' ' 13' ' ' THR . 3.4 mp -96.17 -11.1 26.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.319 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.3 -16.02 27.32 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.464 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.759 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 78.1 m -62.74 119.07 8.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.78 0.324 . . . . 0.0 110.765 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.63 154.58 40.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.75 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.6 m -70.47 92.7 0.84 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.146 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -91.38 -34.02 15.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.015 0.436 . . . . 0.0 110.993 -179.688 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 12.2 t-20 -148.69 63.62 1.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER 78.51 -49.41 0.46 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.113 -178.396 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.6 m -93.93 169.18 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.759 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 1.8 m -90.77 130.58 36.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.096 0.474 . . . . 0.0 111.539 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.543 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 7.9 m-85 -125.88 148.61 49.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.08 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.69 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 48.9 t30 -166.39 74.6 0.17 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.73 -53.84 4.75 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.548 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -124.52 164.38 30.91 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.424 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.548 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 45.1 Cg_endo . . . . . 0 CA--C 1.53 0.304 0 C-N-CA 122.176 1.917 . . . . 0.0 112.109 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.431 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 120.702 0.287 . . . . 0.0 110.236 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.15 -26.71 56.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.507 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.606 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 2.3 mt-10 -80.55 150.81 29.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.474 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.2 t -147.44 130.79 16.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.492 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 1.7 m -89.38 39.62 0.95 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.07 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.568 HG13 ' HD1' ' A' ' 7' ' ' TRP . 7.4 p -66.32 -28.11 42.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.737 0.78 . . . . 0.0 109.456 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.568 ' HD1' HG13 ' A' ' 6' ' ' VAL . 48.3 m95 -135.79 -44.85 0.66 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.737 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -126.72 131.09 23.75 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.86 179.618 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.495 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 33.9 Cg_exo -60.7 148.61 91.09 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.891 2.394 . . . . 0.0 113.004 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 3' ' ' GLU . 17.4 m -62.14 143.58 56.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.91 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.17 -33.57 2.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.29 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.8 t -83.9 -46.99 18.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.85 0.357 . . . . 0.0 111.959 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.738 ' HA ' HD12 ' A' ' 16' ' ' LEU . 68.7 p -88.84 -7.5 56.04 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.768 0.318 . . . . 0.0 111.382 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.95 -34.66 78.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.139 0.495 . . . . 0.0 110.088 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.48 ' H ' ' HG ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -73.36 -11.77 60.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.612 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.738 HD12 ' HA ' ' A' ' 13' ' ' THR . 12.9 mt -94.01 -2.79 52.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.426 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.92 -13.95 52.75 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.952 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.752 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 1.7 m -63.08 115.65 4.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.995 0.426 . . . . 0.0 110.655 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -110.02 156.42 20.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.551 -179.569 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.9 m -65.84 100.99 0.6 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.138 0.494 . . . . 0.0 111.768 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.517 ' HB2' ' HD2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -121.49 108.44 13.64 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.828 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.607 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 19.6 t-20 65.04 46.3 2.83 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.231 0.538 . . . . 0.0 109.866 -178.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER 82.7 -50.96 0.18 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.25 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 3.1 m -87.2 163.55 2.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.363 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.752 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 1.2 m -85.41 130.13 34.66 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.111 0.481 . . . . 0.0 111.199 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.517 ' HD2' ' HB2' ' A' ' 21' ' ' SER . 3.2 m-85 -128.33 150.14 50.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.852 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.696 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 58.5 t30 -173.64 71.1 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.43 -52.98 4.75 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.455 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -119.01 157.99 49.14 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.402 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 N--CA 1.463 -0.274 0 C-N-CA 122.668 2.245 . . . . 0.0 111.975 -179.714 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 12.8 m . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.07 51.57 1.17 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.826 0.346 . . . . 0.0 111.493 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -158.28 149.01 20.51 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -142.38 121.72 13.13 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.926 0.394 . . . . 0.0 109.943 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.603 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 1.1 p -87.15 60.03 5.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.416 0.627 . . . . 0.0 111.238 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.889 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 12.9 t -65.68 -41.14 89.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.362 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -123.4 -56.46 1.71 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.6 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -96.47 131.68 27.92 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.84 179.12 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.603 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 37.9 Cg_endo -66.83 143.04 65.35 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.619 2.213 . . . . 0.0 112.249 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.421 ' HB3' ' OG1' ' A' ' 13' ' ' THR . 1.6 m -57.84 107.99 0.53 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.788 0.328 . . . . 0.0 110.337 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.19 -40.9 6.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.778 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.8 t -72.64 -32.11 39.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.235 0.54 . . . . 0.0 110.521 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -89.21 -1.8 58.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.657 -179.44 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.86 -37.22 84.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.798 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tp -69.07 -16.42 63.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.894 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 tp -91.23 -5.3 55.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.216 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.18 1.96 81.03 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.4 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.612 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 50.0 m -72.55 88.66 1.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.903 0.382 . . . . 0.0 110.493 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.03 153.47 26.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.012 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.9 m -76.52 106.87 8.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.911 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -81.67 -47.77 12.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.363 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -165.84 83.82 0.32 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.184 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.889 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER 68.08 5.95 4.92 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.93 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.5 p -151.43 148.04 15.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.527 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.89 135.68 33.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.758 0.313 . . . . 0.0 111.152 -178.973 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.443 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 4.8 m-85 -137.7 124.41 21.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.909 0.385 . . . . 0.0 111.254 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.612 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 27.1 t-20 -137.55 81.67 1.88 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.3 -53.99 4.25 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.412 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -124.05 163.68 34.14 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.772 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo . . . . . 0 C--N 1.343 0.284 0 C-N-CA 122.415 2.077 . . . . 0.0 111.695 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.232 0.179 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.15 57.28 2.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.018 0.437 . . . . 0.0 111.184 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -150.23 155.66 40.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.318 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.678 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 40.7 t -150.18 143.78 25.24 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.95 -68.81 0.75 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.701 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.401 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 56.9 t 70.81 -56.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 123.61 0.764 . . . . 0.0 111.184 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -118.95 -43.46 2.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.115 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.54 122.17 32.19 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.543 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -51.68 141.93 42.26 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.146 2.564 . . . . 0.0 112.84 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.618 ' HB3' ' OG1' ' A' ' 13' ' ' THR . 2.3 m -47.96 111.51 0.44 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.651 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.98 -41.47 5.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.238 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.44 -20.85 12.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.968 0.413 . . . . 0.0 111.123 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.618 ' OG1' ' HB3' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -88.32 7.74 30.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.094 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.19 -28.69 69.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.516 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.37 -14.93 61.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.41 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.82 -13.28 15.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.257 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.08 18.86 79.39 Favored Glycine 0 C--O 1.227 -0.315 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.72 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.852 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 75.0 m -75.81 107.3 7.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.023 0.44 . . . . 0.0 111.197 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.63 161.25 23.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.207 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.8 m -72.9 101.89 3.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.013 0.435 . . . . 0.0 110.934 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.95 111.48 16.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.512 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 64.05 49.61 2.69 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.573 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.401 ' HG2' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER 74.89 -34.96 0.28 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.529 179.718 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.678 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 1.7 m -95.06 174.69 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.699 0.285 . . . . 0.0 111.162 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.5 m -98.87 124.49 43.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.765 0.317 . . . . 0.0 110.494 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.494 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 1.4 m-30 -133.99 144.4 48.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.072 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.852 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 57.4 t30 -160.16 73.83 0.54 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.74 -59.06 4.48 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.43 HG13 ' H ' ' A' ' 29' ' ' ILE . 0.9 OUTLIER -100.09 157.82 33.15 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.549 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.494 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 2.8 Cg_exo . . . . . 0 N--CA 1.459 -0.541 0 C-N-CA 122.803 2.335 . . . . 0.0 112.18 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.654 ' HB3' HG21 ' A' ' 13' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.744 0.307 . . . . 0.0 110.526 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.44 57.78 2.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.066 0.46 . . . . 0.0 111.21 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -151.9 116.33 5.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.167 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.776 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -110.5 118.52 36.47 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.605 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.6 OUTLIER -87.84 53.37 2.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.359 0.6 . . . . 0.0 111.495 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.909 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 8.0 t -65.82 -44.16 92.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.29 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -120.56 -60.47 1.67 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.245 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.2 OUTLIER -93.49 134.42 26.72 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.943 179.039 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.605 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 16.7 Cg_exo -68.86 162.46 41.34 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.875 2.383 . . . . 0.0 112.397 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 58.7 m -63.67 133.5 53.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.739 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.16 -30.21 1.77 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.68 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.12 -53.86 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.519 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.654 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -89.17 -0.94 57.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.754 0.311 . . . . 0.0 111.36 -179.404 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.17 -43.05 99.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.076 0.465 . . . . 0.0 110.562 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 tp -80.19 -2.61 45.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.172 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.45 -5.04 43.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.94 0.4 . . . . 0.0 110.495 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.51 46.72 2.48 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.735 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.2 m -128.24 130.52 48.07 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.22 156.53 24.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.809 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 54.8 m -78.12 96.28 5.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.437 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.22 -45.66 54.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.887 0.375 . . . . 0.0 110.64 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -162.79 79.35 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.73 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.909 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER 67.39 6.7 5.05 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.747 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.776 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 3.0 p -151.95 145.42 15.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.1 m -80.72 122.05 26.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.894 0.378 . . . . 0.0 110.278 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.69 98.85 2.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.119 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -133.49 88.2 2.46 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.765 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.09 -58.32 4.94 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.583 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.453 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -108.9 154.38 41.9 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.306 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.461 -0.429 0 C-N-CA 122.828 2.352 . . . . 0.0 111.783 -179.857 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.462 ' HB3' HG21 ' A' ' 13' ' ' THR . 1.9 m . . . . . 0 C--O 1.233 0.226 0 CA-C-O 120.698 0.285 . . . . 0.0 110.334 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.51 54.74 2.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.053 0.454 . . . . 0.0 111.419 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -150.52 135.74 17.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.086 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.694 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -133.89 127.8 33.28 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.83 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -88.06 34.61 0.73 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.996 0.427 . . . . 0.0 112.135 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.921 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 20.7 t -62.74 -40.84 90.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -115.92 -62.54 1.58 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.756 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -108.52 136.01 19.96 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.342 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.83 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 20.7 Cg_exo -66.7 167.12 20.06 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.946 2.431 . . . . 0.0 112.627 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m -60.87 124.23 19.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.401 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.47 -29.83 2.17 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.595 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.5 t -90.24 -54.63 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.608 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -89.44 8.7 29.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.96 0.41 . . . . 0.0 111.476 -179.502 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.8 -32.21 73.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.063 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.9 mt -72.23 -11.75 60.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.054 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 tp -94.88 4.28 53.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.052 0.453 . . . . 0.0 110.455 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.64 -3.95 86.44 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.757 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.795 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 80.0 m -61.2 101.4 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.958 0.408 . . . . 0.0 110.584 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -97.81 161.71 13.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.806 -179.084 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 93.1 m -75.06 92.03 2.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.55 -37.98 68.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.026 0.441 . . . . 0.0 110.163 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.421 ' O ' HG12 ' A' ' 24' ' ' VAL . 56.4 t30 -167.16 75.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.294 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.921 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER 66.62 9.56 6.72 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.506 -179.602 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.694 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.1 p -149.79 144.67 17.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 19' ' ' SER . 2.5 m -85.55 115.27 23.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.031 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.501 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 1.6 m-85 -136.16 125.74 25.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.52 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.795 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 63.2 t30 -138.21 74.08 1.46 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.45 -58.97 4.41 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.437 HG13 ' H ' ' A' ' 29' ' ' ILE . 1.0 OUTLIER -96.18 156.34 37.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 109.983 -0.376 . . . . 0.0 109.983 178.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.501 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 5.1 Cg_exo . . . . . 0 N--CA 1.461 -0.409 0 C-N-CA 122.69 2.26 . . . . 0.0 112.093 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.66 57.08 1.56 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.964 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -155.86 111.71 3.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.149 0.499 . . . . 0.0 110.121 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.737 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -110.01 122.65 48.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.41 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.591 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -87.96 50.13 1.93 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.132 0.491 . . . . 0.0 111.311 -179.128 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.992 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 2.1 t -64.96 -48.2 85.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.44 -53.16 2.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.517 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -100.46 131.42 23.9 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.269 179.473 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.591 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 16.6 Cg_exo -68.22 149.43 76.04 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.884 2.39 . . . . 0.0 112.29 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -67.48 143.95 55.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.818 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.29 -24.62 1.6 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.439 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -80.64 -56.61 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.9 0.381 . . . . 0.0 111.64 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.538 ' HA ' HD12 ' A' ' 16' ' ' LEU . 40.3 p -88.29 -5.52 58.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.24 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.9 -39.76 93.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.63 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 mt -78.44 -4.11 46.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.809 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.538 HD12 ' HA ' ' A' ' 13' ' ' THR . 67.5 mt -100.42 2.5 42.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.389 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.93 -23.54 25.4 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.951 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.628 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 82.7 m -62.24 105.68 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.913 0.387 . . . . 0.0 110.624 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -110.09 155.78 21.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.688 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 t -65.52 101.46 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.011 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.77 -39.83 15.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.14 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -165.41 76.06 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.088 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.992 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER 67.38 8.8 6.53 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.458 -179.385 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.737 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 4.0 p -151.88 145.95 15.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 19' ' ' SER . 50.9 m -91.59 126.82 36.8 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.971 0.415 . . . . 0.0 110.949 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -132.2 149.37 52.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.609 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.628 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 58.1 t30 -158.99 73.74 0.62 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.96 -55.69 4.79 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -110.29 160.08 29.7 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo . . . . . 0 C--O 1.233 0.263 0 C-N-CA 122.782 2.322 . . . . 0.0 112.165 -179.621 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.4 ' HB3' HG21 ' A' ' 13' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.7 57.18 2.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.953 0.406 . . . . 0.0 111.629 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.707 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.8 mt-10 -153.01 137.15 16.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.759 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.659 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -131.93 126.17 33.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.833 0.349 . . . . 0.0 110.413 -179.484 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.633 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER -89.03 35.12 0.79 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.023 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.503 HG22 ' HB3' ' A' ' 23' ' ' LYS . 5.1 t -64.1 -31.4 53.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.44 0.638 . . . . 0.0 109.437 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -131.55 -46.02 0.98 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.012 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.633 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -122.22 129.09 25.24 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.925 179.652 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.617 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 30.3 Cg_endo -64.31 150.34 88.47 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.751 2.3 . . . . 0.0 112.844 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.707 ' SG ' ' HB3' ' A' ' 3' ' ' GLU . 47.5 m -60.03 135.09 57.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.814 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.79 -33.26 2.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.062 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.2 t -75.26 -53.11 16.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 0.0 111.149 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.4 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -89.58 6.48 40.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.006 0.431 . . . . 0.0 111.13 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.33 -31.41 72.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.084 0.468 . . . . 0.0 110.489 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mt -69.2 -13.87 62.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.983 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.26 6.35 49.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.345 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.53 6.21 89.05 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.506 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.722 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 19.5 m -62.17 111.75 2.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.824 0.345 . . . . 0.0 110.679 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -111.44 148.52 32.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.219 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -73.88 95.55 2.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.617 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -37.19 66.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.472 0.653 . . . . 0.0 110.213 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.584 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 4.9 t-20 -147.92 63.0 1.12 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.6 OUTLIER 81.75 -52.44 0.25 Allowed 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.668 -177.779 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.659 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.2 p -89.64 144.27 9.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.684 0.278 . . . . 0.0 110.318 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.722 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 21.7 m -74.7 124.63 27.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.891 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.81 96.42 3.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.604 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.681 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 64.7 t30 -118.53 76.2 1.07 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.03 -54.46 4.72 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.446 ' H ' HG13 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -105.93 154.99 39.08 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 N--CA 1.463 -0.316 0 C-N-CA 122.336 2.024 . . . . 0.0 112.224 -179.822 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.555 ' HB3' HG21 ' A' ' 13' ' ' THR . 1.9 m . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.935 0.398 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.19 57.94 3.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.651 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -149.34 117.31 6.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.099 0.476 . . . . 0.0 109.931 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -109.22 142.76 39.58 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -88.94 -87.23 0.17 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.082 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.592 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 44.5 t 71.16 -55.38 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 123.301 0.64 . . . . 0.0 111.115 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -127.65 -38.22 1.91 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.073 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.523 ' H ' HG13 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -109.04 145.3 31.45 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.122 -179.424 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 5.3 Cg_exo -77.64 157.54 32.0 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.944 2.429 . . . . 0.0 112.131 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 m -61.34 128.68 37.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.049 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.68 -32.6 3.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.895 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.8 t -86.93 -49.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.687 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.555 HG21 ' HB3' ' A' ' 1' ' ' CYS . 70.9 p -89.62 4.13 50.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.913 0.387 . . . . 0.0 111.361 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.26 -35.35 78.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.569 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.541 ' H ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -73.08 -12.29 60.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.822 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.59 -1.21 44.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.247 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.5 -1.43 88.35 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.804 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.763 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 71.4 m -61.9 108.94 1.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.995 0.426 . . . . 0.0 110.522 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -103.3 154.95 18.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.933 -179.126 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.0 t -67.87 97.96 0.7 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.587 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.29 -42.21 19.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 2.7 t-20 -156.04 63.41 0.57 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.398 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.592 ' HG2' ' HA ' ' A' ' 6' ' ' VAL . 1.7 mtmp? 76.67 9.1 3.01 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.7 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.662 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.1 p -148.39 142.76 19.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 19' ' ' SER . 3.4 m -85.87 123.01 30.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.942 0.401 . . . . 0.0 111.321 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.461 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -139.34 148.74 43.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.348 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.763 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 63.7 t30 -160.58 74.27 0.52 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.063 0.459 . . . . 0.0 109.816 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.34 -59.7 4.0 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.469 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -89.85 156.82 46.88 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.461 ' HA ' ' CE2' ' A' ' 26' ' ' TYR . 2.8 Cg_exo . . . . . 0 N--CA 1.46 -0.482 0 C-N-CA 122.747 2.298 . . . . 0.0 112.024 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.21 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.51 60.0 2.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.031 0.444 . . . . 0.0 111.424 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.534 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 2.3 tt0 -152.23 122.57 7.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.032 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.0 OUTLIER -116.98 132.12 56.78 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.649 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -89.18 -73.06 0.52 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.12 -179.106 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.54 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 47.8 t 70.94 -56.27 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.505 0.722 . . . . 0.0 110.657 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -125.06 -41.17 2.1 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.393 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.2 mt -116.0 120.64 35.12 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.292 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.649 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 14.9 Cg_endo -57.54 150.16 62.23 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.114 2.543 . . . . 0.0 113.341 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.534 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 17.8 m -62.48 160.21 14.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.509 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.83 -26.3 1.36 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.904 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.1 t -80.96 -60.34 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.19 2.51 54.1 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.962 0.41 . . . . 0.0 111.221 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.15 -33.43 75.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.508 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mt -71.13 -12.32 61.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.952 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.84 6.2 49.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.087 0.47 . . . . 0.0 110.136 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.27 -8.19 79.6 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.372 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.661 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 68.7 m -62.0 107.15 0.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.884 0.373 . . . . 0.0 110.647 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -112.65 161.48 16.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.943 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.6 m -73.47 78.95 1.42 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.657 0.265 . . . . 0.0 111.095 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -36.25 82.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.388 0.613 . . . . 0.0 110.442 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 8.4 t-20 -144.14 57.21 1.33 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.294 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.54 ' HG2' ' HA ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER 79.54 -38.77 0.19 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.418 -178.458 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.0 p -101.02 148.35 7.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.66 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 18.8 m -74.98 117.02 16.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.902 0.382 . . . . 0.0 111.184 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -139.38 115.79 10.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.58 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.661 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 57.4 t30 -135.69 77.96 1.7 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.615 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.21 -60.97 4.21 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -94.92 154.9 39.64 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.461 -0.435 0 C-N-CA 122.772 2.314 . . . . 0.0 112.115 -179.666 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.472 ' HB3' HG21 ' A' ' 13' ' ' THR . 16.6 m . . . . . 0 C--O 1.233 0.231 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.34 54.64 1.44 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.021 0.439 . . . . 0.0 111.567 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -160.69 144.84 13.84 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.502 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.661 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.1 t -147.51 144.93 28.9 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.713 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -86.7 14.83 6.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.418 -178.768 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.519 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 5.0 t -63.59 -39.83 86.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -105.31 -63.42 1.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.205 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.713 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -124.14 158.77 59.6 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.553 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.06 161.76 43.78 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.392 2.061 . . . . 0.0 112.758 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.1 m -64.41 113.66 3.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.051 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.55 -32.95 2.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.719 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.5 t -87.1 -46.8 16.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.477 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.584 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 81.3 p -89.69 3.69 51.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.832 0.349 . . . . 0.0 111.459 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.01 83.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.006 0.432 . . . . 0.0 110.727 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.73 -4.28 42.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.049 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tp -99.83 -1.78 36.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.08 0.467 . . . . 0.0 110.345 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.11 -0.43 81.74 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.39 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.595 ' HA ' ' HB3' ' A' ' 27' ' ' ASN . 61.3 m -64.66 104.5 0.82 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.964 0.411 . . . . 0.0 110.464 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.29 149.91 21.54 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.827 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.5 t -76.16 111.18 11.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.012 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.504 ' HB2' ' H ' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -96.64 -102.0 0.18 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.504 ' H ' ' HB2' ' A' ' 21' ' ' SER . 7.6 p-10 -88.6 61.57 6.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.124 0.488 . . . . 0.0 109.738 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.519 ' HE3' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER 65.37 32.48 9.68 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.871 -179.119 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.661 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.4 p -151.69 145.54 16.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.2 m -86.22 119.74 26.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.931 0.396 . . . . 0.0 110.994 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -134.33 139.49 45.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.607 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.595 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 35.6 p-10 -134.14 22.52 3.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.628 0.728 . . . . 0.0 109.963 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.09 -29.93 8.06 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -119.72 150.86 51.21 Favored Pre-proline 0 N--CA 1.446 -0.642 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo . . . . . 0 N--CA 1.464 -0.251 0 C-N-CA 122.293 1.995 . . . . 0.0 112.356 -178.971 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.234 0.258 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.16 54.67 1.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.998 0.428 . . . . 0.0 111.42 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.452 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 2.4 tt0 -157.92 123.86 4.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.192 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -120.27 132.07 55.18 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.244 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.515 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -88.87 -70.33 0.66 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.15 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.42 HG22 ' HB3' ' A' ' 23' ' ' LYS . 45.9 t 70.66 -56.61 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.578 0.751 . . . . 0.0 110.652 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -126.31 -39.87 2.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.66 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.442 ' H ' HG13 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -114.08 122.99 33.46 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.561 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.515 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 15.3 Cg_endo -57.38 149.5 65.0 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.204 2.603 . . . . 0.0 113.542 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.452 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 34.0 m -64.09 158.55 22.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.397 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.17 -25.55 1.35 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.828 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.09 -60.32 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.15 1.16 56.04 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.817 0.341 . . . . 0.0 111.468 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.87 -32.76 74.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.068 0.461 . . . . 0.0 110.552 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.84 -7.48 53.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.034 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 mp -97.54 7.31 46.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.12 0.486 . . . . 0.0 110.308 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.69 -10.02 70.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.485 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.846 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 70.9 m -62.55 109.21 1.31 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.793 0.33 . . . . 0.0 110.673 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -116.13 154.68 29.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.015 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.4 m -71.28 84.27 0.77 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.656 0.265 . . . . 0.0 111.196 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -34.51 58.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.221 0.534 . . . . 0.0 110.329 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 3.8 t-20 -151.03 61.84 0.91 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.416 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER 79.9 -45.18 0.3 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.708 -178.742 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 1.7 p -96.57 148.9 5.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.846 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 4.2 m -76.57 126.27 30.69 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.158 0.504 . . . . 0.0 111.553 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -134.46 138.45 44.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.114 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.488 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 29.2 p-10 -133.98 15.86 3.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.734 0.778 . . . . 0.0 109.777 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.36 -36.93 2.28 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.418 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -121.42 159.66 49.25 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.587 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo . . . . . 0 N--CA 1.461 -0.393 0 C-N-CA 122.175 1.917 . . . . 0.0 112.471 -179.11 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.453 -0.304 0 CA-C-O 120.741 0.305 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.93 58.09 2.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 111.533 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.449 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 2.5 tt0 -157.68 138.85 13.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.773 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.652 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.6 OUTLIER -137.88 135.44 36.15 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.777 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.708 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -88.45 22.34 2.58 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.563 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.42 HG22 ' HB3' ' A' ' 23' ' ' LYS . 12.4 t -70.4 -23.19 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.427 0.632 . . . . 0.0 109.497 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.04 -51.27 1.32 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.566 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.708 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.7 OUTLIER -126.91 148.06 63.93 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.554 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.05 157.42 57.84 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.474 2.116 . . . . 0.0 112.171 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.7 m -62.74 118.94 8.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.925 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.7 -32.56 2.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.653 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.7 t -87.27 -48.14 15.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.549 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.594 ' HA ' HD12 ' A' ' 16' ' ' LEU . 69.1 p -89.4 -3.97 58.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.821 0.343 . . . . 0.0 111.397 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.08 -37.67 83.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.723 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.52 -12.21 61.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.008 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.594 HD12 ' HA ' ' A' ' 13' ' ' THR . 14.8 mt -97.24 4.46 50.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.319 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.39 -5.07 84.26 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.036 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.822 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 85.2 m -63.73 101.86 0.4 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.995 0.426 . . . . 0.0 110.739 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -95.27 156.59 16.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.837 -179.3 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.6 t -76.23 96.98 4.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.273 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.2 -43.49 33.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.933 0.397 . . . . 0.0 111.054 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -156.97 66.56 0.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.31 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER 72.73 14.01 5.09 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.644 -179.299 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.652 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 1.5 p -151.42 141.22 15.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 3' ' ' GLU . 1.4 m -81.99 118.07 22.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.903 0.382 . . . . 0.0 110.491 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.46 125.33 24.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.9 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.822 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 59.1 t30 -136.33 67.37 1.46 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.68 -59.68 4.42 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.421 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.7 mm -97.37 135.31 21.85 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo . . . . . 0 C--N 1.345 0.387 0 C-N-CA 122.995 2.463 . . . . 0.0 112.578 -179.429 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.668 ' HB3' HG21 ' A' ' 13' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.709 0.29 . . . . 0.0 110.366 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.83 55.95 2.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.025 0.44 . . . . 0.0 111.238 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.504 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 0.7 OUTLIER -155.91 135.15 12.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.804 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.773 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -123.72 130.28 52.4 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -88.12 49.99 1.9 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.236 -179.411 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.818 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -72.25 -66.07 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.755 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.565 ' HZ3' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -127.36 8.8 6.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.727 178.854 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.1 pt -141.21 151.74 62.53 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.359 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.571 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 13.8 Cg_endo -90.43 151.69 4.42 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.98 2.453 . . . . 0.0 111.967 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.76 128.34 35.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.452 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.58 -34.69 2.2 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.028 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.43 -56.11 7.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.929 0.395 . . . . 0.0 111.259 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.668 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -89.8 11.23 20.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.038 0.447 . . . . 0.0 111.262 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.77 -35.37 80.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.462 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.12 -11.59 61.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.19 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.87 2.82 55.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.377 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.01 0.65 89.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.705 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.717 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 86.7 m -62.32 103.4 0.39 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.83 0.347 . . . . 0.0 110.74 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -98.46 159.57 14.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.664 -179.255 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 5' ' ' CYS . 1.6 m -77.04 81.87 3.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.9 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -61.44 1.89 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.128 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.452 ' O ' HG12 ' A' ' 24' ' ' VAL . 3.8 t30 -130.48 67.33 1.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 0.0 110.496 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.818 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.4 OUTLIER 64.99 16.25 10.46 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.041 -179.498 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.773 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.1 p -151.04 144.9 16.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 19' ' ' SER . 3.6 m -80.51 110.76 16.28 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -135.28 118.45 16.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.195 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.717 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 62.3 t30 -131.4 70.04 1.47 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.41 -60.45 4.53 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.42 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.498 HG13 ' HD2' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -95.01 138.27 22.07 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.814 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.498 ' HD2' HG13 ' A' ' 29' ' ' ILE . 21.9 Cg_endo . . . . . 0 C--N 1.346 0.417 0 C-N-CA 122.513 2.142 . . . . 0.0 112.266 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.615 ' HB3' HG21 ' A' ' 13' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.815 0.34 . . . . 0.0 110.708 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.82 59.54 4.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.648 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.473 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 1.3 tt0 -151.22 134.34 15.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.824 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.743 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -123.28 137.0 54.96 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -86.39 -7.84 58.13 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.123 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.4 m -74.36 -12.23 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.461 0.648 . . . . 0.0 109.48 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -112.31 -54.98 2.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.868 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.5 OUTLIER -149.29 148.5 26.71 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.05 179.602 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.456 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 21.8 Cg_exo -64.39 144.78 86.72 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.167 1.911 . . . . 0.0 111.407 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.74 115.56 2.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.983 0.42 . . . . 0.0 110.955 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.87 -33.74 2.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.686 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.2 t -77.86 -55.86 9.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.747 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.615 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -90.03 10.44 24.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.059 0.457 . . . . 0.0 111.036 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.88 -32.54 74.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.446 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 tp -66.71 -16.03 63.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.083 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.04 3.25 49.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.553 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.67 6.6 88.96 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.828 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.673 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 55.6 m -64.95 103.46 0.73 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.683 0.278 . . . . 0.0 110.888 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 m -104.34 143.13 33.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.152 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -66.32 99.15 0.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.9 0.381 . . . . 0.0 111.214 -179.393 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.85 -71.46 0.68 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.741 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -90.61 60.39 4.54 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.712 ' HD2' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER 74.84 -40.86 0.45 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.871 -178.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.743 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 0.5 OUTLIER -103.17 154.69 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.723 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 3.9 m -69.54 120.56 15.51 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.891 0.377 . . . . 0.0 110.594 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -130.37 145.23 51.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.496 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.673 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 65.4 t30 -164.57 73.74 0.25 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.11 -57.33 4.97 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.339 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -106.36 148.73 37.24 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.053 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 29' ' ' ILE . 13.4 Cg_exo . . . . . 0 C--N 1.345 0.349 0 C-N-CA 122.647 2.231 . . . . 0.0 111.857 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.464 ' HB3' HG21 ' A' ' 13' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.743 0.306 . . . . 0.0 110.632 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.93 55.5 1.44 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.094 0.473 . . . . 0.0 111.712 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.421 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 2.0 tt0 -149.35 110.48 4.38 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.887 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.715 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -110.94 117.21 32.76 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.646 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.473 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.6 OUTLIER -87.93 69.51 9.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.279 0.561 . . . . 0.0 110.737 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.921 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 4.7 t -64.13 -38.76 83.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.175 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -127.79 -58.07 1.24 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.969 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.476 ' H ' HG13 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -97.42 143.85 26.9 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.269 179.32 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.473 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 21.0 Cg_exo -66.5 158.4 55.73 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 123.075 2.517 . . . . 0.0 112.942 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.421 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 4.4 m -68.36 151.9 46.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.026 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.45 -25.47 1.31 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.716 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.49 -58.97 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.464 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -88.96 -1.66 58.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.79 0.329 . . . . 0.0 111.432 -179.182 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.33 -34.06 77.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.08 0.467 . . . . 0.0 110.271 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.45 -5.1 48.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.898 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.51 10.07 41.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.351 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.59 -18.22 57.82 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.727 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.675 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 65.8 m -63.27 108.73 1.36 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.821 0.344 . . . . 0.0 110.374 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -104.9 156.84 17.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.697 -179.279 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.5 m -64.42 100.99 0.39 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.879 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.77 71.79 1.18 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.765 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.4 t30 72.17 75.52 0.16 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.095 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.921 ' HG2' ' HA ' ' A' ' 6' ' ' VAL . 7.4 mttp 66.28 4.6 3.25 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.2 p -150.72 135.81 10.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 4.7 m -81.65 132.65 35.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.083 0.468 . . . . 0.0 111.964 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -137.84 163.58 31.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.85 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.675 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 47.9 t30 -167.1 -104.73 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -97.68 -17.2 31.48 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.703 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.475 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -146.0 164.72 23.75 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 47.2 Cg_endo . . . . . 0 CA--C 1.529 0.274 0 C-N-CA 122.287 1.991 . . . . 0.0 111.913 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.725 0.298 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.55 51.0 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.0 111.735 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -158.59 119.06 3.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.892 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.761 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -119.87 121.37 38.9 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.901 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -88.0 56.25 3.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.312 0.577 . . . . 0.0 111.133 -179.38 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.428 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 12.5 t -65.89 -33.09 61.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.384 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -135.48 -48.25 0.7 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.919 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -110.01 132.2 21.56 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.195 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.901 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 22.9 Cg_exo -65.22 153.19 79.44 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.95 2.433 . . . . 0.0 112.622 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.0 m -67.63 147.74 52.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.312 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.81 -23.37 1.57 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.294 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 t -84.36 -57.07 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.846 0.355 . . . . 0.0 111.899 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.678 ' HA ' HD12 ' A' ' 16' ' ' LEU . 35.7 p -88.1 -3.29 58.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.709 0.29 . . . . 0.0 111.373 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 18' ' ' CYS . . . -61.65 -37.03 82.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.108 0.48 . . . . 0.0 110.523 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mt -80.39 -0.78 38.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.007 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.678 HD12 ' HA ' ' A' ' 13' ' ' THR . 39.6 mt -105.11 8.91 34.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.041 0.448 . . . . 0.0 110.584 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.23 -21.57 39.22 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.879 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.774 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 84.8 m -64.07 108.29 1.49 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.979 0.419 . . . . 0.0 110.505 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.37 149.6 32.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.666 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.9 m -65.35 109.44 2.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.329 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.86 -63.28 1.14 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.2 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.78 68.38 1.47 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.109 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' ' 6' ' ' VAL . 19.8 mttm 68.08 15.41 9.43 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.021 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.761 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 3.0 p -152.12 149.26 13.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.774 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 3.9 m -90.95 130.01 36.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.098 0.475 . . . . 0.0 111.491 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -132.33 138.9 47.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.415 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.431 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 31.5 p-10 -133.61 18.47 3.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.932 0.872 . . . . 0.0 109.165 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.53 -32.9 3.25 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -131.67 161.42 62.42 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 114.216 -0.992 . . . . 0.0 108.436 178.135 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 40.7 Cg_endo . . . . . 0 CA--C 1.529 0.241 0 C-N-CA 122.037 1.825 . . . . 0.0 112.424 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.233 0.233 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.21 54.62 1.4 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.969 0.414 . . . . 0.0 111.384 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.547 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 4.7 tt0 -152.75 105.45 2.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.354 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -102.09 138.85 38.5 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.089 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.67 -61.32 1.74 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.846 0.355 . . . . 0.0 111.021 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.992 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 48.3 t 70.09 -59.31 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.704 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -135.15 -33.56 0.9 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.614 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 mt -109.28 123.51 36.55 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.563 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.89 140.38 93.61 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.859 2.373 . . . . 0.0 112.964 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.547 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 2.7 m -64.1 153.77 36.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.091 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.8 -23.83 1.35 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.7 t -77.39 -61.71 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.899 0.38 . . . . 0.0 111.77 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.39 1.15 56.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.908 0.385 . . . . 0.0 111.259 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.03 -34.0 76.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.083 0.468 . . . . 0.0 110.371 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -8.9 57.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.831 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.36 3.91 53.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.219 0.533 . . . . 0.0 110.154 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.92 -14.78 58.59 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.455 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 62.0 m -62.82 104.55 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.915 0.388 . . . . 0.0 110.649 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -107.37 148.52 28.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.511 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.6 t -61.7 107.89 0.9 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.289 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.42 ' HB2' ' H ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER -106.0 -94.58 0.36 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.722 179.557 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.42 ' H ' ' HB2' ' A' ' 21' ' ' SER . 6.7 p-10 -86.33 58.53 5.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.983 0.42 . . . . 0.0 110.333 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.992 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER 72.48 3.62 4.74 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.648 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.1 p -139.19 149.44 23.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 19' ' ' SER . 54.5 m -84.36 124.6 31.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.894 0.378 . . . . 0.0 111.813 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.54 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 6.3 m-85 -129.01 150.75 50.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.076 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.467 ' OD1' HG13 ' A' ' 29' ' ' ILE . 27.4 p-10 -140.56 16.08 2.36 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.63 0.728 . . . . 0.0 109.997 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.22 -41.54 1.56 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.484 HG13 ' H ' ' A' ' 29' ' ' ILE . 0.7 OUTLIER -113.08 160.03 32.53 Favored Pre-proline 0 N--CA 1.446 -0.672 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.218 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.54 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 57.2 Cg_endo . . . . . 0 N--CA 1.46 -0.457 0 C-N-CA 121.739 1.626 . . . . 0.0 112.912 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.68 -33.69 76.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.699 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.72 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 2.4 mt-10 -75.88 138.43 41.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.101 0.477 . . . . 0.0 110.902 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.81 126.14 29.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.722 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 1.8 m -88.79 36.82 0.81 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.556 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 12.9 t -65.71 -31.31 53.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -131.0 -49.8 1.02 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.623 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.61 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.2 mt -117.58 128.45 26.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.906 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 30.7 Cg_endo -63.96 151.17 86.41 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.726 2.284 . . . . 0.0 113.066 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.72 ' SG ' ' HB3' ' A' ' 3' ' ' GLU . 77.3 m -59.89 134.78 57.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.908 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.93 -38.55 2.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.737 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.5 p -88.32 -37.84 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 0.2 OUTLIER -91.96 -5.5 52.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.015 0.436 . . . . 0.0 110.881 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.35 -31.82 73.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.091 0.472 . . . . 0.0 110.549 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 15' ' ' LEU . 1.2 mm? -71.84 -11.24 60.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.968 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.38 8.36 44.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.081 0.467 . . . . 0.0 110.218 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.42 -3.94 83.96 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.413 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.784 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 55.6 m -63.28 110.17 1.8 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 110.811 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.5 141.53 48.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.764 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.83 96.78 1.7 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.782 0.325 . . . . 0.0 110.898 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.76 -37.16 27.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.42 0.629 . . . . 0.0 110.187 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.563 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 5.0 t-20 -146.29 64.99 1.2 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.9 OUTLIER 80.1 -53.61 0.37 Allowed 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.096 -178.124 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.3 m -89.43 150.64 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.705 0.288 . . . . 0.0 110.364 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.784 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 1.6 m -77.35 130.88 37.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.974 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.57 114.74 10.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.395 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.584 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 35.0 p-10 -116.01 19.15 15.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.812 0.815 . . . . 0.0 109.454 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.0 -33.1 3.13 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -128.64 157.18 75.94 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.127 -1.036 . . . . 0.0 108.269 177.856 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo . . . . . 0 N--CA 1.461 -0.386 0 C-N-CA 122.006 1.804 . . . . 0.0 112.524 -179.098 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.515 ' HB3' HG21 ' A' ' 13' ' ' THR . 2.0 m . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 120.729 0.299 . . . . 0.0 110.462 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.64 56.42 1.83 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.513 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -147.28 120.4 8.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.992 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.754 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -122.61 123.05 40.3 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.836 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -86.77 58.31 5.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.242 0.544 . . . . 0.0 111.836 -178.916 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.483 HG22 ' HG2' ' A' ' 23' ' ' LYS . 1.6 t -83.04 -29.01 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.27 -47.51 0.71 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.547 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -116.44 133.78 22.94 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.974 179.784 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.836 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 61.2 Cg_endo -73.62 175.25 10.96 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.739 2.293 . . . . 0.0 112.768 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.4 m -60.32 120.1 9.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.848 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.01 -39.61 2.49 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.345 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.1 m -95.93 -42.21 12.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.515 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -90.7 3.52 54.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.015 0.436 . . . . 0.0 111.26 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.62 -35.42 80.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.309 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.3 tp -71.36 -11.44 60.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.937 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.35 2.68 56.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.021 0.438 . . . . 0.0 110.237 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.71 -6.43 83.01 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.596 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.724 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 72.0 m -64.53 98.39 0.25 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.867 0.365 . . . . 0.0 110.784 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 1.2 m -92.37 155.61 17.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.34 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.4 m -63.8 97.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.078 0.466 . . . . 0.0 111.53 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.44 62.5 3.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.707 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.0 t30 69.83 90.92 0.09 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.024 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.483 ' HG2' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER 69.54 -10.13 0.6 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 178.308 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.754 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 1.7 p -149.32 138.49 15.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 121.532 -0.73 . . . . 0.0 111.25 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 19' ' ' SER . 6.8 m -80.95 125.25 29.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.66 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.452 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -138.53 150.58 46.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.886 0.374 . . . . 0.0 110.966 -179.594 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.724 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 64.0 t30 -161.77 67.88 0.28 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.184 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.87 -60.22 4.42 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.94 156.3 46.95 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 61.1 Cg_endo . . . . . 0 N--CA 1.461 -0.415 0 C-N-CA 122.413 2.075 . . . . 0.0 112.254 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 10.8 m . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.633 0.254 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.77 49.21 1.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.913 0.387 . . . . 0.0 111.815 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.576 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 5.8 tt0 -154.63 135.36 13.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.586 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.4 t -130.08 134.96 47.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.823 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.778 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -89.85 -77.48 0.39 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.525 -179.147 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.4 t 72.02 -56.77 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.691 0.797 . . . . 0.0 110.444 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -115.62 -46.92 2.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.303 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mt -118.51 121.21 31.16 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.152 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.778 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 52.2 Cg_exo -55.01 144.81 66.73 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.019 2.479 . . . . 0.0 112.821 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.576 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 3.3 m -57.39 150.35 18.62 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.936 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.1 -20.84 4.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.734 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.8 t -81.2 -54.77 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 0.0 111.321 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.594 ' HA ' HD13 ' A' ' 16' ' ' LEU . 40.9 p -88.85 4.08 48.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.812 0.339 . . . . 0.0 111.601 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.34 86.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.156 0.503 . . . . 0.0 110.421 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.82 -6.01 52.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.75 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.594 HD13 ' HA ' ' A' ' 13' ' ' THR . 3.4 mp -96.17 -11.1 26.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.319 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.3 -16.02 27.32 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.464 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.759 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 78.1 m -62.74 119.07 8.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.78 0.324 . . . . 0.0 110.765 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.63 154.58 40.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.75 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.6 m -70.47 92.7 0.84 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.146 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -91.38 -34.02 15.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.015 0.436 . . . . 0.0 110.993 -179.688 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 12.2 t-20 -148.69 63.62 1.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER 78.51 -49.41 0.46 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.113 -178.396 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.6 m -93.93 169.18 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.759 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 1.8 m -90.77 130.58 36.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.096 0.474 . . . . 0.0 111.539 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.543 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 7.9 m-85 -125.88 148.61 49.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.08 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.69 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 48.9 t30 -166.39 74.6 0.17 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.73 -53.84 4.75 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.548 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -124.52 164.38 30.91 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.424 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.548 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 45.1 Cg_endo . . . . . 0 CA--C 1.53 0.304 0 C-N-CA 122.176 1.917 . . . . 0.0 112.109 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.431 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 120.702 0.287 . . . . 0.0 110.236 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.15 -26.71 56.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.507 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.606 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 2.3 mt-10 -80.55 150.81 29.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.474 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.2 t -147.44 130.79 16.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.492 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 1.7 m -89.38 39.62 0.95 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.07 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.568 HG13 ' HD1' ' A' ' 7' ' ' TRP . 7.4 p -66.32 -28.11 42.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.737 0.78 . . . . 0.0 109.456 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.568 ' HD1' HG13 ' A' ' 6' ' ' VAL . 48.3 m95 -135.79 -44.85 0.66 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.737 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -126.72 131.09 23.75 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.86 179.618 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.495 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 33.9 Cg_exo -60.7 148.61 91.09 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.891 2.394 . . . . 0.0 113.004 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 3' ' ' GLU . 17.4 m -62.14 143.58 56.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.91 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.17 -33.57 2.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.29 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.8 t -83.9 -46.99 18.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.85 0.357 . . . . 0.0 111.959 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.738 ' HA ' HD12 ' A' ' 16' ' ' LEU . 68.7 p -88.84 -7.5 56.04 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.768 0.318 . . . . 0.0 111.382 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.95 -34.66 78.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.139 0.495 . . . . 0.0 110.088 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.48 ' H ' ' HG ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -73.36 -11.77 60.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.612 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.738 HD12 ' HA ' ' A' ' 13' ' ' THR . 12.9 mt -94.01 -2.79 52.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.426 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.92 -13.95 52.75 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.952 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.752 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 1.7 m -63.08 115.65 4.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.995 0.426 . . . . 0.0 110.655 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -110.02 156.42 20.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.551 -179.569 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.9 m -65.84 100.99 0.6 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.138 0.494 . . . . 0.0 111.768 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.517 ' HB2' ' HD2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -121.49 108.44 13.64 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.828 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.607 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 19.6 t-20 65.04 46.3 2.83 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.231 0.538 . . . . 0.0 109.866 -178.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER 82.7 -50.96 0.18 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.25 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 3.1 m -87.2 163.55 2.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.363 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.752 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 1.2 m -85.41 130.13 34.66 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.111 0.481 . . . . 0.0 111.199 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.517 ' HD2' ' HB2' ' A' ' 21' ' ' SER . 3.2 m-85 -128.33 150.14 50.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.852 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.696 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 58.5 t30 -173.64 71.1 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.43 -52.98 4.75 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.455 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -119.01 157.99 49.14 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.402 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 N--CA 1.463 -0.274 0 C-N-CA 122.668 2.245 . . . . 0.0 111.975 -179.714 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 12.8 m . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.07 51.57 1.17 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.826 0.346 . . . . 0.0 111.493 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -158.28 149.01 20.51 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -142.38 121.72 13.13 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.926 0.394 . . . . 0.0 109.943 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.603 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 1.1 p -87.15 60.03 5.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.416 0.627 . . . . 0.0 111.238 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.889 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 12.9 t -65.68 -41.14 89.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.362 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -123.4 -56.46 1.71 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.6 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -96.47 131.68 27.92 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.84 179.12 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.603 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 37.9 Cg_endo -66.83 143.04 65.35 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.619 2.213 . . . . 0.0 112.249 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.421 ' HB3' ' OG1' ' A' ' 13' ' ' THR . 1.6 m -57.84 107.99 0.53 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.788 0.328 . . . . 0.0 110.337 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.19 -40.9 6.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.778 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.8 t -72.64 -32.11 39.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.235 0.54 . . . . 0.0 110.521 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -89.21 -1.8 58.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.657 -179.44 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.86 -37.22 84.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.798 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tp -69.07 -16.42 63.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.894 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 tp -91.23 -5.3 55.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.216 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.18 1.96 81.03 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.4 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.612 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 50.0 m -72.55 88.66 1.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.903 0.382 . . . . 0.0 110.493 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.03 153.47 26.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.012 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.9 m -76.52 106.87 8.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.911 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -81.67 -47.77 12.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.363 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -165.84 83.82 0.32 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.184 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.889 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER 68.08 5.95 4.92 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.93 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.5 p -151.43 148.04 15.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.527 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.89 135.68 33.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.758 0.313 . . . . 0.0 111.152 -178.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.443 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 4.8 m-85 -137.7 124.41 21.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.909 0.385 . . . . 0.0 111.254 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.612 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 27.1 t-20 -137.55 81.67 1.88 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.3 -53.99 4.25 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.412 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -124.05 163.68 34.14 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.772 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo . . . . . 0 C--N 1.343 0.284 0 C-N-CA 122.415 2.077 . . . . 0.0 111.695 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.232 0.179 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.15 57.28 2.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.018 0.437 . . . . 0.0 111.184 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -150.23 155.66 40.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.318 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.678 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 40.7 t -150.18 143.78 25.24 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.95 -68.81 0.75 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.701 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.401 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 56.9 t 70.81 -56.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 123.61 0.764 . . . . 0.0 111.184 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -118.95 -43.46 2.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.115 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.54 122.17 32.19 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.543 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -51.68 141.93 42.26 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.146 2.564 . . . . 0.0 112.84 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.618 ' HB3' ' OG1' ' A' ' 13' ' ' THR . 2.3 m -47.96 111.51 0.44 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.651 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.98 -41.47 5.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.238 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.44 -20.85 12.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.968 0.413 . . . . 0.0 111.123 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.618 ' OG1' ' HB3' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -88.32 7.74 30.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.094 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.19 -28.69 69.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.516 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.37 -14.93 61.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.41 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.82 -13.28 15.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.257 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.08 18.86 79.39 Favored Glycine 0 C--O 1.227 -0.315 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.72 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.852 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 75.0 m -75.81 107.3 7.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.023 0.44 . . . . 0.0 111.197 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.63 161.25 23.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.207 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.8 m -72.9 101.89 3.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.013 0.435 . . . . 0.0 110.934 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.95 111.48 16.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.512 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 64.05 49.61 2.69 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.573 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.401 ' HG2' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER 74.89 -34.96 0.28 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.529 179.718 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.678 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 1.7 m -95.06 174.69 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.699 0.285 . . . . 0.0 111.162 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.5 m -98.87 124.49 43.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.765 0.317 . . . . 0.0 110.494 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.494 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 1.4 m-30 -133.99 144.4 48.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.072 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.852 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 57.4 t30 -160.16 73.83 0.54 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.74 -59.06 4.48 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.43 HG13 ' H ' ' A' ' 29' ' ' ILE . 0.9 OUTLIER -100.09 157.82 33.15 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.549 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.494 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 2.8 Cg_exo . . . . . 0 N--CA 1.459 -0.541 0 C-N-CA 122.803 2.335 . . . . 0.0 112.18 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.654 ' HB3' HG21 ' A' ' 13' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.744 0.307 . . . . 0.0 110.526 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.44 57.78 2.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.066 0.46 . . . . 0.0 111.21 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -151.9 116.33 5.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.167 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.776 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -110.5 118.52 36.47 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.605 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.6 OUTLIER -87.84 53.37 2.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.359 0.6 . . . . 0.0 111.495 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.909 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 8.0 t -65.82 -44.16 92.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.29 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -120.56 -60.47 1.67 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.245 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.2 OUTLIER -93.49 134.42 26.72 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.943 179.039 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.605 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 16.7 Cg_exo -68.86 162.46 41.34 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.875 2.383 . . . . 0.0 112.397 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 58.7 m -63.67 133.5 53.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.739 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.16 -30.21 1.77 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.68 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.12 -53.86 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.519 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.654 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -89.17 -0.94 57.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.754 0.311 . . . . 0.0 111.36 -179.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.17 -43.05 99.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.076 0.465 . . . . 0.0 110.562 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 tp -80.19 -2.61 45.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.172 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.45 -5.04 43.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.94 0.4 . . . . 0.0 110.495 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.51 46.72 2.48 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.735 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.2 m -128.24 130.52 48.07 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.22 156.53 24.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.809 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 54.8 m -78.12 96.28 5.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.437 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.22 -45.66 54.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.887 0.375 . . . . 0.0 110.64 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -162.79 79.35 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.73 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.909 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER 67.39 6.7 5.05 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.747 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.776 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 3.0 p -151.95 145.42 15.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.1 m -80.72 122.05 26.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.894 0.378 . . . . 0.0 110.278 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.69 98.85 2.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.119 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -133.49 88.2 2.46 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.765 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.09 -58.32 4.94 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.583 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.453 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -108.9 154.38 41.9 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.306 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.461 -0.429 0 C-N-CA 122.828 2.352 . . . . 0.0 111.783 -179.857 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.462 ' HB3' HG21 ' A' ' 13' ' ' THR . 1.9 m . . . . . 0 C--O 1.233 0.226 0 CA-C-O 120.698 0.285 . . . . 0.0 110.334 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.51 54.74 2.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.053 0.454 . . . . 0.0 111.419 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -150.52 135.74 17.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.086 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.694 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -133.89 127.8 33.28 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.83 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -88.06 34.61 0.73 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.996 0.427 . . . . 0.0 112.135 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.921 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 20.7 t -62.74 -40.84 90.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -115.92 -62.54 1.58 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.756 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -108.52 136.01 19.96 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.342 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.83 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 20.7 Cg_exo -66.7 167.12 20.06 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.946 2.431 . . . . 0.0 112.627 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m -60.87 124.23 19.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.401 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.47 -29.83 2.17 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.595 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.5 t -90.24 -54.63 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.608 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -89.44 8.7 29.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.96 0.41 . . . . 0.0 111.476 -179.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.8 -32.21 73.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.063 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.9 mt -72.23 -11.75 60.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.054 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 tp -94.88 4.28 53.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.052 0.453 . . . . 0.0 110.455 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.64 -3.95 86.44 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.757 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.795 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 80.0 m -61.2 101.4 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.958 0.408 . . . . 0.0 110.584 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -97.81 161.71 13.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.806 -179.084 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 93.1 m -75.06 92.03 2.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.55 -37.98 68.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.026 0.441 . . . . 0.0 110.163 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.421 ' O ' HG12 ' A' ' 24' ' ' VAL . 56.4 t30 -167.16 75.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.294 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.921 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER 66.62 9.56 6.72 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.506 -179.602 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.694 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.1 p -149.79 144.67 17.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 19' ' ' SER . 2.5 m -85.55 115.27 23.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.031 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.501 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 1.6 m-85 -136.16 125.74 25.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.52 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.795 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 63.2 t30 -138.21 74.08 1.46 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.45 -58.97 4.41 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.437 HG13 ' H ' ' A' ' 29' ' ' ILE . 1.0 OUTLIER -96.18 156.34 37.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 109.983 -0.376 . . . . 0.0 109.983 178.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.501 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 5.1 Cg_exo . . . . . 0 N--CA 1.461 -0.409 0 C-N-CA 122.69 2.26 . . . . 0.0 112.093 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.66 57.08 1.56 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.964 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -155.86 111.71 3.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.149 0.499 . . . . 0.0 110.121 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.737 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -110.01 122.65 48.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.41 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.591 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -87.96 50.13 1.93 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.132 0.491 . . . . 0.0 111.311 -179.128 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.992 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 2.1 t -64.96 -48.2 85.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.44 -53.16 2.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.517 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -100.46 131.42 23.9 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.269 179.473 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.591 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 16.6 Cg_exo -68.22 149.43 76.04 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.884 2.39 . . . . 0.0 112.29 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -67.48 143.95 55.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.818 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.29 -24.62 1.6 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.439 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -80.64 -56.61 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.9 0.381 . . . . 0.0 111.64 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.538 ' HA ' HD12 ' A' ' 16' ' ' LEU . 40.3 p -88.29 -5.52 58.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.24 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.9 -39.76 93.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.63 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 mt -78.44 -4.11 46.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.809 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.538 HD12 ' HA ' ' A' ' 13' ' ' THR . 67.5 mt -100.42 2.5 42.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.389 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.93 -23.54 25.4 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.951 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.628 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 82.7 m -62.24 105.68 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.913 0.387 . . . . 0.0 110.624 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -110.09 155.78 21.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.688 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 t -65.52 101.46 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.011 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.77 -39.83 15.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.14 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -165.41 76.06 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.088 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.992 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER 67.38 8.8 6.53 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.458 -179.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.737 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 4.0 p -151.88 145.95 15.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 19' ' ' SER . 50.9 m -91.59 126.82 36.8 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.971 0.415 . . . . 0.0 110.949 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -132.2 149.37 52.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.609 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.628 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 58.1 t30 -158.99 73.74 0.62 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.96 -55.69 4.79 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -110.29 160.08 29.7 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo . . . . . 0 C--O 1.233 0.263 0 C-N-CA 122.782 2.322 . . . . 0.0 112.165 -179.621 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.4 ' HB3' HG21 ' A' ' 13' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.7 57.18 2.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.953 0.406 . . . . 0.0 111.629 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.707 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.8 mt-10 -153.01 137.15 16.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.759 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.659 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -131.93 126.17 33.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.833 0.349 . . . . 0.0 110.413 -179.484 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.633 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER -89.03 35.12 0.79 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.023 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.503 HG22 ' HB3' ' A' ' 23' ' ' LYS . 5.1 t -64.1 -31.4 53.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.44 0.638 . . . . 0.0 109.437 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -131.55 -46.02 0.98 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.012 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.633 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -122.22 129.09 25.24 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.925 179.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.617 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 30.3 Cg_endo -64.31 150.34 88.47 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.751 2.3 . . . . 0.0 112.844 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.707 ' SG ' ' HB3' ' A' ' 3' ' ' GLU . 47.5 m -60.03 135.09 57.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.814 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.79 -33.26 2.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.062 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.2 t -75.26 -53.11 16.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 0.0 111.149 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.4 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -89.58 6.48 40.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.006 0.431 . . . . 0.0 111.13 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.33 -31.41 72.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.084 0.468 . . . . 0.0 110.489 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mt -69.2 -13.87 62.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.983 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.26 6.35 49.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.345 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.53 6.21 89.05 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.506 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.722 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 19.5 m -62.17 111.75 2.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.824 0.345 . . . . 0.0 110.679 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -111.44 148.52 32.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.219 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -73.88 95.55 2.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.617 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -37.19 66.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.472 0.653 . . . . 0.0 110.213 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.584 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 4.9 t-20 -147.92 63.0 1.12 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.6 OUTLIER 81.75 -52.44 0.25 Allowed 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.668 -177.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.659 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.2 p -89.64 144.27 9.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.684 0.278 . . . . 0.0 110.318 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.722 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 21.7 m -74.7 124.63 27.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.891 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.81 96.42 3.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.604 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.681 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 64.7 t30 -118.53 76.2 1.07 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.03 -54.46 4.72 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.446 ' H ' HG13 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -105.93 154.99 39.08 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 N--CA 1.463 -0.316 0 C-N-CA 122.336 2.024 . . . . 0.0 112.224 -179.822 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.555 ' HB3' HG21 ' A' ' 13' ' ' THR . 1.9 m . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.935 0.398 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.19 57.94 3.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.651 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -149.34 117.31 6.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.099 0.476 . . . . 0.0 109.931 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -109.22 142.76 39.58 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -88.94 -87.23 0.17 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.082 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.592 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 44.5 t 71.16 -55.38 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 123.301 0.64 . . . . 0.0 111.115 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -127.65 -38.22 1.91 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.073 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.523 ' H ' HG13 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -109.04 145.3 31.45 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.122 -179.424 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 5.3 Cg_exo -77.64 157.54 32.0 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.944 2.429 . . . . 0.0 112.131 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 m -61.34 128.68 37.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.049 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.68 -32.6 3.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.895 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.8 t -86.93 -49.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.687 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.555 HG21 ' HB3' ' A' ' 1' ' ' CYS . 70.9 p -89.62 4.13 50.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.913 0.387 . . . . 0.0 111.361 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.26 -35.35 78.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.569 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.541 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -73.08 -12.29 60.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.822 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.59 -1.21 44.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.247 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.5 -1.43 88.35 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.804 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.763 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 71.4 m -61.9 108.94 1.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.995 0.426 . . . . 0.0 110.522 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -103.3 154.95 18.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.933 -179.126 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.0 t -67.87 97.96 0.7 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.587 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.29 -42.21 19.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 2.7 t-20 -156.04 63.41 0.57 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.398 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.592 ' HG2' ' HA ' ' A' ' 6' ' ' VAL . 1.7 mtmp? 76.67 9.1 3.01 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.7 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.662 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.1 p -148.39 142.76 19.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 19' ' ' SER . 3.4 m -85.87 123.01 30.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.942 0.401 . . . . 0.0 111.321 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.461 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -139.34 148.74 43.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.348 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.763 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 63.7 t30 -160.58 74.27 0.52 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.063 0.459 . . . . 0.0 109.816 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.34 -59.7 4.0 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.469 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -89.85 156.82 46.88 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.461 ' HA ' ' CE2' ' A' ' 26' ' ' TYR . 2.8 Cg_exo . . . . . 0 N--CA 1.46 -0.482 0 C-N-CA 122.747 2.298 . . . . 0.0 112.024 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.21 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.51 60.0 2.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.031 0.444 . . . . 0.0 111.424 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.534 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 2.3 tt0 -152.23 122.57 7.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.032 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.0 OUTLIER -116.98 132.12 56.78 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.649 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -89.18 -73.06 0.52 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.12 -179.106 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.54 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 47.8 t 70.94 -56.27 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.505 0.722 . . . . 0.0 110.657 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -125.06 -41.17 2.1 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.393 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.2 mt -116.0 120.64 35.12 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.292 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.649 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 14.9 Cg_endo -57.54 150.16 62.23 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.114 2.543 . . . . 0.0 113.341 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.534 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 17.8 m -62.48 160.21 14.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.509 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.83 -26.3 1.36 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.904 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.1 t -80.96 -60.34 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.19 2.51 54.1 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.962 0.41 . . . . 0.0 111.221 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.15 -33.43 75.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.508 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mt -71.13 -12.32 61.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.952 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.84 6.2 49.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.087 0.47 . . . . 0.0 110.136 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.27 -8.19 79.6 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.372 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.661 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 68.7 m -62.0 107.15 0.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.884 0.373 . . . . 0.0 110.647 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -112.65 161.48 16.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.943 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.6 m -73.47 78.95 1.42 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.657 0.265 . . . . 0.0 111.095 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -36.25 82.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.388 0.613 . . . . 0.0 110.442 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 8.4 t-20 -144.14 57.21 1.33 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.294 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.54 ' HG2' ' HA ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER 79.54 -38.77 0.19 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.418 -178.458 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.0 p -101.02 148.35 7.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.66 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 18.8 m -74.98 117.02 16.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.902 0.382 . . . . 0.0 111.184 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -139.38 115.79 10.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.58 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.661 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 57.4 t30 -135.69 77.96 1.7 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.615 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.21 -60.97 4.21 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -94.92 154.9 39.64 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.461 -0.435 0 C-N-CA 122.772 2.314 . . . . 0.0 112.115 -179.666 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.472 ' HB3' HG21 ' A' ' 13' ' ' THR . 16.6 m . . . . . 0 C--O 1.233 0.231 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.34 54.64 1.44 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.021 0.439 . . . . 0.0 111.567 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -160.69 144.84 13.84 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.502 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.661 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.1 t -147.51 144.93 28.9 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.713 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -86.7 14.83 6.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.418 -178.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.519 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 5.0 t -63.59 -39.83 86.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -105.31 -63.42 1.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.205 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.713 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -124.14 158.77 59.6 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.553 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.06 161.76 43.78 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.392 2.061 . . . . 0.0 112.758 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.1 m -64.41 113.66 3.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.051 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.55 -32.95 2.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.719 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.5 t -87.1 -46.8 16.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.477 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.584 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 81.3 p -89.69 3.69 51.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.832 0.349 . . . . 0.0 111.459 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.01 83.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.006 0.432 . . . . 0.0 110.727 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.73 -4.28 42.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.049 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tp -99.83 -1.78 36.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.08 0.467 . . . . 0.0 110.345 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.11 -0.43 81.74 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.39 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.595 ' HA ' ' HB3' ' A' ' 27' ' ' ASN . 61.3 m -64.66 104.5 0.82 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.964 0.411 . . . . 0.0 110.464 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.29 149.91 21.54 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.827 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.5 t -76.16 111.18 11.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.012 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.504 ' HB2' ' H ' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -96.64 -102.0 0.18 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.504 ' H ' ' HB2' ' A' ' 21' ' ' SER . 7.6 p-10 -88.6 61.57 6.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.124 0.488 . . . . 0.0 109.738 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.519 ' HE3' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER 65.37 32.48 9.68 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.871 -179.119 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.661 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.4 p -151.69 145.54 16.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.2 m -86.22 119.74 26.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.931 0.396 . . . . 0.0 110.994 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -134.33 139.49 45.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.607 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.595 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 35.6 p-10 -134.14 22.52 3.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.628 0.728 . . . . 0.0 109.963 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.09 -29.93 8.06 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -119.72 150.86 51.21 Favored Pre-proline 0 N--CA 1.446 -0.642 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo . . . . . 0 N--CA 1.464 -0.251 0 C-N-CA 122.293 1.995 . . . . 0.0 112.356 -178.971 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.234 0.258 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.16 54.67 1.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.998 0.428 . . . . 0.0 111.42 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.452 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 2.4 tt0 -157.92 123.86 4.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.192 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -120.27 132.07 55.18 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.244 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.515 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -88.87 -70.33 0.66 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.15 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.42 HG22 ' HB3' ' A' ' 23' ' ' LYS . 45.9 t 70.66 -56.61 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.578 0.751 . . . . 0.0 110.652 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -126.31 -39.87 2.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.66 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.442 ' H ' HG13 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -114.08 122.99 33.46 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.561 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.515 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 15.3 Cg_endo -57.38 149.5 65.0 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.204 2.603 . . . . 0.0 113.542 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.452 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 34.0 m -64.09 158.55 22.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.397 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.17 -25.55 1.35 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.828 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.09 -60.32 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.15 1.16 56.04 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.817 0.341 . . . . 0.0 111.468 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.87 -32.76 74.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.068 0.461 . . . . 0.0 110.552 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.84 -7.48 53.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.034 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 mp -97.54 7.31 46.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.12 0.486 . . . . 0.0 110.308 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.69 -10.02 70.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.485 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.846 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 70.9 m -62.55 109.21 1.31 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.793 0.33 . . . . 0.0 110.673 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -116.13 154.68 29.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.015 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.4 m -71.28 84.27 0.77 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.656 0.265 . . . . 0.0 111.196 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -34.51 58.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.221 0.534 . . . . 0.0 110.329 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 3.8 t-20 -151.03 61.84 0.91 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.416 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER 79.9 -45.18 0.3 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.708 -178.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 1.7 p -96.57 148.9 5.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.846 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 4.2 m -76.57 126.27 30.69 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.158 0.504 . . . . 0.0 111.553 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -134.46 138.45 44.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.114 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.488 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 29.2 p-10 -133.98 15.86 3.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.734 0.778 . . . . 0.0 109.777 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.36 -36.93 2.28 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.418 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -121.42 159.66 49.25 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo . . . . . 0 N--CA 1.461 -0.393 0 C-N-CA 122.175 1.917 . . . . 0.0 112.471 -179.11 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.453 -0.304 0 CA-C-O 120.741 0.305 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.93 58.09 2.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 111.533 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.449 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 2.5 tt0 -157.68 138.85 13.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.773 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.652 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.6 OUTLIER -137.88 135.44 36.15 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.708 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -88.45 22.34 2.58 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.563 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.42 HG22 ' HB3' ' A' ' 23' ' ' LYS . 12.4 t -70.4 -23.19 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.427 0.632 . . . . 0.0 109.497 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.04 -51.27 1.32 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.566 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.708 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.7 OUTLIER -126.91 148.06 63.93 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.554 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.05 157.42 57.84 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.474 2.116 . . . . 0.0 112.171 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.7 m -62.74 118.94 8.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.925 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.7 -32.56 2.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.653 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.7 t -87.27 -48.14 15.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.549 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.594 ' HA ' HD12 ' A' ' 16' ' ' LEU . 69.1 p -89.4 -3.97 58.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.821 0.343 . . . . 0.0 111.397 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.08 -37.67 83.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.723 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.52 -12.21 61.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.008 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.594 HD12 ' HA ' ' A' ' 13' ' ' THR . 14.8 mt -97.24 4.46 50.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.319 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.39 -5.07 84.26 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.036 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.822 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 85.2 m -63.73 101.86 0.4 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.995 0.426 . . . . 0.0 110.739 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -95.27 156.59 16.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.837 -179.3 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.6 t -76.23 96.98 4.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.273 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.2 -43.49 33.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.933 0.397 . . . . 0.0 111.054 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -156.97 66.56 0.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.31 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER 72.73 14.01 5.09 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.644 -179.299 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.652 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 1.5 p -151.42 141.22 15.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 3' ' ' GLU . 1.4 m -81.99 118.07 22.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.903 0.382 . . . . 0.0 110.491 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.46 125.33 24.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.9 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.822 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 59.1 t30 -136.33 67.37 1.46 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.68 -59.68 4.42 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.421 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.7 mm -97.37 135.31 21.85 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo . . . . . 0 C--N 1.345 0.387 0 C-N-CA 122.995 2.463 . . . . 0.0 112.578 -179.429 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.668 ' HB3' HG21 ' A' ' 13' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.709 0.29 . . . . 0.0 110.366 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.83 55.95 2.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.025 0.44 . . . . 0.0 111.238 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.504 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 0.7 OUTLIER -155.91 135.15 12.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.804 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.773 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -123.72 130.28 52.4 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -88.12 49.99 1.9 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.236 -179.411 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.818 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -72.25 -66.07 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.755 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.565 ' HZ3' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -127.36 8.8 6.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.727 178.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.1 pt -141.21 151.74 62.53 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.359 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.571 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 13.8 Cg_endo -90.43 151.69 4.42 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.98 2.453 . . . . 0.0 111.967 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.76 128.34 35.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.452 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.58 -34.69 2.2 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.028 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.43 -56.11 7.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.929 0.395 . . . . 0.0 111.259 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.668 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -89.8 11.23 20.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.038 0.447 . . . . 0.0 111.262 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.77 -35.37 80.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.462 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.12 -11.59 61.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.19 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.87 2.82 55.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.377 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.01 0.65 89.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.705 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.717 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 86.7 m -62.32 103.4 0.39 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.83 0.347 . . . . 0.0 110.74 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -98.46 159.57 14.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.664 -179.255 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 5' ' ' CYS . 1.6 m -77.04 81.87 3.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.9 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -61.44 1.89 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.128 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.452 ' O ' HG12 ' A' ' 24' ' ' VAL . 3.8 t30 -130.48 67.33 1.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 0.0 110.496 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.818 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.4 OUTLIER 64.99 16.25 10.46 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.041 -179.498 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.773 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.1 p -151.04 144.9 16.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 19' ' ' SER . 3.6 m -80.51 110.76 16.28 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -135.28 118.45 16.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.195 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.717 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 62.3 t30 -131.4 70.04 1.47 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.41 -60.45 4.53 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.42 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.498 HG13 ' HD2' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -95.01 138.27 22.07 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.498 ' HD2' HG13 ' A' ' 29' ' ' ILE . 21.9 Cg_endo . . . . . 0 C--N 1.346 0.417 0 C-N-CA 122.513 2.142 . . . . 0.0 112.266 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.615 ' HB3' HG21 ' A' ' 13' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.815 0.34 . . . . 0.0 110.708 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.82 59.54 4.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.648 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.473 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 1.3 tt0 -151.22 134.34 15.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.824 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.743 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -123.28 137.0 54.96 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -86.39 -7.84 58.13 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.123 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.4 m -74.36 -12.23 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.461 0.648 . . . . 0.0 109.48 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -112.31 -54.98 2.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.868 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.5 OUTLIER -149.29 148.5 26.71 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.05 179.602 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.456 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 21.8 Cg_exo -64.39 144.78 86.72 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.167 1.911 . . . . 0.0 111.407 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.74 115.56 2.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.983 0.42 . . . . 0.0 110.955 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.87 -33.74 2.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.686 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.2 t -77.86 -55.86 9.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.747 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.615 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -90.03 10.44 24.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.059 0.457 . . . . 0.0 111.036 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.88 -32.54 74.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.446 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 tp -66.71 -16.03 63.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.083 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.04 3.25 49.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.553 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.67 6.6 88.96 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.828 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.673 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 55.6 m -64.95 103.46 0.73 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.683 0.278 . . . . 0.0 110.888 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 m -104.34 143.13 33.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.152 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -66.32 99.15 0.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.9 0.381 . . . . 0.0 111.214 -179.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.85 -71.46 0.68 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.741 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -90.61 60.39 4.54 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.712 ' HD2' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER 74.84 -40.86 0.45 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.871 -178.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.743 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 0.5 OUTLIER -103.17 154.69 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 3.9 m -69.54 120.56 15.51 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.891 0.377 . . . . 0.0 110.594 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -130.37 145.23 51.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.496 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.673 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 65.4 t30 -164.57 73.74 0.25 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.11 -57.33 4.97 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.339 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -106.36 148.73 37.24 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.053 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 29' ' ' ILE . 13.4 Cg_exo . . . . . 0 C--N 1.345 0.349 0 C-N-CA 122.647 2.231 . . . . 0.0 111.857 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.464 ' HB3' HG21 ' A' ' 13' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.743 0.306 . . . . 0.0 110.632 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.93 55.5 1.44 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.094 0.473 . . . . 0.0 111.712 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.421 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 2.0 tt0 -149.35 110.48 4.38 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.887 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.715 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -110.94 117.21 32.76 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.646 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.473 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.6 OUTLIER -87.93 69.51 9.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.279 0.561 . . . . 0.0 110.737 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.921 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 4.7 t -64.13 -38.76 83.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.175 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -127.79 -58.07 1.24 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.969 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.476 ' H ' HG13 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -97.42 143.85 26.9 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.269 179.32 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.473 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 21.0 Cg_exo -66.5 158.4 55.73 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 123.075 2.517 . . . . 0.0 112.942 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.421 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 4.4 m -68.36 151.9 46.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.026 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.45 -25.47 1.31 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.716 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.49 -58.97 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.464 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -88.96 -1.66 58.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.79 0.329 . . . . 0.0 111.432 -179.182 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.33 -34.06 77.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.08 0.467 . . . . 0.0 110.271 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.45 -5.1 48.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.898 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.51 10.07 41.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.351 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.59 -18.22 57.82 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.727 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.675 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 65.8 m -63.27 108.73 1.36 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.821 0.344 . . . . 0.0 110.374 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -104.9 156.84 17.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.697 -179.279 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.5 m -64.42 100.99 0.39 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.879 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.77 71.79 1.18 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.765 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.4 t30 72.17 75.52 0.16 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.095 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.921 ' HG2' ' HA ' ' A' ' 6' ' ' VAL . 7.4 mttp 66.28 4.6 3.25 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.2 p -150.72 135.81 10.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 4.7 m -81.65 132.65 35.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.083 0.468 . . . . 0.0 111.964 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -137.84 163.58 31.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.85 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.675 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 47.9 t30 -167.1 -104.73 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -97.68 -17.2 31.48 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.703 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.475 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -146.0 164.72 23.75 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 47.2 Cg_endo . . . . . 0 CA--C 1.529 0.274 0 C-N-CA 122.287 1.991 . . . . 0.0 111.913 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.725 0.298 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.55 51.0 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.0 111.735 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -158.59 119.06 3.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.892 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.761 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -119.87 121.37 38.9 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.901 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -88.0 56.25 3.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.312 0.577 . . . . 0.0 111.133 -179.38 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.428 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 12.5 t -65.89 -33.09 61.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.384 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -135.48 -48.25 0.7 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.919 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -110.01 132.2 21.56 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.195 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.901 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 22.9 Cg_exo -65.22 153.19 79.44 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.95 2.433 . . . . 0.0 112.622 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.0 m -67.63 147.74 52.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.312 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.81 -23.37 1.57 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.294 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 t -84.36 -57.07 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.846 0.355 . . . . 0.0 111.899 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.678 ' HA ' HD12 ' A' ' 16' ' ' LEU . 35.7 p -88.1 -3.29 58.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.709 0.29 . . . . 0.0 111.373 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 18' ' ' CYS . . . -61.65 -37.03 82.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.108 0.48 . . . . 0.0 110.523 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mt -80.39 -0.78 38.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.007 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.678 HD12 ' HA ' ' A' ' 13' ' ' THR . 39.6 mt -105.11 8.91 34.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.041 0.448 . . . . 0.0 110.584 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.23 -21.57 39.22 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.879 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.774 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 84.8 m -64.07 108.29 1.49 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.979 0.419 . . . . 0.0 110.505 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.37 149.6 32.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.666 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.9 m -65.35 109.44 2.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.329 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.86 -63.28 1.14 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.2 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.78 68.38 1.47 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.109 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' ' 6' ' ' VAL . 19.8 mttm 68.08 15.41 9.43 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.021 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.761 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 3.0 p -152.12 149.26 13.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.774 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 3.9 m -90.95 130.01 36.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.098 0.475 . . . . 0.0 111.491 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -132.33 138.9 47.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.415 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.431 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 31.5 p-10 -133.61 18.47 3.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.932 0.872 . . . . 0.0 109.165 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.53 -32.9 3.25 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -131.67 161.42 62.42 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 114.216 -0.992 . . . . 0.0 108.436 178.135 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 40.7 Cg_endo . . . . . 0 CA--C 1.529 0.241 0 C-N-CA 122.037 1.825 . . . . 0.0 112.424 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.233 0.233 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.21 54.62 1.4 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.969 0.414 . . . . 0.0 111.384 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.547 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 4.7 tt0 -152.75 105.45 2.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.354 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -102.09 138.85 38.5 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.089 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.67 -61.32 1.74 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.846 0.355 . . . . 0.0 111.021 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.992 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 48.3 t 70.09 -59.31 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.704 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -135.15 -33.56 0.9 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.614 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 mt -109.28 123.51 36.55 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.563 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.89 140.38 93.61 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.859 2.373 . . . . 0.0 112.964 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.547 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 2.7 m -64.1 153.77 36.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.091 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.8 -23.83 1.35 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.7 t -77.39 -61.71 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.899 0.38 . . . . 0.0 111.77 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.39 1.15 56.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.908 0.385 . . . . 0.0 111.259 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.03 -34.0 76.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.083 0.468 . . . . 0.0 110.371 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -8.9 57.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.831 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.36 3.91 53.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.219 0.533 . . . . 0.0 110.154 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.92 -14.78 58.59 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.455 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 62.0 m -62.82 104.55 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.915 0.388 . . . . 0.0 110.649 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -107.37 148.52 28.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.511 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.6 t -61.7 107.89 0.9 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.289 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.42 ' HB2' ' H ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER -106.0 -94.58 0.36 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.722 179.557 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.42 ' H ' ' HB2' ' A' ' 21' ' ' SER . 6.7 p-10 -86.33 58.53 5.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.983 0.42 . . . . 0.0 110.333 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.992 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER 72.48 3.62 4.74 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.648 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.1 p -139.19 149.44 23.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 19' ' ' SER . 54.5 m -84.36 124.6 31.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.894 0.378 . . . . 0.0 111.813 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.54 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 6.3 m-85 -129.01 150.75 50.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.076 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.467 ' OD1' HG13 ' A' ' 29' ' ' ILE . 27.4 p-10 -140.56 16.08 2.36 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.63 0.728 . . . . 0.0 109.997 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.22 -41.54 1.56 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.484 HG13 ' H ' ' A' ' 29' ' ' ILE . 0.7 OUTLIER -113.08 160.03 32.53 Favored Pre-proline 0 N--CA 1.446 -0.672 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.218 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.54 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 57.2 Cg_endo . . . . . 0 N--CA 1.46 -0.457 0 C-N-CA 121.739 1.626 . . . . 0.0 112.912 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.68 -33.69 76.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.699 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.72 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 2.4 mt-10 -75.88 138.43 41.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.101 0.477 . . . . 0.0 110.902 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.81 126.14 29.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.722 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 1.8 m -88.79 36.82 0.81 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.556 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 12.9 t -65.71 -31.31 53.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -131.0 -49.8 1.02 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.623 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.61 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.2 mt -117.58 128.45 26.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.906 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 30.7 Cg_endo -63.96 151.17 86.41 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.726 2.284 . . . . 0.0 113.066 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.72 ' SG ' ' HB3' ' A' ' 3' ' ' GLU . 77.3 m -59.89 134.78 57.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.908 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.93 -38.55 2.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.737 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.5 p -88.32 -37.84 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 0.2 OUTLIER -91.96 -5.5 52.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.015 0.436 . . . . 0.0 110.881 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.35 -31.82 73.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.091 0.472 . . . . 0.0 110.549 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 15' ' ' LEU . 1.2 mm? -71.84 -11.24 60.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.968 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.38 8.36 44.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.081 0.467 . . . . 0.0 110.218 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.42 -3.94 83.96 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.413 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.784 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 55.6 m -63.28 110.17 1.8 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 110.811 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.5 141.53 48.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.764 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.83 96.78 1.7 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.782 0.325 . . . . 0.0 110.898 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.76 -37.16 27.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.42 0.629 . . . . 0.0 110.187 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.563 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 5.0 t-20 -146.29 64.99 1.2 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.9 OUTLIER 80.1 -53.61 0.37 Allowed 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.096 -178.124 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.3 m -89.43 150.64 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.705 0.288 . . . . 0.0 110.364 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.784 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 1.6 m -77.35 130.88 37.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.974 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.57 114.74 10.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.395 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.584 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 35.0 p-10 -116.01 19.15 15.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.812 0.815 . . . . 0.0 109.454 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.0 -33.1 3.13 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -128.64 157.18 75.94 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.127 -1.036 . . . . 0.0 108.269 177.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo . . . . . 0 N--CA 1.461 -0.386 0 C-N-CA 122.006 1.804 . . . . 0.0 112.524 -179.098 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.515 ' HB3' HG21 ' A' ' 13' ' ' THR . 2.0 m . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 120.729 0.299 . . . . 0.0 110.462 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.64 56.42 1.83 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.513 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -147.28 120.4 8.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.992 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.754 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -122.61 123.05 40.3 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.836 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -86.77 58.31 5.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.242 0.544 . . . . 0.0 111.836 -178.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.483 HG22 ' HG2' ' A' ' 23' ' ' LYS . 1.6 t -83.04 -29.01 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.27 -47.51 0.71 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.547 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -116.44 133.78 22.94 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.974 179.784 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.836 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 61.2 Cg_endo -73.62 175.25 10.96 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.739 2.293 . . . . 0.0 112.768 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.4 m -60.32 120.1 9.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.848 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.01 -39.61 2.49 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.345 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.1 m -95.93 -42.21 12.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.515 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -90.7 3.52 54.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.015 0.436 . . . . 0.0 111.26 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.62 -35.42 80.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.309 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.3 tp -71.36 -11.44 60.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.937 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.35 2.68 56.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.021 0.438 . . . . 0.0 110.237 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.71 -6.43 83.01 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.596 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.724 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 72.0 m -64.53 98.39 0.25 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.867 0.365 . . . . 0.0 110.784 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 1.2 m -92.37 155.61 17.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.34 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.4 m -63.8 97.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.078 0.466 . . . . 0.0 111.53 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.44 62.5 3.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.707 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.0 t30 69.83 90.92 0.09 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.024 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.483 ' HG2' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER 69.54 -10.13 0.6 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 178.308 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.754 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 1.7 p -149.32 138.49 15.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 121.532 -0.73 . . . . 0.0 111.25 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 19' ' ' SER . 6.8 m -80.95 125.25 29.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.66 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.452 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -138.53 150.58 46.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.886 0.374 . . . . 0.0 110.966 -179.594 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.724 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 64.0 t30 -161.77 67.88 0.28 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.184 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.87 -60.22 4.42 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.94 156.3 46.95 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 61.1 Cg_endo . . . . . 0 N--CA 1.461 -0.415 0 C-N-CA 122.413 2.075 . . . . 0.0 112.254 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 10.8 m . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.633 0.254 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.77 49.21 1.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.913 0.387 . . . . 0.0 111.815 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.576 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 5.8 tt0 -154.63 135.36 13.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.586 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.4 t -130.08 134.96 47.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.823 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.778 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -89.85 -77.48 0.39 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.525 -179.147 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.4 t 72.02 -56.77 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.691 0.797 . . . . 0.0 110.444 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -115.62 -46.92 2.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.303 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mt -118.51 121.21 31.16 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.152 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.778 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 52.2 Cg_exo -55.01 144.81 66.73 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.019 2.479 . . . . 0.0 112.821 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.576 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 3.3 m -57.39 150.35 18.62 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.936 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.1 -20.84 4.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.734 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.8 t -81.2 -54.77 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 0.0 111.321 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.594 ' HA ' HD13 ' A' ' 16' ' ' LEU . 40.9 p -88.85 4.08 48.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.812 0.339 . . . . 0.0 111.601 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.34 86.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.156 0.503 . . . . 0.0 110.421 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.82 -6.01 52.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.75 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.594 HD13 ' HA ' ' A' ' 13' ' ' THR . 3.4 mp -96.17 -11.1 26.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.319 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.3 -16.02 27.32 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.464 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.759 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 78.1 m -62.74 119.07 8.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.78 0.324 . . . . 0.0 110.765 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.63 154.58 40.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.75 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.6 m -70.47 92.7 0.84 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.146 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -91.38 -34.02 15.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.015 0.436 . . . . 0.0 110.993 -179.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 12.2 t-20 -148.69 63.62 1.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER 78.51 -49.41 0.46 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.113 -178.396 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.6 m -93.93 169.18 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.759 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 1.8 m -90.77 130.58 36.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.096 0.474 . . . . 0.0 111.539 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.543 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 7.9 m-85 -125.88 148.61 49.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.08 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.69 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 48.9 t30 -166.39 74.6 0.17 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.73 -53.84 4.75 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.548 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -124.52 164.38 30.91 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.548 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 45.1 Cg_endo . . . . . 0 CA--C 1.53 0.304 0 C-N-CA 122.176 1.917 . . . . 0.0 112.109 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.431 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 120.702 0.287 . . . . 0.0 110.236 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.15 -26.71 56.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.507 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.606 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 2.3 mt-10 -80.55 150.81 29.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.474 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.2 t -147.44 130.79 16.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.492 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 1.7 m -89.38 39.62 0.95 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.07 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.568 HG13 ' HD1' ' A' ' 7' ' ' TRP . 7.4 p -66.32 -28.11 42.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.737 0.78 . . . . 0.0 109.456 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.568 ' HD1' HG13 ' A' ' 6' ' ' VAL . 48.3 m95 -135.79 -44.85 0.66 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.737 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -126.72 131.09 23.75 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.86 179.618 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.495 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 33.9 Cg_exo -60.7 148.61 91.09 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.891 2.394 . . . . 0.0 113.004 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 3' ' ' GLU . 17.4 m -62.14 143.58 56.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.91 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.17 -33.57 2.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.29 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.8 t -83.9 -46.99 18.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.85 0.357 . . . . 0.0 111.959 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.738 ' HA ' HD12 ' A' ' 16' ' ' LEU . 68.7 p -88.84 -7.5 56.04 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.768 0.318 . . . . 0.0 111.382 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.95 -34.66 78.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.139 0.495 . . . . 0.0 110.088 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.48 ' H ' ' HG ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -73.36 -11.77 60.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.612 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.738 HD12 ' HA ' ' A' ' 13' ' ' THR . 12.9 mt -94.01 -2.79 52.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.426 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.92 -13.95 52.75 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.952 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.752 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 1.7 m -63.08 115.65 4.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.995 0.426 . . . . 0.0 110.655 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -110.02 156.42 20.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.551 -179.569 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.9 m -65.84 100.99 0.6 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.138 0.494 . . . . 0.0 111.768 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.517 ' HB2' ' HD2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -121.49 108.44 13.64 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.607 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 19.6 t-20 65.04 46.3 2.83 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.231 0.538 . . . . 0.0 109.866 -178.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER 82.7 -50.96 0.18 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.25 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 3.1 m -87.2 163.55 2.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.363 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.752 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 1.2 m -85.41 130.13 34.66 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.111 0.481 . . . . 0.0 111.199 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.517 ' HD2' ' HB2' ' A' ' 21' ' ' SER . 3.2 m-85 -128.33 150.14 50.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.852 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.696 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 58.5 t30 -173.64 71.1 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.43 -52.98 4.75 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.455 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -119.01 157.99 49.14 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.402 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 N--CA 1.463 -0.274 0 C-N-CA 122.668 2.245 . . . . 0.0 111.975 -179.714 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 12.8 m . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.07 51.57 1.17 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.826 0.346 . . . . 0.0 111.493 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -158.28 149.01 20.51 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -142.38 121.72 13.13 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.926 0.394 . . . . 0.0 109.943 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.603 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 1.1 p -87.15 60.03 5.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.416 0.627 . . . . 0.0 111.238 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.889 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 12.9 t -65.68 -41.14 89.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.362 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -123.4 -56.46 1.71 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.6 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -96.47 131.68 27.92 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.84 179.12 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.603 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 37.9 Cg_endo -66.83 143.04 65.35 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.619 2.213 . . . . 0.0 112.249 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.421 ' HB3' ' OG1' ' A' ' 13' ' ' THR . 1.6 m -57.84 107.99 0.53 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.788 0.328 . . . . 0.0 110.337 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.19 -40.9 6.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.778 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.8 t -72.64 -32.11 39.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.235 0.54 . . . . 0.0 110.521 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -89.21 -1.8 58.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.657 -179.44 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.86 -37.22 84.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.798 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tp -69.07 -16.42 63.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.894 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 tp -91.23 -5.3 55.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.216 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.18 1.96 81.03 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.4 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.612 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 50.0 m -72.55 88.66 1.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.903 0.382 . . . . 0.0 110.493 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.03 153.47 26.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.012 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.9 m -76.52 106.87 8.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.911 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -81.67 -47.77 12.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.363 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -165.84 83.82 0.32 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.184 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.889 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER 68.08 5.95 4.92 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.93 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.5 p -151.43 148.04 15.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.527 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.89 135.68 33.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.758 0.313 . . . . 0.0 111.152 -178.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.443 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 4.8 m-85 -137.7 124.41 21.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.909 0.385 . . . . 0.0 111.254 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.612 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 27.1 t-20 -137.55 81.67 1.88 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.3 -53.99 4.25 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.412 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -124.05 163.68 34.14 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo . . . . . 0 C--N 1.343 0.284 0 C-N-CA 122.415 2.077 . . . . 0.0 111.695 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.232 0.179 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.15 57.28 2.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.018 0.437 . . . . 0.0 111.184 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -150.23 155.66 40.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.318 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.678 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 40.7 t -150.18 143.78 25.24 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.95 -68.81 0.75 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.701 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.401 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 56.9 t 70.81 -56.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 123.61 0.764 . . . . 0.0 111.184 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -118.95 -43.46 2.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.115 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.54 122.17 32.19 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.543 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -51.68 141.93 42.26 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.146 2.564 . . . . 0.0 112.84 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.618 ' HB3' ' OG1' ' A' ' 13' ' ' THR . 2.3 m -47.96 111.51 0.44 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.651 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.98 -41.47 5.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.238 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.44 -20.85 12.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.968 0.413 . . . . 0.0 111.123 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.618 ' OG1' ' HB3' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -88.32 7.74 30.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.094 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.19 -28.69 69.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.516 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.37 -14.93 61.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.41 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.82 -13.28 15.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.257 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.08 18.86 79.39 Favored Glycine 0 C--O 1.227 -0.315 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.72 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.852 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 75.0 m -75.81 107.3 7.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.023 0.44 . . . . 0.0 111.197 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.63 161.25 23.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.207 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.8 m -72.9 101.89 3.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.013 0.435 . . . . 0.0 110.934 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.95 111.48 16.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.512 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 64.05 49.61 2.69 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.573 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.401 ' HG2' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER 74.89 -34.96 0.28 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.529 179.718 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.678 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 1.7 m -95.06 174.69 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.699 0.285 . . . . 0.0 111.162 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.5 m -98.87 124.49 43.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.765 0.317 . . . . 0.0 110.494 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.494 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 1.4 m-30 -133.99 144.4 48.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.072 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.852 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 57.4 t30 -160.16 73.83 0.54 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.74 -59.06 4.48 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.43 HG13 ' H ' ' A' ' 29' ' ' ILE . 0.9 OUTLIER -100.09 157.82 33.15 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.549 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.494 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 2.8 Cg_exo . . . . . 0 N--CA 1.459 -0.541 0 C-N-CA 122.803 2.335 . . . . 0.0 112.18 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.654 ' HB3' HG21 ' A' ' 13' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.744 0.307 . . . . 0.0 110.526 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.44 57.78 2.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.066 0.46 . . . . 0.0 111.21 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -151.9 116.33 5.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.167 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.776 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -110.5 118.52 36.47 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.605 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.6 OUTLIER -87.84 53.37 2.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.359 0.6 . . . . 0.0 111.495 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.909 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 8.0 t -65.82 -44.16 92.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.29 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 55.2 m95 -120.56 -60.47 1.67 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.245 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.2 OUTLIER -93.49 134.42 26.72 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.943 179.039 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.605 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 16.7 Cg_exo -68.86 162.46 41.34 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.875 2.383 . . . . 0.0 112.397 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 58.7 m -63.67 133.5 53.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.739 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.16 -30.21 1.77 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.68 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.12 -53.86 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.519 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.654 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -89.17 -0.94 57.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.754 0.311 . . . . 0.0 111.36 -179.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.17 -43.05 99.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.076 0.465 . . . . 0.0 110.562 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 tp -80.19 -2.61 45.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.172 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.45 -5.04 43.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.94 0.4 . . . . 0.0 110.495 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.51 46.72 2.48 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.735 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.2 m -128.24 130.52 48.07 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.22 156.53 24.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.809 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 54.8 m -78.12 96.28 5.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.437 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.22 -45.66 54.83 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.887 0.375 . . . . 0.0 110.64 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -162.79 79.35 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.73 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.909 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER 67.39 6.7 5.05 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.747 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.776 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 3.0 p -151.95 145.42 15.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.1 m -80.72 122.05 26.65 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.894 0.378 . . . . 0.0 110.278 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.69 98.85 2.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.119 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -133.49 88.2 2.46 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.765 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.09 -58.32 4.94 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.583 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.453 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -108.9 154.38 41.9 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.306 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.461 -0.429 0 C-N-CA 122.828 2.352 . . . . 0.0 111.783 -179.857 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.462 ' HB3' HG21 ' A' ' 13' ' ' THR . 1.9 m . . . . . 0 C--O 1.233 0.226 0 CA-C-O 120.698 0.285 . . . . 0.0 110.334 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.51 54.74 2.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.053 0.454 . . . . 0.0 111.419 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -150.52 135.74 17.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.086 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.694 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -133.89 127.8 33.28 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.83 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -88.06 34.61 0.73 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.996 0.427 . . . . 0.0 112.135 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.921 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 20.7 t -62.74 -40.84 90.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -115.92 -62.54 1.58 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.756 178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -108.52 136.01 19.96 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.342 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.83 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 20.7 Cg_exo -66.7 167.12 20.06 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.946 2.431 . . . . 0.0 112.627 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m -60.87 124.23 19.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.401 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.47 -29.83 2.17 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.595 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.5 t -90.24 -54.63 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.608 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -89.44 8.7 29.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.96 0.41 . . . . 0.0 111.476 -179.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.8 -32.21 73.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.063 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.9 mt -72.23 -11.75 60.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.054 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 tp -94.88 4.28 53.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.052 0.453 . . . . 0.0 110.455 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.64 -3.95 86.44 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.757 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.795 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 80.0 m -61.2 101.4 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.958 0.408 . . . . 0.0 110.584 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -97.81 161.71 13.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.806 -179.084 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 93.1 m -75.06 92.03 2.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.55 -37.98 68.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.026 0.441 . . . . 0.0 110.163 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.421 ' O ' HG12 ' A' ' 24' ' ' VAL . 56.4 t30 -167.16 75.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.294 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.921 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER 66.62 9.56 6.72 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.506 -179.602 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.694 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.1 p -149.79 144.67 17.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 19' ' ' SER . 2.5 m -85.55 115.27 23.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.031 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.501 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 1.6 m-85 -136.16 125.74 25.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.52 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.795 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 63.2 t30 -138.21 74.08 1.46 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.45 -58.97 4.41 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.437 HG13 ' H ' ' A' ' 29' ' ' ILE . 1.0 OUTLIER -96.18 156.34 37.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 109.983 -0.376 . . . . 0.0 109.983 178.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.501 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 5.1 Cg_exo . . . . . 0 N--CA 1.461 -0.409 0 C-N-CA 122.69 2.26 . . . . 0.0 112.093 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.66 57.08 1.56 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.964 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -155.86 111.71 3.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.149 0.499 . . . . 0.0 110.121 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.737 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -110.01 122.65 48.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.41 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.591 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -87.96 50.13 1.93 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.132 0.491 . . . . 0.0 111.311 -179.128 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.992 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 2.1 t -64.96 -48.2 85.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.44 -53.16 2.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.517 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -100.46 131.42 23.9 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.269 179.473 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.591 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 16.6 Cg_exo -68.22 149.43 76.04 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.884 2.39 . . . . 0.0 112.29 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -67.48 143.95 55.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.818 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.29 -24.62 1.6 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.439 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -80.64 -56.61 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.9 0.381 . . . . 0.0 111.64 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.538 ' HA ' HD12 ' A' ' 16' ' ' LEU . 40.3 p -88.29 -5.52 58.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.24 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.9 -39.76 93.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.63 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 mt -78.44 -4.11 46.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.809 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.538 HD12 ' HA ' ' A' ' 13' ' ' THR . 67.5 mt -100.42 2.5 42.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.389 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 107.93 -23.54 25.4 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.951 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.628 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 82.7 m -62.24 105.68 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.913 0.387 . . . . 0.0 110.624 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -110.09 155.78 21.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.688 -179.292 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 t -65.52 101.46 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.011 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.77 -39.83 15.56 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.14 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -165.41 76.06 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.088 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.992 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER 67.38 8.8 6.53 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.458 -179.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.737 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 4.0 p -151.88 145.95 15.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 19' ' ' SER . 50.9 m -91.59 126.82 36.8 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.971 0.415 . . . . 0.0 110.949 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -132.2 149.37 52.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.609 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.628 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 58.1 t30 -158.99 73.74 0.62 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.96 -55.69 4.79 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -110.29 160.08 29.7 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo . . . . . 0 C--O 1.233 0.263 0 C-N-CA 122.782 2.322 . . . . 0.0 112.165 -179.621 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.4 ' HB3' HG21 ' A' ' 13' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.7 57.18 2.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.953 0.406 . . . . 0.0 111.629 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.707 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.8 mt-10 -153.01 137.15 16.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.759 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.659 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -131.93 126.17 33.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.833 0.349 . . . . 0.0 110.413 -179.484 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.633 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER -89.03 35.12 0.79 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.023 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.503 HG22 ' HB3' ' A' ' 23' ' ' LYS . 5.1 t -64.1 -31.4 53.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.44 0.638 . . . . 0.0 109.437 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -131.55 -46.02 0.98 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.012 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.633 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -122.22 129.09 25.24 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.925 179.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.617 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 30.3 Cg_endo -64.31 150.34 88.47 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.751 2.3 . . . . 0.0 112.844 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.707 ' SG ' ' HB3' ' A' ' 3' ' ' GLU . 47.5 m -60.03 135.09 57.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.814 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.79 -33.26 2.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.062 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.2 t -75.26 -53.11 16.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 0.0 111.149 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.4 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -89.58 6.48 40.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.006 0.431 . . . . 0.0 111.13 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.33 -31.41 72.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.084 0.468 . . . . 0.0 110.489 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mt -69.2 -13.87 62.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.983 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.26 6.35 49.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.345 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 79.53 6.21 89.05 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.506 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.722 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 19.5 m -62.17 111.75 2.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.824 0.345 . . . . 0.0 110.679 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -111.44 148.52 32.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.219 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -73.88 95.55 2.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.617 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -37.19 66.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.472 0.653 . . . . 0.0 110.213 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.584 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 4.9 t-20 -147.92 63.0 1.12 Allowed 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.6 OUTLIER 81.75 -52.44 0.25 Allowed 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.668 -177.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.659 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.2 p -89.64 144.27 9.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.684 0.278 . . . . 0.0 110.318 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.722 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 21.7 m -74.7 124.63 27.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.891 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.81 96.42 3.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.604 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.681 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 64.7 t30 -118.53 76.2 1.07 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.03 -54.46 4.72 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.446 ' H ' HG13 ' A' ' 29' ' ' ILE . 1.0 OUTLIER -105.93 154.99 39.08 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 N--CA 1.463 -0.316 0 C-N-CA 122.336 2.024 . . . . 0.0 112.224 -179.822 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.555 ' HB3' HG21 ' A' ' 13' ' ' THR . 1.9 m . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.935 0.398 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.19 57.94 3.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.651 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -149.34 117.31 6.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.099 0.476 . . . . 0.0 109.931 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -109.22 142.76 39.58 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -88.94 -87.23 0.17 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.082 -178.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.592 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 44.5 t 71.16 -55.38 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 123.301 0.64 . . . . 0.0 111.115 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -127.65 -38.22 1.91 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.073 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.523 ' H ' HG13 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -109.04 145.3 31.45 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.122 -179.424 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 5.3 Cg_exo -77.64 157.54 32.0 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.944 2.429 . . . . 0.0 112.131 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 m -61.34 128.68 37.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.049 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.68 -32.6 3.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.895 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.8 t -86.93 -49.4 14.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.687 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.555 HG21 ' HB3' ' A' ' 1' ' ' CYS . 70.9 p -89.62 4.13 50.41 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.913 0.387 . . . . 0.0 111.361 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.26 -35.35 78.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.569 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.541 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -73.08 -12.29 60.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.822 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.59 -1.21 44.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.247 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.5 -1.43 88.35 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.804 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.763 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 71.4 m -61.9 108.94 1.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.995 0.426 . . . . 0.0 110.522 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -103.3 154.95 18.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.933 -179.126 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.0 t -67.87 97.96 0.7 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.587 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.29 -42.21 19.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 2.7 t-20 -156.04 63.41 0.57 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.398 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.592 ' HG2' ' HA ' ' A' ' 6' ' ' VAL . 1.7 mtmp? 76.67 9.1 3.01 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.7 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.662 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.1 p -148.39 142.76 19.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 19' ' ' SER . 3.4 m -85.87 123.01 30.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.942 0.401 . . . . 0.0 111.321 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.461 ' CE2' ' HA ' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -139.34 148.74 43.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.348 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.763 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 63.7 t30 -160.58 74.27 0.52 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.063 0.459 . . . . 0.0 109.816 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.34 -59.7 4.0 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.469 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -89.85 156.82 46.88 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.461 ' HA ' ' CE2' ' A' ' 26' ' ' TYR . 2.8 Cg_exo . . . . . 0 N--CA 1.46 -0.482 0 C-N-CA 122.747 2.298 . . . . 0.0 112.024 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.21 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.51 60.0 2.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.031 0.444 . . . . 0.0 111.424 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.534 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 2.3 tt0 -152.23 122.57 7.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.032 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.0 OUTLIER -116.98 132.12 56.78 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.649 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -89.18 -73.06 0.52 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.12 -179.106 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.54 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 47.8 t 70.94 -56.27 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.505 0.722 . . . . 0.0 110.657 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -125.06 -41.17 2.1 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.393 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.2 mt -116.0 120.64 35.12 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.292 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.649 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 14.9 Cg_endo -57.54 150.16 62.23 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.114 2.543 . . . . 0.0 113.341 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.534 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 17.8 m -62.48 160.21 14.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.509 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.83 -26.3 1.36 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.904 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.1 t -80.96 -60.34 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.19 2.51 54.1 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.962 0.41 . . . . 0.0 111.221 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.15 -33.43 75.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.508 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mt -71.13 -12.32 61.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.952 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.84 6.2 49.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.087 0.47 . . . . 0.0 110.136 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.27 -8.19 79.6 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.372 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.661 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 68.7 m -62.0 107.15 0.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.884 0.373 . . . . 0.0 110.647 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -112.65 161.48 16.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.943 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.6 m -73.47 78.95 1.42 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.657 0.265 . . . . 0.0 111.095 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -36.25 82.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.388 0.613 . . . . 0.0 110.442 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 8.4 t-20 -144.14 57.21 1.33 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.294 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.54 ' HG2' ' HA ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER 79.54 -38.77 0.19 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.418 -178.458 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.0 p -101.02 148.35 7.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.66 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 18.8 m -74.98 117.02 16.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.902 0.382 . . . . 0.0 111.184 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -139.38 115.79 10.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.58 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.661 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 57.4 t30 -135.69 77.96 1.7 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.615 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.21 -60.97 4.21 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -94.92 154.9 39.64 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.461 -0.435 0 C-N-CA 122.772 2.314 . . . . 0.0 112.115 -179.666 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.472 ' HB3' HG21 ' A' ' 13' ' ' THR . 16.6 m . . . . . 0 C--O 1.233 0.231 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.34 54.64 1.44 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.021 0.439 . . . . 0.0 111.567 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -160.69 144.84 13.84 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.502 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.661 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.1 t -147.51 144.93 28.9 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.713 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -86.7 14.83 6.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.418 -178.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.519 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 5.0 t -63.59 -39.83 86.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -105.31 -63.42 1.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.205 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.713 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -124.14 158.77 59.6 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.553 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.06 161.76 43.78 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.392 2.061 . . . . 0.0 112.758 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.1 m -64.41 113.66 3.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.051 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.55 -32.95 2.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.719 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.5 t -87.1 -46.8 16.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.477 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.584 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 81.3 p -89.69 3.69 51.91 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.832 0.349 . . . . 0.0 111.459 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.01 83.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.006 0.432 . . . . 0.0 110.727 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.73 -4.28 42.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.049 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tp -99.83 -1.78 36.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.08 0.467 . . . . 0.0 110.345 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.11 -0.43 81.74 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.39 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.595 ' HA ' ' HB3' ' A' ' 27' ' ' ASN . 61.3 m -64.66 104.5 0.82 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.964 0.411 . . . . 0.0 110.464 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.29 149.91 21.54 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.827 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.5 t -76.16 111.18 11.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.012 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.504 ' HB2' ' H ' ' A' ' 22' ' ' ASN . 0.1 OUTLIER -96.64 -102.0 0.18 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.504 ' H ' ' HB2' ' A' ' 21' ' ' SER . 7.6 p-10 -88.6 61.57 6.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.124 0.488 . . . . 0.0 109.738 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.519 ' HE3' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER 65.37 32.48 9.68 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.871 -179.119 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.661 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.4 p -151.69 145.54 16.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.2 m -86.22 119.74 26.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.931 0.396 . . . . 0.0 110.994 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -134.33 139.49 45.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.607 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.595 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 35.6 p-10 -134.14 22.52 3.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.628 0.728 . . . . 0.0 109.963 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.09 -29.93 8.06 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -119.72 150.86 51.21 Favored Pre-proline 0 N--CA 1.446 -0.642 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo . . . . . 0 N--CA 1.464 -0.251 0 C-N-CA 122.293 1.995 . . . . 0.0 112.356 -178.971 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.234 0.258 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.16 54.67 1.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.998 0.428 . . . . 0.0 111.42 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.452 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 2.4 tt0 -157.92 123.86 4.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.192 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -120.27 132.07 55.18 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.244 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.515 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -88.87 -70.33 0.66 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.15 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.42 HG22 ' HB3' ' A' ' 23' ' ' LYS . 45.9 t 70.66 -56.61 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.578 0.751 . . . . 0.0 110.652 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -126.31 -39.87 2.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.66 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.442 ' H ' HG13 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -114.08 122.99 33.46 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.561 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.515 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 15.3 Cg_endo -57.38 149.5 65.0 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.204 2.603 . . . . 0.0 113.542 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.452 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 34.0 m -64.09 158.55 22.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.397 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.17 -25.55 1.35 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.828 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.09 -60.32 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.15 1.16 56.04 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.817 0.341 . . . . 0.0 111.468 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.87 -32.76 74.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.068 0.461 . . . . 0.0 110.552 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.84 -7.48 53.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.034 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 mp -97.54 7.31 46.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.12 0.486 . . . . 0.0 110.308 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.69 -10.02 70.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.485 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.846 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 70.9 m -62.55 109.21 1.31 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.793 0.33 . . . . 0.0 110.673 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -116.13 154.68 29.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.015 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.4 m -71.28 84.27 0.77 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.656 0.265 . . . . 0.0 111.196 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -34.51 58.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.221 0.534 . . . . 0.0 110.329 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 3.8 t-20 -151.03 61.84 0.91 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.416 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER 79.9 -45.18 0.3 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.708 -178.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 1.7 p -96.57 148.9 5.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.846 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 4.2 m -76.57 126.27 30.69 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.158 0.504 . . . . 0.0 111.553 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -134.46 138.45 44.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.114 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.488 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 29.2 p-10 -133.98 15.86 3.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.734 0.778 . . . . 0.0 109.777 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.36 -36.93 2.28 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.418 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -121.42 159.66 49.25 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo . . . . . 0 N--CA 1.461 -0.393 0 C-N-CA 122.175 1.917 . . . . 0.0 112.471 -179.11 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.453 -0.304 0 CA-C-O 120.741 0.305 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.93 58.09 2.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 111.533 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.449 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 2.5 tt0 -157.68 138.85 13.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.773 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.652 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.6 OUTLIER -137.88 135.44 36.15 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.708 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -88.45 22.34 2.58 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.563 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.42 HG22 ' HB3' ' A' ' 23' ' ' LYS . 12.4 t -70.4 -23.19 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.427 0.632 . . . . 0.0 109.497 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.04 -51.27 1.32 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.566 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.708 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.7 OUTLIER -126.91 148.06 63.93 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.554 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.05 157.42 57.84 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.474 2.116 . . . . 0.0 112.171 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.7 m -62.74 118.94 8.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.925 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.7 -32.56 2.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.653 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.7 t -87.27 -48.14 15.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.549 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.594 ' HA ' HD12 ' A' ' 16' ' ' LEU . 69.1 p -89.4 -3.97 58.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.821 0.343 . . . . 0.0 111.397 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.08 -37.67 83.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.723 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.52 -12.21 61.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.008 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.594 HD12 ' HA ' ' A' ' 13' ' ' THR . 14.8 mt -97.24 4.46 50.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.319 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.39 -5.07 84.26 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.036 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.822 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 85.2 m -63.73 101.86 0.4 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.995 0.426 . . . . 0.0 110.739 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -95.27 156.59 16.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.837 -179.3 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.6 t -76.23 96.98 4.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.273 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.2 -43.49 33.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.933 0.397 . . . . 0.0 111.054 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -156.97 66.56 0.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.31 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER 72.73 14.01 5.09 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.644 -179.299 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.652 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 1.5 p -151.42 141.22 15.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 3' ' ' GLU . 1.4 m -81.99 118.07 22.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.903 0.382 . . . . 0.0 110.491 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.46 125.33 24.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.9 -179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.822 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 59.1 t30 -136.33 67.37 1.46 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.68 -59.68 4.42 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.421 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.7 mm -97.37 135.31 21.85 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo . . . . . 0 C--N 1.345 0.387 0 C-N-CA 122.995 2.463 . . . . 0.0 112.578 -179.429 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.668 ' HB3' HG21 ' A' ' 13' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.709 0.29 . . . . 0.0 110.366 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.83 55.95 2.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.025 0.44 . . . . 0.0 111.238 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.504 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 0.7 OUTLIER -155.91 135.15 12.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.804 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.773 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -123.72 130.28 52.4 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -88.12 49.99 1.9 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.236 -179.411 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.818 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -72.25 -66.07 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.755 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.565 ' HZ3' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -127.36 8.8 6.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.727 178.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.1 pt -141.21 151.74 62.53 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.359 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.571 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 13.8 Cg_endo -90.43 151.69 4.42 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.98 2.453 . . . . 0.0 111.967 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -63.76 128.34 35.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.452 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.58 -34.69 2.2 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.028 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.43 -56.11 7.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.929 0.395 . . . . 0.0 111.259 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.668 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -89.8 11.23 20.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.038 0.447 . . . . 0.0 111.262 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.77 -35.37 80.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.462 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mt -70.12 -11.59 61.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.19 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.87 2.82 55.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.377 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.01 0.65 89.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.705 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.717 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 86.7 m -62.32 103.4 0.39 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.83 0.347 . . . . 0.0 110.74 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -98.46 159.57 14.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.664 -179.255 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 5' ' ' CYS . 1.6 m -77.04 81.87 3.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.9 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -61.44 1.89 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.128 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.452 ' O ' HG12 ' A' ' 24' ' ' VAL . 3.8 t30 -130.48 67.33 1.49 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 0.0 110.496 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.818 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.4 OUTLIER 64.99 16.25 10.46 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.041 -179.498 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.773 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.1 p -151.04 144.9 16.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 19' ' ' SER . 3.6 m -80.51 110.76 16.28 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -135.28 118.45 16.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.195 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.717 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 62.3 t30 -131.4 70.04 1.47 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.41 -60.45 4.53 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.42 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.498 HG13 ' HD2' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -95.01 138.27 22.07 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.498 ' HD2' HG13 ' A' ' 29' ' ' ILE . 21.9 Cg_endo . . . . . 0 C--N 1.346 0.417 0 C-N-CA 122.513 2.142 . . . . 0.0 112.266 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.615 ' HB3' HG21 ' A' ' 13' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.815 0.34 . . . . 0.0 110.708 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.82 59.54 4.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.648 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.473 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 1.3 tt0 -151.22 134.34 15.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.824 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.743 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -123.28 137.0 54.96 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -86.39 -7.84 58.13 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.123 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.4 m -74.36 -12.23 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.461 0.648 . . . . 0.0 109.48 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -112.31 -54.98 2.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.868 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.5 OUTLIER -149.29 148.5 26.71 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.05 179.602 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.456 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 21.8 Cg_exo -64.39 144.78 86.72 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.167 1.911 . . . . 0.0 111.407 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.74 115.56 2.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.983 0.42 . . . . 0.0 110.955 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.87 -33.74 2.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.686 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.2 t -77.86 -55.86 9.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.747 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.615 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -90.03 10.44 24.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.059 0.457 . . . . 0.0 111.036 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.88 -32.54 74.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.446 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 tp -66.71 -16.03 63.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.083 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.04 3.25 49.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.553 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.67 6.6 88.96 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.828 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.673 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 55.6 m -64.95 103.46 0.73 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.683 0.278 . . . . 0.0 110.888 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.1 m -104.34 143.13 33.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.152 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -66.32 99.15 0.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.9 0.381 . . . . 0.0 111.214 -179.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.85 -71.46 0.68 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.741 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -90.61 60.39 4.54 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.712 ' HD2' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER 74.84 -40.86 0.45 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.871 -178.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.743 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 0.5 OUTLIER -103.17 154.69 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 3.9 m -69.54 120.56 15.51 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.891 0.377 . . . . 0.0 110.594 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -130.37 145.23 51.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.496 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.673 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 65.4 t30 -164.57 73.74 0.25 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.11 -57.33 4.97 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.339 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -106.36 148.73 37.24 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.053 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 29' ' ' ILE . 13.4 Cg_exo . . . . . 0 C--N 1.345 0.349 0 C-N-CA 122.647 2.231 . . . . 0.0 111.857 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.464 ' HB3' HG21 ' A' ' 13' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.743 0.306 . . . . 0.0 110.632 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.93 55.5 1.44 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.094 0.473 . . . . 0.0 111.712 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.421 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 2.0 tt0 -149.35 110.48 4.38 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.887 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.715 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -110.94 117.21 32.76 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.646 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.473 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.6 OUTLIER -87.93 69.51 9.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.279 0.561 . . . . 0.0 110.737 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.921 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 4.7 t -64.13 -38.76 83.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.175 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -127.79 -58.07 1.24 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.969 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.476 ' H ' HG13 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -97.42 143.85 26.9 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.269 179.32 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.473 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 21.0 Cg_exo -66.5 158.4 55.73 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 123.075 2.517 . . . . 0.0 112.942 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.421 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 4.4 m -68.36 151.9 46.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.026 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.45 -25.47 1.31 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.716 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.49 -58.97 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.464 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -88.96 -1.66 58.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.79 0.329 . . . . 0.0 111.432 -179.182 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.33 -34.06 77.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.08 0.467 . . . . 0.0 110.271 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.45 -5.1 48.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.898 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.51 10.07 41.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.351 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.59 -18.22 57.82 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.727 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.675 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 65.8 m -63.27 108.73 1.36 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.821 0.344 . . . . 0.0 110.374 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.1 OUTLIER -104.9 156.84 17.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.697 -179.279 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 23.5 m -64.42 100.99 0.39 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.879 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.77 71.79 1.18 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.765 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.4 t30 72.17 75.52 0.16 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.095 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.921 ' HG2' ' HA ' ' A' ' 6' ' ' VAL . 7.4 mttp 66.28 4.6 3.25 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.715 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.2 p -150.72 135.81 10.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 4.7 m -81.65 132.65 35.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.083 0.468 . . . . 0.0 111.964 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -137.84 163.58 31.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.85 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.675 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 47.9 t30 -167.1 -104.73 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -97.68 -17.2 31.48 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.703 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.475 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -146.0 164.72 23.75 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 47.2 Cg_endo . . . . . 0 CA--C 1.529 0.274 0 C-N-CA 122.287 1.991 . . . . 0.0 111.913 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.725 0.298 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.55 51.0 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.0 111.735 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -158.59 119.06 3.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.892 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.761 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -119.87 121.37 38.9 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.901 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -88.0 56.25 3.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.312 0.577 . . . . 0.0 111.133 -179.38 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.428 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 12.5 t -65.89 -33.09 61.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.384 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -135.48 -48.25 0.7 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.919 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -110.01 132.2 21.56 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.195 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.901 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 22.9 Cg_exo -65.22 153.19 79.44 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.95 2.433 . . . . 0.0 112.622 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.0 m -67.63 147.74 52.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.312 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.81 -23.37 1.57 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.294 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 t -84.36 -57.07 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.846 0.355 . . . . 0.0 111.899 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.678 ' HA ' HD12 ' A' ' 16' ' ' LEU . 35.7 p -88.1 -3.29 58.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.709 0.29 . . . . 0.0 111.373 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 18' ' ' CYS . . . -61.65 -37.03 82.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.108 0.48 . . . . 0.0 110.523 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.7 mt -80.39 -0.78 38.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.007 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.678 HD12 ' HA ' ' A' ' 13' ' ' THR . 39.6 mt -105.11 8.91 34.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.041 0.448 . . . . 0.0 110.584 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.23 -21.57 39.22 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.879 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.774 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 84.8 m -64.07 108.29 1.49 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.979 0.419 . . . . 0.0 110.505 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.37 149.6 32.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.666 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 67.9 m -65.35 109.44 2.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.329 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.86 -63.28 1.14 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.2 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.78 68.38 1.47 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.109 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' ' 6' ' ' VAL . 19.8 mttm 68.08 15.41 9.43 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.021 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.761 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 3.0 p -152.12 149.26 13.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.774 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 3.9 m -90.95 130.01 36.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.098 0.475 . . . . 0.0 111.491 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -132.33 138.9 47.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.415 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.431 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 31.5 p-10 -133.61 18.47 3.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.932 0.872 . . . . 0.0 109.165 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.53 -32.9 3.25 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -131.67 161.42 62.42 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 114.216 -0.992 . . . . 0.0 108.436 178.135 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 40.7 Cg_endo . . . . . 0 CA--C 1.529 0.241 0 C-N-CA 122.037 1.825 . . . . 0.0 112.424 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.233 0.233 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.21 54.62 1.4 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.969 0.414 . . . . 0.0 111.384 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.547 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 4.7 tt0 -152.75 105.45 2.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.354 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -102.09 138.85 38.5 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.089 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.67 -61.32 1.74 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.846 0.355 . . . . 0.0 111.021 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.992 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 48.3 t 70.09 -59.31 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.704 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -135.15 -33.56 0.9 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.614 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 mt -109.28 123.51 36.55 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.563 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.89 140.38 93.61 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.859 2.373 . . . . 0.0 112.964 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.547 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 2.7 m -64.1 153.77 36.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.091 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.8 -23.83 1.35 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.7 t -77.39 -61.71 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.899 0.38 . . . . 0.0 111.77 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.39 1.15 56.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.908 0.385 . . . . 0.0 111.259 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.03 -34.0 76.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.083 0.468 . . . . 0.0 110.371 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -8.9 57.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.831 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.36 3.91 53.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.219 0.533 . . . . 0.0 110.154 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.92 -14.78 58.59 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.455 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 62.0 m -62.82 104.55 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.915 0.388 . . . . 0.0 110.649 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -107.37 148.52 28.96 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.511 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.6 t -61.7 107.89 0.9 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.289 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.42 ' HB2' ' H ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER -106.0 -94.58 0.36 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.722 179.557 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.42 ' H ' ' HB2' ' A' ' 21' ' ' SER . 6.7 p-10 -86.33 58.53 5.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.983 0.42 . . . . 0.0 110.333 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.992 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER 72.48 3.62 4.74 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.648 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.1 p -139.19 149.44 23.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 19' ' ' SER . 54.5 m -84.36 124.6 31.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.894 0.378 . . . . 0.0 111.813 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.54 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 6.3 m-85 -129.01 150.75 50.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.076 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.467 ' OD1' HG13 ' A' ' 29' ' ' ILE . 27.4 p-10 -140.56 16.08 2.36 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.63 0.728 . . . . 0.0 109.997 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.22 -41.54 1.56 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.484 HG13 ' H ' ' A' ' 29' ' ' ILE . 0.7 OUTLIER -113.08 160.03 32.53 Favored Pre-proline 0 N--CA 1.446 -0.672 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.218 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.54 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 57.2 Cg_endo . . . . . 0 N--CA 1.46 -0.457 0 C-N-CA 121.739 1.626 . . . . 0.0 112.912 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.68 -33.69 76.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.699 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.72 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 2.4 mt-10 -75.88 138.43 41.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.101 0.477 . . . . 0.0 110.902 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.81 126.14 29.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.722 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 1.8 m -88.79 36.82 0.81 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.556 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 12.9 t -65.71 -31.31 53.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -131.0 -49.8 1.02 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.623 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.61 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.2 mt -117.58 128.45 26.0 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.906 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 30.7 Cg_endo -63.96 151.17 86.41 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.726 2.284 . . . . 0.0 113.066 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.72 ' SG ' ' HB3' ' A' ' 3' ' ' GLU . 77.3 m -59.89 134.78 57.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.908 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -123.93 -38.55 2.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.737 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.5 p -88.32 -37.84 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 0.2 OUTLIER -91.96 -5.5 52.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.015 0.436 . . . . 0.0 110.881 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.35 -31.82 73.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.091 0.472 . . . . 0.0 110.549 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 15' ' ' LEU . 1.2 mm? -71.84 -11.24 60.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.968 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.38 8.36 44.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.081 0.467 . . . . 0.0 110.218 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.42 -3.94 83.96 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.413 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.784 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 55.6 m -63.28 110.17 1.8 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 110.811 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.5 141.53 48.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.764 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.83 96.78 1.7 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.782 0.325 . . . . 0.0 110.898 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.76 -37.16 27.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.42 0.629 . . . . 0.0 110.187 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.563 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 5.0 t-20 -146.29 64.99 1.2 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.9 OUTLIER 80.1 -53.61 0.37 Allowed 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.096 -178.124 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.3 m -89.43 150.64 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 120.705 0.288 . . . . 0.0 110.364 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.784 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 1.6 m -77.35 130.88 37.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.974 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.57 114.74 10.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.395 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.584 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 35.0 p-10 -116.01 19.15 15.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.812 0.815 . . . . 0.0 109.454 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.0 -33.1 3.13 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -128.64 157.18 75.94 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.127 -1.036 . . . . 0.0 108.269 177.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo . . . . . 0 N--CA 1.461 -0.386 0 C-N-CA 122.006 1.804 . . . . 0.0 112.524 -179.098 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.515 ' HB3' HG21 ' A' ' 13' ' ' THR . 2.0 m . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 120.729 0.299 . . . . 0.0 110.462 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.64 56.42 1.83 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.513 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -147.28 120.4 8.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.992 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.754 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -122.61 123.05 40.3 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.836 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.1 OUTLIER -86.77 58.31 5.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.242 0.544 . . . . 0.0 111.836 -178.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.483 HG22 ' HG2' ' A' ' 23' ' ' LYS . 1.6 t -83.04 -29.01 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.27 -47.51 0.71 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.547 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -116.44 133.78 22.94 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.974 179.784 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.836 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 61.2 Cg_endo -73.62 175.25 10.96 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.739 2.293 . . . . 0.0 112.768 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.4 m -60.32 120.1 9.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.848 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.01 -39.61 2.49 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.345 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.1 m -95.93 -42.21 12.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.515 HG21 ' HB3' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -90.7 3.52 54.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.015 0.436 . . . . 0.0 111.26 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.62 -35.42 80.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.309 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.3 tp -71.36 -11.44 60.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.937 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.35 2.68 56.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.021 0.438 . . . . 0.0 110.237 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.71 -6.43 83.01 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.596 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.724 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 72.0 m -64.53 98.39 0.25 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.867 0.365 . . . . 0.0 110.784 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 1.2 m -92.37 155.61 17.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.34 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.4 m -63.8 97.18 0.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.078 0.466 . . . . 0.0 111.53 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.44 62.5 3.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.707 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.0 t30 69.83 90.92 0.09 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.024 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.483 ' HG2' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER 69.54 -10.13 0.6 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 178.308 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.754 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 1.7 p -149.32 138.49 15.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 121.532 -0.73 . . . . 0.0 111.25 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 19' ' ' SER . 6.8 m -80.95 125.25 29.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.66 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.452 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -138.53 150.58 46.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.886 0.374 . . . . 0.0 110.966 -179.594 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.724 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 64.0 t30 -161.77 67.88 0.28 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.184 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.87 -60.22 4.42 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.94 156.3 46.95 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 61.1 Cg_endo . . . . . 0 N--CA 1.461 -0.415 0 C-N-CA 122.413 2.075 . . . . 0.0 112.254 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 10.8 m . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.633 0.254 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.77 49.21 1.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.913 0.387 . . . . 0.0 111.815 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.576 ' CD ' ' HB3' ' A' ' 10' ' ' CYS . 5.8 tt0 -154.63 135.36 13.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.586 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.4 t -130.08 134.96 47.72 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.823 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.778 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -89.85 -77.48 0.39 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.525 -179.147 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.4 t 72.02 -56.77 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.691 0.797 . . . . 0.0 110.444 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -115.62 -46.92 2.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.303 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.5 mt -118.51 121.21 31.16 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.152 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.778 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 52.2 Cg_exo -55.01 144.81 66.73 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.019 2.479 . . . . 0.0 112.821 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.576 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . 3.3 m -57.39 150.35 18.62 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.936 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.1 -20.84 4.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.734 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.8 t -81.2 -54.77 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 0.0 111.321 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.594 ' HA ' HD13 ' A' ' 16' ' ' LEU . 40.9 p -88.85 4.08 48.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.812 0.339 . . . . 0.0 111.601 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.34 86.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.156 0.503 . . . . 0.0 110.421 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.82 -6.01 52.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.75 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.594 HD13 ' HA ' ' A' ' 13' ' ' THR . 3.4 mp -96.17 -11.1 26.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.319 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.3 -16.02 27.32 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.464 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.759 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 78.1 m -62.74 119.07 8.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.78 0.324 . . . . 0.0 110.765 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.63 154.58 40.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.75 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 18.6 m -70.47 92.7 0.84 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.146 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -91.38 -34.02 15.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.015 0.436 . . . . 0.0 110.993 -179.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 12.2 t-20 -148.69 63.62 1.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER 78.51 -49.41 0.46 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.113 -178.396 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.6 m -93.93 169.18 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.759 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 1.8 m -90.77 130.58 36.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.096 0.474 . . . . 0.0 111.539 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.543 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 7.9 m-85 -125.88 148.61 49.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.08 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.69 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 48.9 t30 -166.39 74.6 0.17 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.73 -53.84 4.75 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.548 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -124.52 164.38 30.91 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.424 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.548 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 45.1 Cg_endo . . . . . 0 CA--C 1.53 0.304 0 C-N-CA 122.176 1.917 . . . . 0.0 112.109 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.431 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 120.702 0.287 . . . . 0.0 110.236 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.15 -26.71 56.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.507 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.606 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 2.3 mt-10 -80.55 150.81 29.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.474 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.2 t -147.44 130.79 16.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.492 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 1.7 m -89.38 39.62 0.95 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.07 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.568 HG13 ' HD1' ' A' ' 7' ' ' TRP . 7.4 p -66.32 -28.11 42.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.737 0.78 . . . . 0.0 109.456 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.568 ' HD1' HG13 ' A' ' 6' ' ' VAL . 48.3 m95 -135.79 -44.85 0.66 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.737 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -126.72 131.09 23.75 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.86 179.618 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.495 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 33.9 Cg_exo -60.7 148.61 91.09 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.891 2.394 . . . . 0.0 113.004 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 3' ' ' GLU . 17.4 m -62.14 143.58 56.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.91 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.17 -33.57 2.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.29 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.8 t -83.9 -46.99 18.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.85 0.357 . . . . 0.0 111.959 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.738 ' HA ' HD12 ' A' ' 16' ' ' LEU . 68.7 p -88.84 -7.5 56.04 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.768 0.318 . . . . 0.0 111.382 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.95 -34.66 78.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.139 0.495 . . . . 0.0 110.088 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.48 ' H ' ' HG ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -73.36 -11.77 60.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.612 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.738 HD12 ' HA ' ' A' ' 13' ' ' THR . 12.9 mt -94.01 -2.79 52.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.426 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.92 -13.95 52.75 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.952 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.752 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 1.7 m -63.08 115.65 4.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.995 0.426 . . . . 0.0 110.655 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -110.02 156.42 20.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.551 -179.569 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.9 m -65.84 100.99 0.6 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.138 0.494 . . . . 0.0 111.768 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.517 ' HB2' ' HD2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -121.49 108.44 13.64 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.607 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 19.6 t-20 65.04 46.3 2.83 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.231 0.538 . . . . 0.0 109.866 -178.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER 82.7 -50.96 0.18 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.25 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 3.1 m -87.2 163.55 2.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.363 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.752 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 1.2 m -85.41 130.13 34.66 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.111 0.481 . . . . 0.0 111.199 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.517 ' HD2' ' HB2' ' A' ' 21' ' ' SER . 3.2 m-85 -128.33 150.14 50.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.852 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.696 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 58.5 t30 -173.64 71.1 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.43 -52.98 4.75 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.455 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -119.01 157.99 49.14 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.402 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 N--CA 1.463 -0.274 0 C-N-CA 122.668 2.245 . . . . 0.0 111.975 -179.714 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 12.8 m . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.07 51.57 1.17 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.826 0.346 . . . . 0.0 111.493 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -158.28 149.01 20.51 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -142.38 121.72 13.13 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.926 0.394 . . . . 0.0 109.943 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.603 ' HB3' ' HA ' ' A' ' 9' ' ' PRO . 1.1 p -87.15 60.03 5.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.416 0.627 . . . . 0.0 111.238 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.889 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . 12.9 t -65.68 -41.14 89.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.362 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -123.4 -56.46 1.71 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.6 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -96.47 131.68 27.92 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.84 179.12 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.603 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 37.9 Cg_endo -66.83 143.04 65.35 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.619 2.213 . . . . 0.0 112.249 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.421 ' HB3' ' OG1' ' A' ' 13' ' ' THR . 1.6 m -57.84 107.99 0.53 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.788 0.328 . . . . 0.0 110.337 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.19 -40.9 6.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.778 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.8 t -72.64 -32.11 39.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.235 0.54 . . . . 0.0 110.521 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -89.21 -1.8 58.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.657 -179.44 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.86 -37.22 84.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.798 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 tp -69.07 -16.42 63.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.894 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 tp -91.23 -5.3 55.03 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.216 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.18 1.96 81.03 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.4 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.612 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 50.0 m -72.55 88.66 1.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.903 0.382 . . . . 0.0 110.493 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.03 153.47 26.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.012 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.9 m -76.52 106.87 8.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.911 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -81.67 -47.77 12.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.363 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -165.84 83.82 0.32 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.184 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.889 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER 68.08 5.95 4.92 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.93 -179.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 2.5 p -151.43 148.04 15.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.527 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -87.89 135.68 33.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.758 0.313 . . . . 0.0 111.152 -178.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.443 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 4.8 m-85 -137.7 124.41 21.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.909 0.385 . . . . 0.0 111.254 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.612 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 27.1 t-20 -137.55 81.67 1.88 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.3 -53.99 4.25 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.412 ' H ' HG13 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -124.05 163.68 34.14 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo . . . . . 0 C--N 1.343 0.284 0 C-N-CA 122.415 2.077 . . . . 0.0 111.695 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.232 0.179 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.15 57.28 2.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.018 0.437 . . . . 0.0 111.184 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -150.23 155.66 40.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.318 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.678 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 40.7 t -150.18 143.78 25.24 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.95 -68.81 0.75 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.701 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.401 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 56.9 t 70.81 -56.55 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 123.61 0.764 . . . . 0.0 111.184 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -118.95 -43.46 2.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.115 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.54 122.17 32.19 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.543 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -51.68 141.93 42.26 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.146 2.564 . . . . 0.0 112.84 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.618 ' HB3' ' OG1' ' A' ' 13' ' ' THR . 2.3 m -47.96 111.51 0.44 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.651 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.98 -41.47 5.85 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.238 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.44 -20.85 12.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.968 0.413 . . . . 0.0 111.123 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.618 ' OG1' ' HB3' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -88.32 7.74 30.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.094 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.19 -28.69 69.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.516 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.37 -14.93 61.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.41 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.82 -13.28 15.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.257 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.08 18.86 79.39 Favored Glycine 0 C--O 1.227 -0.315 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.72 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.852 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 75.0 m -75.81 107.3 7.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.023 0.44 . . . . 0.0 111.197 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.63 161.25 23.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.207 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.8 m -72.9 101.89 3.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.013 0.435 . . . . 0.0 110.934 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.95 111.48 16.07 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.512 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 64.05 49.61 2.69 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.573 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.401 ' HG2' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER 74.89 -34.96 0.28 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.529 179.718 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.678 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 1.7 m -95.06 174.69 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.699 0.285 . . . . 0.0 111.162 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.5 m -98.87 124.49 43.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.765 0.317 . . . . 0.0 110.494 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.494 ' CE1' ' HA ' ' A' ' 30' ' ' PRO . 1.4 m-30 -133.99 144.4 48.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.072 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.852 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 57.4 t30 -160.16 73.83 0.54 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.74 -59.06 4.48 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.43 HG13 ' H ' ' A' ' 29' ' ' ILE . 0.9 OUTLIER -100.09 157.82 33.15 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.549 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.494 ' HA ' ' CE1' ' A' ' 26' ' ' TYR . 2.8 Cg_exo . . . . . 0 N--CA 1.459 -0.541 0 C-N-CA 122.803 2.335 . . . . 0.0 112.18 -179.769 . . . . . . . . 1 1 . 1 stop_ save_